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Abstract
The central theme of this thesis is to investigate the use of non-parametric methods for making
inferences about a random sample with an unknown distribution function. The overarching aim
is the development of new methods to make inferences regarding the nature of the unknown dis-
tribution to enhance medical research. Initially, the focus is exclusively on the asymmetry of a
random variable. In particular, a recently proposed measure of asymmetry provides the founda-
tion for the proposal and development of a new test for symmetry. The potential applications of
the test and measure are applied to a number of medical research settings including randomised
trials. Moreover, guidance is provided on its implementation, with particular emphasis on the
problem of small sample estimation.
This investigation is then generalised to examine asymmetry across multiple studies. In par-
ticular, meta-analysis methods are used to synthesise information about the amount of asym-
metry in several studies. Further, a detailed simulation study is carried out to investigate the
impact of asymmetry on linear models and meta-analyses of randomised trials, in terms of the
accuracy of the treatment effect estimate and the coverage of confidence and prediction intervals.
Finally, the scope of the investigation is widened to encompass the problem of comparing
and synthesising information about the probability density function and cumulative distribution
function, based on samples from multiple studies. The meta-analysis of the smooth distribution
function estimate is then applied to propose new methods for conducting meta-analyses of
diagnostic test accuracy, which have a number of merits compared to the existing methodology.
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Chapter 1
Introduction
1.1 Overview of thesis
The central theme of this thesis is to investigate the use of non-parametric methods for making
inferences about a random sample with an unknown distribution function, with particular focus
on application to medical research settings. The overarching aim is the development of new
methods to make inferences regarding the nature of the unknown distribution, with particu-
lar emphasis on effectively measuring the asymmetry of the random variable and to test for
symmetry in these cases.
Distributional assumptions play a fundamental role in almost all statistical analyses. Indeed,
the primary aim of many statistical analyses is to draw conclusions (and quantify the uncertainty
of these conclusions) regarding the distribution of a random sample. This amounts to, at the
most fundamental level, determining the distribution function from which the random sample
is independently drawn. The classical approach is to narrow the investigation by assuming a
specific parametric form for this distribution function. Usually, this reduces the problem to
determining the mean and the variance of a specific family of distributions.
Likewise, symmetric random variables are important for the development and application
of statistical theory. In particular, symmetry is an important assumption for many statistical
models. For example, symmetry assumptions are essential in deriving many point or interval
estimations of location parameters. Furthermore, a wide range of statistical techniques, many
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of which have applications in medical statistics, rely on assumptions of normality and hence
symmetry. For example, linear regression models assume that residuals are normally distributed,
and assessing the symmetry of the residual distribution is an important precursor in assessing
the normality of the residuals. The problem of assumption validation is particularly pertinent
in medical statistics where model assumptions are often not validated in practice, or at the very
least not referred to in the literature when the results are presented.
As we have already mentioned, our principle focus is to investigate measuring the asymmetry
of the unknown distribution, and to test for symmetry. Recent research by Patil et al. [88] has
produced new measures of asymmetry, which have been shown to effectively quantify the amount
of asymmetry. We propose a new test based upon one such measure η̂. We derive the asymptotic
distribution of the test statistic and we analyse the performance of the proposed test through
the use of a simulation study.
We also show that the measure η̂ has a number of viable applications in medical statistics. For
example, we show that it is an effective tool for validation of model assumptions. Furthermore,
we show that η̂ can play a crucial role in identifying when to transform the data, what type of
transformation is likely to be effective, and evaluating whether the transformation has been a
success. η̂ can even be used as a summary statistic in randomised trials, alongside the mean
and variance to assess the baseline similarities of treatment and control groups.
The problem of small sample estimation of η is also identified and addressed, by discussing
a new procedure for making inferences about η, which has a number of advantages when there
are only a small number of observations. Both methods are applied to the more general problem
of assessing the asymmetry in multiple trials. This methodology has a number of genuine ap-
plications in medical research, principally, allowing the comparison and synthesis of information
about the distribution of multiple (possibly heterogeneous) samples from a single population.
We conclude our investigation of asymmetry with an extensive analysis of how ignoring the
presence of asymmetry impacts the accuracy of the inferences drawn from a number of statistical
models, and to what extent they are robust to departures from symmetry.
Finally, we move away from the investigation of the asymmetry of an unknown distribution
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and consider, more generally, a method for synthesising information about the distribution as a
whole. That is, we widen the scope of our investigation to encompass the problem of comparing
and synthesising information about the probability density function and cumulative distribution
function, based on several samples from heterogeneous (but similar) populations.
We proceed in section 1.2 with a thorough introduction of the concepts of symmetry, asymme-
try and skewness in the context of random variables. In particular, we clearly define symmetric
random variables and discuss some of their elementary properties. In section 1.3 we introduce
a few examples of statistical tests and models, which rely on the assumption of symmetry or
normality to draw effective inferences. In section 1.4 we introduce a variety of non-parametric
methods, which are used to analyse the distribution of a random sample in a more general sense.
In section 1.5 we summarise the aims of the thesis and in section 1.6 we provide an outline of
the remaining chapters.
1.2 Symmetry, asymmetry and skewness
1.2.1 Symmetry
The concept of symmetry has existed in a wide variety of contexts in both science and art
for thousands of years. Indeed, it is often considered the pinnacle of aesthetics in art and
architecture. Furthermore, it is fundamental in understanding the structure of macroscopic
and microscopic bodies in biology and chemistry. Serfling [110] gives a wonderful description
of symmetry, drawing on its revered properties as a ‘principle of order’ and ‘an abstraction of
balance, harmony and perfection.’
The idea of symmetry in a single univariate random variable is very well understood. First,
we provide the definition of a symmetric random variable given by Hershkorn and Chapman
[52] and then discuss some of the elementary properties of symmetric random variables. Unless
otherwise stated, all random variables X are assumed to be continuous.
Definition 1.1 A random variable X with cumulative distribution function F is said to be
3
symmetric, if there exists a real number θ such that
F (θ − x) = 1− F (θ + x) ∀x ∈ R.
If the probability density function f exists then Lemma 1.2 establishes an equivalent definition
of symmetry.
Lemma 1.2 If X is a symmetric, absolutely continuous random variable X with continuous
density f and centre of symmetry θ, then
f (θ − x) = f(θ + x) ∀x ∈ R.
Proof. By Definition 1.1,
F (θ − x) = 1− F (θ + x) ∀x ∈ R.
Then, via differentiation with respect to x,
f (θ − x) = f(θ + x) ∀x ∈ R. 
Examples of symmetric random variables include the Normal and Cauchy distribution, shown
in Figure 1.1. We shall now state and prove some of the elementary properties of symmetric
random variables, beginning with the following theorem.
Theorem 1.3 Let X be a symmetric random variable with distribution function F . Then the
centre of symmetry θ is the median of the random variable X.
Proof. Because the random variable X is symmetric we have F (θ − x) = 1−F (θ+ x) ∀x ∈ R.
Then, by setting x = 0 we obtain
F (θ) = 1− F (θ)⇒ F (θ) = 1
2
.
Hence, θ is the median. 
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Figure 1.1: The density functions of the symmetric Normal and Cauchy random variables.
Theorem 1.4 Let X be a symmetric random variable with density function f . Then, providing
the mean E[X] exists, the centre of symmetry θ is also equal to the mean.
Proof. Without loss of generality take θ = 0, as we can always define a random variable Y =
X − θ so that the centre of symmetry is equal to zero. First, observe that
E[X] =
∫ ∞
−∞
xf(x)dx =
∫ 0
−∞
xf(x)dx+
∫ ∞
0
xf(x)dx
Now we apply the transformation y = −x to the left integral to obtain
E[X] =
∫ 0
∞
(−y)f(−y)(−dy) +
∫ ∞
0
xf(x)dx.
We can now apply the hypothesis of symmetry f(−x) = f(x) for all x. Doing so, we obtain
E[X] =
∫ 0
∞
xf(x)dx+
∫ ∞
0
xf(x)dx = −
∫ ∞
0
xf(x)dx+
∫ ∞
0
xf(x)dx = 0.
Hence, in general E[X] = θ. 
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1.2.2 Asymmetry
Whilst the idea of symmetry is very easily understood, quantifying the absence of symmetry is
a more subtle problem. It is trivial to define an asymmetric random variable as one which does
not fulfil Definition 1.1. Some examples of asymmetric random variables are the Log-Normal,
Folded Normal and Exponential random variables, which can be seen in Figure 1.2.
0 1 2 3 4
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Figure 1.2: The density functions of the asymmetric Log-Normal, Folded Normal and Exponen-
tial random variables.
However, intuitively it is believed that asymmetry is something that can be measured. When
presented with two similar density curves, it is usually possible to provide some rationale on
why one is more or less asymmetric than the other density curve. However, it is difficult to find
a mathematical expression to calibrate or quantify the amount of asymmetry.
MacGillivray [76] actually proposes an asymmetry measure by modifying an existing measure
for skewness, a property which we discuss in more detail in section 1.2.3. The quantile measure
of skewness for a continuous random variable, with distribution function F and median θ, is
given by
γ(u;F ) =
F−1(1− u) + F−1(u)− 2θ
F−1(1− u)− F−1(u) .
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MacGillivray [76] proposes the following adaptation to the measure so that
Γ (F ) = sup
α≤u≤ 1
2
γ(u;F ),
for some α > 0 provides a suitable measure of asymmetry. MacGillivray shows that Γ maintains
a reasonable ordering with respect to asymmetry, and that Γ can be interpreted as the “minimum
standardised difference between F and a symmetric distribution about θ”. However, a drawback
to this measure is that the parameter α means that α × 100% of the probability mass at each
tail is not included in the measure. Since the tails obviously play a crucial role in identifying
and quantifying asymmetry this is a significant shortcoming.
More recently, Boshnakov [11] proposed an interesting alternative for measuring the asymme-
try of unimodal density functions. For a given unimodal density function f , Boshnakov defines
lincr and ldecr as the length of the regions where f is increasing and deceasing respectively. Also
by letting l = lincr + ldecr, it is readily verified that for a symmetric density we have
lincr
l
=
ldecr
l
=
1
2
.
Boshnakov [11] provides several contenders for a coefficient (or index) of asymmetry. These are
given by
r+ = E
[
ldecr
l
]
,
r− = E
[
lincr
l
]
,
and
ra = r+ − r−.
It is clear that for symmetric densities that r+ = r− = 12 and ra = 0. Boshnakov [11] com-
ments that the above measures provide a useful indication of the amount of asymmetry present.
However, the condition that f must be a unimodal density is a very restricting one.
Li and Morris [73] provide a simpler and more intuitive measure, provided the density func-
7
tion f exists. For a density function f with mean µ, Li and Morris propose
s1(f) =
∫ ∞
−∞
|f(µ+ x)− f(µ− x)|dx,
as a measure for asymmetry. Clearly 0 ≤ s1 ≤ 2 for all f and s1 = 0 if and only if f is symmetric.
There are other measures that one can propose using the current tests of symmetry. Whilst
these have not been formally proposed as measures of asymmetry, due to their use in tests of
symmetry, one expects that they should at least capture departure from symmetry. For example
for a distribution function F , Boos [10] uses the sample version of
s2(F ) =
∫ ∞
−∞
(F (θ + x) + F (θ − x)− 1)2dx,
where θ is the median, to define a test for symmetry. Alternatively Rothman and Woodroofe
[105] use the sample version of
s3(F ) =
∫ ∞
−∞
(F (θ + x) + F (θ − x)− 1)2dF (x),
to test for symmetry. Note that these measures are zero for symmetric densities and are positive
for asymmetric density functions.
1.2.3 Skewness
Due to the difficultly involved in quantifying asymmetry, very often skewness is used to make
inferences about the symmetry of random variables. Indeed, these two concepts are very closely
related, primarily because skewness is zero for a symmetric density. Furthermore, the direction
of the skew provides an indication of the direction of asymmetry. Therefore, the use of skewness
is valid upto a certain point. Since one of the themes of this thesis is borne out of the fact
that skewness and symmetry are different concepts, it is pertinent that we define skewness and
compare it with asymmetry.
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Pearson [91] first proposed measuring skewness using
γ1 =
µ−M
σ
,
for a univariate random variable with mean µ, mode M and variance σ2. Two other measures
of skewness (also attributed to Pearson) are given by
γ2 =
µ− θ
σ
,
and
γ3 =
µ3
σ3
,
where θ is the median and µ3 is the third central moment,
µ3 = E
[
(X − µ)3] .
Another common measure of skewness, proposed by David and Johnson [22], is the quantile
measure which we introduced in the previous subsection,
γ(u;F ) =
F−1(1− u) + F−1(u)− 2θ
F−1(1− u)− F−1(u) .
Alternatively, van Zwet [122] takes a different approach and formalises the concept of skewness
by proposing the following ordering of random variables based on skewness.
Definition 1.5 Let F and G be two distribution functions, and let f and g be their respective
density functions. Then g is more skewed to the right than f if and only if G−1(F ) is convex
on the support of F . In van Zwet’s notation this is denoted by F <
c
G.
From here, van Zwet is able to show that the operator <
c
can be used to order probability
distributions based on the amount of skewness present. Our interest is to order probability dis-
tributions according to their size of asymmetry and it is reasonable to expect this to be different
from the ordering based upon skewness. Indeed, there is a problem with simply substituting
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asymmetry for skewness as, whilst they are similar, they are not equivalent properties. Indeed,
the measures of skewness are designed to highlight the tail behaviour of density functions. This
can lead to discrepancy between skewness and asymmetry. For example, consider the following
density functions
f(x) =
 exp(−x) if 0 < x <∞0 otherwise,
and
g(x) =
 (α− 1)(x+ 1)
−α if 0 < x <∞
0 otherwise.
Here α is a real parameter greater than one. First, note that their respective distribution
functions are given by
F (x) =
 1− exp(−x) if 0 < x <∞0 otherwise,
and
G(x) =
 1− (x+ 1)
−α+1 if 0 < x <∞
0 otherwise.
Then using van Zwet’s definition of skewness (Definition 1.5) we see that
G−1(F (x)) = exp
(
x
α− 1
)
− 1,
on the interval 0 < x <∞. This is clearly a convex function on the support of F and, therefore,
in van Zwet’s notation we have that F <
c
G. That is, g is more skewed to the right than f . This
is to be expected, as g has a heavier right-hand tail than f . However, from Figure 1.3 it is clear
that the probability mass is more evenly spread under g, suggesting that g is less asymmetric
than f . Hence, skewness cannot always be considered a reliable substitute for asymmetry.
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Figure 1.3: Plots of the density functions f and g with α = 2.
1.2.4 Testing for symmetry
The null hypothesis of a test for symmetry, in the case where the probability density function f
exists, is
H0 : f(θ − x) = f(θ + x) ∀x ∈ R.
There are several approaches to test the above hypothesis, and these tests can be separated
into two approaches. They either apply direct use of the definition for symmetry (Definition
1.1 or 1.2) or involve exploiting the relationship between asymmetry and skewness. Most im-
portantly, however, these test statistics are constructed such that they capture the departure
from symmetry, and not the size of asymmetry, if the alternative is true. As a result, as the
amount of asymmetry increases, these tests do not necessarily exhibit an increase in power. A
key aim of the thesis is to demonstrate and address this issue, and we return to this subject in
Chapter 2. In the next section we discuss a couple of commonly used statistical methods which
rely, either implicitly or explicitly, on the assumption of symmetry.
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1.3 Symmetry and other distributional assumptions in statisti-
cal tests and models
There are a vast array of statistical methods which rely on the assumption of asymmetry, either
explicitly or implicitly. For example, the one sample Wilcoxon signed-rank test for the location
of the median relies on the assumption that the data are drawn from a symmetric population.
Often the assumption of symmetry is less explicit. For example, many other commonly used
statistical models rely on assumptions of normality, which implicitly assumes that the data are
symmetric.
1.3.1 Wilcoxon signed-rank test
The one sample Wilcoxon signed-rank test can be thought of as the non-parametric equivalent
of Student’s t-test [128]. For a single sample X1, · · · , Xn, it tests the null hypothesis that the
median θ is equal to some known value θ0. That is, it tests
H0 : θ = θ0,
using the test statistic,
W =
∣∣∣∣∣
n∑
i=1
sign (Xi − θ0)Ri
∣∣∣∣∣ , (1.6)
where Ri is the rank of |Xi − θ0| . The test does not assume a specific probability distribution
for the data, however, it does assume that,
1. The data are independently sampled from the same distribution.
2. The data are measured on an ordinal scale.
3. The distribution is symmetric about the median θ.
This test is not at all robust to departures from symmetry and will provide misleading results
when asymmetry is present in the data [123]. Indeed, it is often posed as a test for symmetry
about a median θ, something we shall elaborate on later in Chapter 2 when we discuss tests for
symmetry in more detail.
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1.3.2 Linear models
Now consider the following simple linear model applied to two groups of data,
Yj = β0 + β1Xj + ej , j = 1, · · · , n,
where Yj is some continuous response and Xj is a group identifier and can be equal to 0 or 1.
For example, in a clinical trial setting Xj = 0 could represent a placebo, while Xj = 1 could
represent a new treatment. It is assumed that
1. The residuals ej are normally distributed.
2. The variances are homogeneous in both groups.
3. The errors are independent.
It is often stated that linear models are robust to small departures from normality [82]. As a
result, the inferences that one makes with the model should not be too badly biased by the
existence of some slight skewness. However, for more serious departures from normality (e.g.
heavily skewed data) the usual inferences that one draws from the model (e.g. treatment effect
estimates or confidence intervals) might be more seriously compromised.
In the next section we introduce several commonly used non-parametric methods which are
utilised to analyse the distribution of a random variable from an unknown population.
1.4 Non-parametric methods for analysing the distribution of
data
The primary aim of many statistical analyses is to draw conclusions (and quantify the uncertainty
of these conclusions) regarding the distribution of a random sample. This amounts to, at the
most fundamental level, determining the distribution function from which the random sample is
independently drawn. The classical approach narrows the investigation by a considerable degree
by assuming a specific parametric form for this distribution function. Usually, this reduces
the problem to determining the mean and the variance of a specific family of distributions.
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Typically this distribution is chosen to be the Normal distribution, which is commonly the most
mathematically tractable route.
The principle weakness of the parametric approach is that the results are sensitive to the
parametric assumption, and misspecification of the parametric distribution can lead to erroneous
conclusions. One way to alleviate this problem is to adopt more flexible parametric models, for
example, those which include additional parameters that allow for skewness or additional weight
in the tails of the distribution [18].
An alternative approach is to adopt so called non-parametric approaches, which don’t assume
a specific functional form for the distribution or density function. These methods are particularly
useful when there are no clear theoretical grounds for assuming a single parametric form. The
key difference with non-parametric methods is that it allows the data to ‘speak for itself’ without
restrictive assumptions about the shape of the underlying distribution of density function.
For example, let X1, · · · , Xn be a random sample from a random variable with distribution
function F and probability density function f . Then the empirical distribution function,
Fn(x) =
1
n
n∑
i=1
I[Xi < x],
is a truly non-parametric estimate of the distribution function F (x). Fn(x) is an extremely
efficient point estimate of F (x), however, one could argue that Fn(x) is not a very good estimate
of the curve F (x). Indeed, the resultant curve is an increasing step function with change points
at the points Xi. It could be reasoned, therefore, that Fn(x) is guilty of excessively pandering
to the data. This may lead to over-fitting to chance data points.
One way to avoid this problem is to apply a smoothing method. A smoothing method utilises
all the available information in the neighbourhood of the point x to generate an estimate of the
function. This process commonly reduces the uncertainty in the estimate at x, at the cost of
introducing a certain amount of bias. It also allows the generation of smooth curves over a range
of values. For example, consider the kernel density estimate of f ,
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f̂(x) =
1
nh
n∑
i=1
K
(
Xi − x
h
)
,
where K is a kernel density and h is the bandwidth. The bandwidth defines the width of the
bin about x, within which the data Xi can influence the estimate of f(x). As a consequence the
bandwidth h directly controls the degree of smoothing.
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Figure 1.4: Kernel density estimates of a standard Normal sample of size n = 50 for a range of
bandwidths h, compared with the true density curve.
Non-parametric kernel density estimates were first pioneered by Rosenblatt [104] and Parzen
[87]. Under suitable smoothness conditions (including the existence of f ′′, the second derivative
of f) it is readily calculated that the bias of f̂(x) is
E
[
f̂(x)
]
− f(x) = 1
2
f ′′(x)h2
∫
R
x2K(u)du+O
(
h4
)
,
and the variance is
Var
[
f̂(x)
]
=
f(x)
nh
∫
R
K2(u)du+ o
(
1
nh
)
.
Hence, it is clear that as h increases the variance is reduced by the order 1h , but the bias increases
quadratically. Thus, h is a smoothing parameter that directly controls the trade off between
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bias and variance. This is exhibited in Figure 1.4, which shows the kernel density estimates
of a Normal sample of size n = 50 using a Normal kernel K and a range of bandwidths h. It
is apparent that the bandwidth h = 2 is too large and results in an ‘over-smoothed’ density
estimate f̂ with has low variance but excessive bias. By contrast, the kernel density estimate
with bandwidth h = 0.1 is ‘under-smoothed’ and is overly sensitive to stochastic variability in
the sample. In other words, in this case the density estimate has reduced the bias, but at the cost
of excessive variance in the estimate. Finally, it is clear from the figure that the density estimate
using the bandwidth h = 0.42 provides a good approximation to the true density function and
adequately balances the bias and variance.
The mean integrated square error (MISE) summarises the bias and variance in a single
measure and is given by
MISE
(
f̂(x)
)
=
1
nh
∫
R
K2(u)du+
1
4
h4
(∫
R
u2K(u)dx
)2(∫
R
(
f ′′(x)
)2
dx
)2
+ o
(
h4
)
+ o
(
1
nh
)
.
The optimal bandwidth, that minimises the asymptotic MISE, is
hopt =
(∫
RK
2(u)du
) 1
5(∫
R u
2K(u)du
) 2
5
(∫
R (f
′′(x))2 dx
) 1
5
n
1
5
.
Of course, this optimal bandwidth cannot be used in practice, as it depends on the unknown
density f via its second derivative f ′′. As a result, there are a number of data based procedures
to select the bandwidth h. The simplest procedure, suggested by Silverman [114], is to use the
bandwidth which is optimal for Gaussian f and K,
h∗opt =
(
4σ̂5
3n
) 1
5
,
where σ̂ is the standard deviation of the sample. This is precisely the method used to obtain
the optimal bandwidth h = 0.42 in Figure 1.4, and it provides a good estimate of the optimal
bandwidth when the assumptions of Normal f and K hold. Alternative methods, which are more
robust to violations of this assumption, include the plug-in method [111] and cross validation
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[46].
Epanechnikov [32] demonstrated that the optimal kernel K, in terms of mean square error,
is given by
Kopt(u) =
3
4
(1− u2)I [−1 ≤ u < 1] .
However, it is also shown by Wand and Jones [124] that the efficiency of more conventional
kernels, such as the Normal and uniform densities, remains relatively close to the Epanechnikov
kernel.
The distribution function F (x) can also be estimated using the smooth estimate,
F̂ (x) =
∫ x
−∞
f̂(u)du
=
∫ x
−∞
1
nh
n∑
i=1
K
(
u−Xi
h
)
du
=
1
nh
n∑
i=1
∫ x
−∞
K
(
u−Xi
h
)
du
=
1
n
n∑
i=1
∫ x−Xi
h
−∞
K (v) dv
=
1
n
n∑
i=1
K
(
x−Xi
h
)
,
where K(x) =
∫ x
−∞K(u)du is a cumulative distribution kernel function.
In this thesis we will focus predominantly on kernel density estimation, however, there are
a variety of other non-parametric methods for estimating a density function. For example, one
can use wavelet estimation [26], spline smoothing [42], or local polynomial smoothing [106].
1.5 Aims of the thesis
The overarching aim of this thesis is to investigate new methods for making inferences about the
nature of an unknown distribution based on a random sample, with particular attention paid to
applications in medical research. More specifically, the aims are outlined as follows.
• Develop a new test for symmetry based on a recently proposed measure of asymmetry,
which improves upon the existing methods.
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• Explore this measure of asymmetry in a number of applications relating to the analysis of
randomised control trials.
• Modify the measure of asymmetry to improve upon its small sample properties.
• Extend this approach to measure asymmetry in several studies investigating the same
population, by developing a formal meta-analysis model for the asymmetry measure.
• Determine the impact of ignoring departures from symmetry on the inferences drawn from
statistical models, with special attention paid to prediction intervals that are derived from
meta-analyses.
• Expand the investigation further to consider a meta-analysis of a non-parametric estimate
of the density or distribution function.
• Develop new methods for conducting meta-analyses of diagnostic test accuracy studies,
which have a number of desirable features compared to the existing methodology.
1.6 Outline of the upcoming chapters in this thesis
In Chapter 2 we introduce and discuss some of the commonly used tests for symmetry. Through
the use of a simulation study we identify that the existing tests do not have power which
accurately reflects the magnitude of asymmetry in the sample. As a result, we propose a new
test based on a recently proposed measure of asymmetry η̂, which has been shown to effectively
capture the amount of asymmetry. We derive the asymptotic properties of this new test statistic
and compare the power of the new test with the existing methods.
In Chapter 3 we discuss the potential applications of the new test, with a particular emphasis
on informing the analysis of randomised trials in medical research. Moreover, with the help of
a large data set consisting of multiple randomised control trials investigating hypertension, we
also show that the measure η̂ is an effective summary statistic. Indeed, η̂ can be used for making
inferences such as assessing baseline imbalance in clinical trials and checking for asymmetry in
linear model residuals. Furthermore, η̂ can be a useful aid in preconditioning data. That is, it
can be used to objectively determine whether asymmetry within data is sufficient to require a
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normalising transform, inform what sort of transformation is likely to be effective, and provide
an objective measure of whether the transformation has been a success.
In Chapter 4 we demonstrate that it is not appropriate to assume a Normal distribution
for η̂ for small samples, before proposing a new estimation procedure which is more robust to
small samples. Furthermore, we derive the asymptotic distribution of this new measure and
demonstrate that this distribution is more robust to small samples. We also introduce and
discuss the bootstrap, to assist in the calculation of the standard error of the new measure
and thereby allow us to construct accurate confidence intervals. We also appraise the new
methodology using a simulation study and a couple of real data examples.
In Chapter 5 we investigate measuring asymmetry in data across several studies with the aim
of obtaining an ‘overall’ measure of asymmetry in the underlying population. In particular, we
explore the potential pitfalls of naively pooling data across all studies (and ignoring the original
clustering), before proposing a more formal meta-analysis model to summarise the asymmetry
in a robust fashion.
In Chapter 6 we carry out a simulation study to assess what effect, if any, the presence
of skewed data has on a number of common statistical models. In particular, we discuss the
potential pitfalls of ignoring violations of symmetry or normality assumptions.
In Chapter 7 we generalise the methods of Chapter 5 to allow for the synthesis of information
about the entire density or distribution function of several studies. We also provide a detailed
demonstration of one potential application of this method, namely, conducting meta-analyses of
diagnostic test accuracy studies. In particular, we propose a novel method that has a number
of desirable properties when compared to the existing methodology in this area.
In Chapter 8 we present the conclusions of this thesis, and discuss the areas for future work.
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Chapter 2
η - A measure of asymmetry and a
new test of symmetry
2.1 Introduction
As we have previously discussed, symmetric random variables are important for the development
and application of statistical theory. In particular, symmetry is an important assumption for
many statistical models. For example, symmetry assumptions are often essential to the deriva-
tion of point or interval estimates of location parameters. In non-parametric statistics such as
the Wilcoxon signed-rank test, given in equation (1.6) in the previous chapter, it is fundamental
to assume that the data are drawn from a symmetric population [128]. In the latter case one
should investigate whether that the data are indeed symmetric, before proceeding with the test.
Furthermore, a wide range of statistical techniques rely on the assumption of symmetry implic-
itly, through the assumption of normality. For example, linear regression models assume that
residuals are normally distributed. Assessing the symmetry of the residual distribution is an
important precursor in assessing the normality of the residuals. As a result, there are a wealth
of options for the statistician wishing to conduct tests of symmetry on a set of data and we
discuss some of these in section 2.2.
In this chapter we examine the power of several existing tests of symmetry and, in doing
so, motivate the development of a new test. In section 2.2 we carry out a simulation study to
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examine the power of the existing tests of symmetry. In section 2.3 we introduce a recently
proposed measure of asymmetry η, which has been shown to adequately quantify the amount
of asymmetry [88]. Using this new measure we construct a new test, which aims to improve on
the power of the existing tests. We discuss the asymptotic properties of the new test statistic
and finally, we carry out a simulation study and compare the power of the new test with the
existing tests. In section 2.4 we provide a short worked example of how the test can be applied
to test for symmetry in a real data set. In section 2.5 we provide some concluding remarks on
the measure η and the new test.
Aims of the chapter:
• Examine the power of existing tests for symmetry.
• Propose and develop a new test for symmetry Tn.
• Compare the performance of Tn with existing tests.
2.2 Testing symmetry
2.2.1 Introduction
In this section we carry out a simulation study on several existing tests of symmetry, namely,
the tests proposed by Cabilio and Masaro [17], Antille et al. [3], Randles et al. [95], Gupta [43],
and McWilliams [81]. We study the power of these tests using simulated data from a number
of different distributions with varying degrees of asymmetry. For example, Figure 2.1 shows
the density functions of some of these random variables, namely, the Normal, Cauchy, Normal
mixtures, Log-Normal, Folded Normal, and Exponential distributions. The Normal mixtures
are constructed using
pN(0, 1) + (1− p)N(2, 2),
for p = 0.945, 0.872, 0.773, and 0.606.
It is clear from the figure that the Normal and Cauchy densities are symmetric about zero,
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Figure 2.1: The left plot shows the symmetric Normal and Cauchy density curves. The middle
plot shows the density curves of Normal mixtures of the form pN(0, 1) + (1 − p)N(2, 2), for
0 < p < 1. The rightmost plot shows the three ‘highly’ asymmetric densities which, in order of
increasing asymmetry, are Log-Normal, Folded Normal and Exponential.
whilst the other density functions are clearly asymmetric. However, we are entitled to ask, ‘which
of these asymmetric densities is the most asymmetric?’ In this case, it is possible to obtain a
visual impression of the size of asymmetry present in the random variables. For example consider
the middle plot in Figure 2.1, which shows four Normal mixture densities. As p decreases the
N(2, 2) population has more of an effect on the mixture density and the curve is skewed to
the right. It is clear that as p decreases from 1 towards 0.5, the resultant density becomes
more asymmetric. Note how, in the rightmost plot containing the most extreme cases, the Log-
Normal density is even further skewed to the right and as a result, it is reasonable to say that
it is even more asymmetric than the Normal mixtures. Further, the Folded Normal and the
Exponential density represent an even more extreme example of asymmetry as they have no left
tail whatsoever. Observe that the Folded Normal curve has a ‘more even spread’ of probability
mass compared to the exponential curve, hence one can reason that a Folded Normal random
variable is not as asymmetric as an Exponential random variable.
Thus, for the random variables given above we can arrive at the following ordering of asym-
metry, based on visual interpretation.
Normal <a Normal mixtures <a Log-Normal <a Folded Normal <a Exponential,
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where the binary operator <a represents the sentence “appears to be less asymmetric than”. An
‘ideal’ test statistic would have power which reflects this increasing departure from symmetry.
2.2.2 Existing tests for symmetry
Consider a random sample X1, · · · , Xn identically drawn from a probability distribution. Then,
Cabilio and Masaro [17] propose a test based on sample skewness,
S1 =
√
n
x− θ˜
s
,
where x and θ˜ are the sample mean and sample median respectively and s is the sample stan-
dard deviation. The simple rationale behind this statistic is the necessary condition that for
a symmetric continuous population the mean is equal to the median. Thus, significantly large
values of |S1| are indicative of departure from symmetry. The main focus of S1 is detecting
departure from symmetry and and not the quantification of asymmetry.
Another test is suggested by Antille et al. [3], who define the following test statistic based
on ranks,
R(α) = 1√
n
n∑
i=1
Gα
R
(
|Xi − θ˜|
)
2(n+ 1)
 sign(Xi − θ˜) ,
where Gα(x) = min(x,
1
2 − α) and R(Xi) is defined as the rank of Xi among the Xis. Antille
et al. [3] propose a test based on R(α), and determine the asymptotic properties of the test
statistic. For simplicity we only consider α = 0 and denote S2 = R(0). For symmetric random
variables one expects that the distances
∣∣∣Xi − θ˜∣∣∣ should be of a similar magnitude on both sides
of the median. In this case, one also expects the ranks R
(
|Xi − θ˜|
)
to be evenly distributed on
both sides of θ. Thus, under the null hypothesis of symmetry S2 is very close to zero and hence
one rejects the null for large values of |S2|.
Alternatively, Randles et al. [95] define the following ‘triples’ test,
S3 =
1
3
(
n
3
)−1 ∑
i<j<k
[
sign(Xi +Xj − 2Xk) + sign(Xi +Xk − 2Xj) + sign(Xj +Xk − 2Xi)
]
.
A triple of observations (Xi, Xj , Xk) is defined as a right triple if the middle observation is closer
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to the smallest observation than it is to the largest observation, and vice-versa for a left triple.
Thus, defined in this way, S3 is a constant multiple of the difference between the proportion of
right and left triples. As a result, E[S3] = 0 when the underlying distribution is symmetric.
Suggesting that the class of asymmetric distributions for which E[S3] = 0 is small, Randles et al.
[95] use S3 to test for symmetry.
Gupta [43] details the classical test of skewness based on
S4 =
1
n
∑n
i=1(Xi −X)3(
1
n−1
∑n
i=1(Xi −X)2
) 3
2
.
Again, as with S1 the rationale behind this test statistic is that a symmetric population has
zero skewness. Indeed, the theoretical analogue of S4 is precisely Pearson’s skewness measure
γ3 introduced in Chapter 1. Thus, significantly large values of |S4| are indicative of departure
from symmetry. However, as with the other test statistics discussed here the main focus of this
test statistic is to identify departure from symmetry and and not to quantify the asymmetry.
Finally, we consider the test proposed by McWilliams [81], based on a runs statistic. Suppose
now thatX1, X2, · · · , Xn, denote a random sample with median 0. Further, letX(1), X(2), · · · , X(n)
denote the sample values ordered from smallest to largest according to their absolute value, but
retaining their sign, and let ∆i indicate the sign of X(i), i = 1, 2, · · · , n, by way of defining
∆i = 1 when X(i) > 0 and zero otherwise. Then define
S5 = 1 + I2 + I3 + · · ·+ In,
where
Ik =
 0 if ∆k = ∆k−11 if ∆k 6= ∆k−1 , k = 2, · · · , n
which counts the number of runs in the sequence {∆i}. For symmetric random variables the
probability of two successive observations X(k−1) and Xk having the same sign is equal to 12 .
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Hence, under the null hypothesis of symmetry, S5−1 has a binomial distribution with parameters
n− 1 and 12 . By contrast, for asymmetric distributions one may be more likely to obtain a run
of successive observations with the same sign. This results in a larger number of the Ik being
equal to zero and, thus, one rejects the null hypothesis if S5 falls in the lower tail of the null
distribution.
With the exception of S5 all of the test statistics discussed here are asymptotically normally
distributed. For further details regarding the sampling distributions of S1, · · · , S5 refer to Table
2.3 in the next section. In the next subsection we conduct a simulation study to assess the power
of the tests discussed here.
2.2.3 Simulation study
Aims and methods
We now approximate the power (i.e. calculate the empirical power) of the tests proposed by
Cabilio and Masaro [17], Antille et al. [3], Randles et al. [95], Gupta [43] and McWilliams
[81] for a range of different distributions. In particular, we consider the symmetric Normal
distribution; the Normal mixtures; as well as the the extreme Log-Normal, Folded Normal and
Exponential distributions. We also supplement these random variables with the symmetric
Cauchy distribution, as well as several other classes of asymmetric distributions, namely, the
Skew Normal distributions proposed by Azzalini [4]; the Sinh-arcsinh distribution proposed by
Jones and Pewsey [64]; and the skewed distributions introduced by Fernandez and Steel [33].
The Skew Normal distribution with parameter λ has density function
SN(z;λ) = 2φ(z)Φ(λz), −∞ < z <∞,
where φ and Φ are the standard Normal density and distribution functions respectively. When
λ = 0 this reduces to the symmetric standard Normal distribution. When λ > 0 the distribution
is skewed to the right and when λ < 0 the distribution is skewed to the left.
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The Sinh-arcsinh distribution has density function
SAS(z; ε, δ) =
1√
2pi
δCε,δ(z)√
1 + z2
exp
{
−1
2
S2ε,δ(z)
}
,
where
Cε,δ(x) = cosh
[
δ sinh−1(x)− ε] ,
and
Sε,δ(x) = sinh
[
δ sinh−1(x)− ε] .
Here ε ∈ R plays the role of a skewness parameter, while δ > 0 controls the weight of the tails.
The skewed Fernandez and Steel distribution has density function
FAS(z; γ) =
2
γ + 1γ
{
f
(
z
γ
)
I[z ≥ 0] + f (γz) I[z < 0]
}
,
for a unimodal density function f and some γ ∈ (0,∞). This distribution is symmetric when
γ = 1 and is asymmetric whenever γ 6= 1.
Figure 2.2 shows the probability density functions of the Skew Normal, Sinh-arcsinh and
Fernandez and Steel distributions for a range of the skewness parameters λ, ε and γ.
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Figure 2.2: The probability density functions of the Skew Normal, Sinh-arcsinh and Fernandez
and Steel distribution for a range of skewness parameters.
For the simulation study we consider the Skew Normal distributions with λ = 1.2135, 1.795,
2.429, 3.221, 4.310, 5.970, 8.890, 15.570 respectively; the Sinh-arcsinh distribution with δ = 1
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and ε = 0.1, 0.203, 0.311, 0.430, 0.565, 0.727, 0.939, 1.263; the Fernandez and Steel distribution
where f is the standard Normal probability density function and γ = 1.111, 1.238, 1.385, 1.564,
1.791, 2.098, 2.557, 3.388.
We simulate samples of varying sizes (n = 30, 50 and 70) from each of the probability models
using the statistical package R. We simulate each sample 10, 000 times and calculate the test
statistics each time to obtain a large sample from the sampling distributions of the test statistics.
In each sample the null hypothesis of symmetry is accepted or rejected at the level α = 0.05,
based on the value of these statistics. The critical value, at which to reject the null hypothesis of
symmetry, is determined from the asymptotic distribution of the test statistics, given in Table
2.3. Finally, the empirical powers (the proportion of rejections) of each of the tests are reported.
Table 2.1 outlines the simulation procedure.
We present the empirical powers of the test based on sample skewness S1 proposed by Cabilio
and Masaro [17]; the test based on ranks S2 suggested by Antille et al. [3]; the triples test S3
proposed by Randles et al. [95]; the classical test of skewness S4 presented by Gupta [43]; and
runs test S5 proposed by McWilliams [81]. Table 2.2 gives a brief summary of the test statistics.
Further details regarding the sampling distributions of S1, · · · , S5 are given in Table 2.3.
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Step 1 Simulate samples of size n = 30, 50 and 70 from each of the distributions.
Step 2 Calculate the test statistics S1, S2, S3, S4 and S5 based on these samples.
Step 3 If the test statistics fall inside the respective rejection region of the test
(see Table 2.3) then reject the null hypothesis of symmetry at the 5%
level.
Step 4 Repeat Steps 1-3 10, 000 times and report the proportion of rejections
(empirical power).
Table 2.1: Step by step guide to the simulation study for the existing tests of symmetry.
Reference Test statistic
Cabilio and Masaro [17] S1 =
√
n
x− θ˜
s
Antille et al. [3] S2 =
1√
n
n∑
i=1
G0
R
(
|Xi − θ˜|
)
2(n+ 1)
 sign(Xi − θ˜)
Randles et al. [95] S3 =
1
3
(
n
3
)−1 ∑
i<j<k
[
sign(Xi +Xj − 2Xk)
+ sign(Xi +Xk − 2Xj) + sign(Xj +Xk − 2Xi)
]
Gupta [43] S4 =
1
n
∑n
i=1(Xi −X)3(
1
n−1
∑n
i=1(Xi −X)2
) 3
2
McWilliams [81] S5 = 1 + I2 + I3 + · · ·+ In
Table 2.2: Summary of the existing tests for symmetry used in the simulation study.
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S1 S1
L−→ N(0, σ21),
where σ21 = 1 +
1
em,x(F )
− 2√
em,x(F )
E
∣∣∣∣X − µσ
∣∣∣∣ ,
and em,x(F ) = 4σ
2f2(0) .
S2 S2
L−→ N(0, σ22),
where σ22 =
1
48
+
1
4
(
A− 1
2
)
,
and A =
1
f(0)
∫ 1
0
f(F−1(u))du.
S3 S3
L−→ N(0, σ23),
where σ23 = n
(
n
3
)−1 3∑
c=1
(
3
c
)(
n− 3
3− c
)
Var [f∗c (X1, · · · , Xc)] ,
and f∗c (x1, · · · , xc) = E
[
f∗(x1, · · · , xc, Xc+1, · · ·X3)
]
, c = 1, 2, 3
and f∗(Xi, Xj , Xk) =
1
3
[
sign(Xi +Xj − 2Xk) + sign(Xi +Xk − 2Xj)
+sign(Xj +Xk − 2Xi)
]
.
S4 S4
L−→ N(0, σ24),
where σ24 =
y6 − 6y2y4 + 9y32
ny32
,
and yj = E
[
Xj
]
.
S5 S5 ∼ Bin
(
n− 1, 1
2
)
.
Table 2.3: Sampling distributions for the test statistics S1, · · · , S5 under the null hypothesis of
symmetry.
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Results
Let NM1, NM2, NM3, NM4 denote the Normal mixtures with p = 0.945, 0.872, 0.773, 0.606
respectively, and let SN1-SN8, denote the Skew Normal distribution with λ = 1.2135, 1.795,
2.429, 3.221, 4.310, 5.970, 8.890, 15.570 respectively. Let SAS1-SAS8 denote the Sinh-arcsinh
distribution with δ = 1 and ε = 0.1, 0.203, 0.311, 0.430, 0.565, 0.727, 0.939, 1.263 respectively.
Let FAS1-FAS8 denote the Fernandez and Steel distribution with γ = 1.111, 1.238, 1.385, 1.564,
1.791, 2.098, 2.557, 3.388 respectively. The empirical powers are shown in Table 2.4 and Table
2.5. The tables also include a column entitled η, which is a measure of the asymmetry in the
distribution, something we will define in detail in section 2.3.
In Table 2.5, observe that for S1 the test has nominal empirical power for the symmetric
Normal distribution, in keeping with the set level of 0.05. For n = 30 the empirical power is 0.036
rising to 0.04 for n = 70. As expected, the power steadily increases for the Normal mixtures
and Skew Normal distributions, however, the amount of power is not related to the amount
of asymmetry as determined by our previous ‘visual inspection’. For example, for n = 30 in
Table 2.4 the test S1 has power equal to 0.282 and 0.709 for the Folded Normal and Log-Normal
distributions respectively, although we understand the Folded Normal distribution to be the
more asymmetric distribution.
The performance of the test S2 is very similar to S1. For the symmetric distributions the
test has nominal power and this slowly increases for the Normal mixtures and Skew Normal
distributions. However, in the very asymmetric cases there is very little relation between the
power of the test and the amount of asymmetry in the distribution. For example, in Table 2.4
for n = 70, although the Log-Normal density is less asymmetric than Exponential density, the
power of S2 does not reflect this with values of 0.704 and 0.603 respectively. To reiterate, whilst
the test has good rejection levels for non-symmetric distributions, its power does not reflect the
size of asymmetry.
For the asymmetric distributions the test S3 does achieve very high empirical power. Also,
although it is not perfect, it does appear to capture the size of the asymmetry more accurately
than S1 and S2. However, the test does not appear to be a conservative. Indeed, the test has
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η Dist.
S1 S2 S3
n = 30 n = 50 n = 70 n = 30 n = 50 n = 70 n = 30 n = 50 n = 70
0 N 0.036 0.042 0.040 0.016 0.030 0.035 0.082 0.068 0.065
0 C 0.033 0.029 0.023 0.004 0.011 0.012 0.108 0.079 0.075
0.1 NM1 0.040 0.055 0.064 0.015 0.027 0.031 0.113 0.125 0.134
0.2 NM2 0.078 0.110 0.159 0.017 0.031 0.041 0.200 0.284 0.353
0.3 NM3 0.128 0.238 0.338 0.023 0.050 0.074 0.369 0.519 0.645
0.4 NM4 0.212 0.368 0.509 0.047 0.109 0.173 0.483 0.693 0.835
0.1 SN1 0.043 0.046 0.052 0.018 0.032 0.036 0.100 0.100 0.106
0.2 SN2 0.062 0.075 0.100 0.026 0.039 0.058 0.152 0.186 0.229
0.3 SN3 0.086 0.135 0.185 0.031 0.062 0.092 0.224 0.327 0.427
0.4 SN4 0.130 0.209 0.286 0.042 0.087 0.139 0.332 0.494 0.638
0.5 SN5 0.184 0.295 0.394 0.066 0.133 0.198 0.438 0.629 0.770
0.6 SN6 0.224 0.353 0.471 0.082 0.165 0.243 0.524 0.734 0.867
0.7 SN7 0.251 0.393 0.523 0.097 0.190 0.275 0.588 0.790 0.903
0.8 SN8 0.267 0.407 0.548 0.106 0.207 0.306 0.617 0.826 0.932
0.1 SAS1 0.042 0.053 0.053 0.020 0.033 0.040 0.101 0.098 0.100
0.2 SAS2 0.057 0.084 0.097 0.023 0.047 0.059 0.149 0.178 0.216
0.3 SAS3 0.091 0.133 0.180 0.034 0.062 0.095 0.227 0.312 0.413
0.4 SAS4 0.141 0.226 0.310 0.050 0.100 0.151 0.332 0.487 0.627
0.5 SAS5 0.211 0.344 0.459 0.071 0.158 0.226 0.476 0.677 0.815
0.6 SAS6 0.292 0.471 0.615 0.097 0.215 0.322 0.615 0.826 0.923
0.7 SAS7 0.398 0.623 0.761 0.141 0.309 0.440 0.742 0.920 0.978
0.8 SAS8 0.516 0.732 0.863 0.198 0.394 0.562 0.843 0.967 0.995
0.1 FAS1 0.044 0.048 0.054 0.022 0.030 0.044 0.099 0.090 0.096
0.2 FAS2 0.056 0.079 0.099 0.024 0.051 0.064 0.141 0.173 0.207
0.3 FAS3 0.090 0.127 0.167 0.034 0.070 0.096 0.208 0.293 0.376
0.4 FAS4 0.120 0.185 0.244 0.046 0.092 0.129 0.292 0.432 0.552
0.5 FAS5 0.154 0.242 0.326 0.058 0.125 0.176 0.390 0.571 0.696
0.6 FAS6 0.191 0.305 0.399 0.074 0.150 0.221 0.472 0.662 0.814
0.7 FAS7 0.223 0.356 0.457 0.087 0.177 0.255 0.536 0.745 0.871
0.8 FAS8 0.245 0.387 0.511 0.099 0.196 0.281 0.590 0.799 0.908
0.91 LN 0.709 0.916 0.976 0.263 0.514 0.704 0.973 0.999 1.000
0.95 FN 0.282 0.426 0.552 0.114 0.213 0.309 0.633 0.837 0.936
1 EXP 0.610 0.841 0.940 0.217 0.450 0.603 0.917 0.992 0.999
Table 2.4: Empirical power of the tests based on S1, S2 and S3 for a variety of density functions
and sample sizes.
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η Dist.
S4 S5
n = 30 n = 50 n = 70 n = 30 n = 50 n = 70
0 N 0.027 0.034 0.041 0.016 0.030 0.031
0 C 0.024 0.013 0.009 0.014 0.025 0.029
0.1 NM1 0.033 0.045 0.061 0.015 0.030 0.037
0.2 NM2 0.088 0.160 0.244 0.017 0.046 0.051
0.3 NM3 0.187 0.354 0.523 0.027 0.061 0.085
0.4 NM4 0.275 0.499 0.669 0.042 0.100 0.137
0.1 SN1 0.039 0.052 0.068 0.017 0.030 0.035
0.2 SN2 0.058 0.102 0.159 0.020 0.035 0.045
0.3 SN3 0.098 0.198 0.307 0.026 0.048 0.065
0.4 SN4 0.146 0.298 0.467 0.036 0.076 0.103
0.5 SN5 0.198 0.407 0.603 0.052 0.116 0.149
0.6 SN6 0.247 0.500 0.693 0.074 0.152 0.217
0.7 SN7 0.284 0.553 0.750 0.092 0.194 0.289
0.8 SN8 0.305 0.593 0.779 0.122 0.255 0.367
0.1 SAS1 0.038 0.048 0.067 0.015 0.029 0.038
0.2 SAS2 0.054 0.099 0.143 0.019 0.033 0.042
0.3 SAS3 0.093 0.186 0.284 0.027 0.052 0.069
0.4 SAS4 0.154 0.310 0.467 0.036 0.077 0.100
0.5 SAS5 0.223 0.449 0.635 0.052 0.113 0.166
0.6 SAS6 0.304 0.571 0.761 0.080 0.180 0.262
0.7 SAS7 0.383 0.662 0.823 0.128 0.285 0.392
0.8 SAS8 0.446 0.722 0.844 0.204 0.432 0.591
0.1 FAS1 0.037 0.045 0.063 0.015 0.032 0.033
0.2 FAS2 0.057 0.095 0.144 0.018 0.039 0.046
0.3 FAS3 0.085 0.164 0.262 0.024 0.051 0.068
0.4 FAS4 0.131 0.270 0.422 0.037 0.071 0.092
0.5 FAS5 0.180 0.366 0.556 0.050 0.102 0.140
0.6 FAS6 0.226 0.466 0.659 0.061 0.142 0.196
0.7 FAS7 0.260 0.525 0.728 0.091 0.193 0.274
0.8 FAS8 0.294 0.576 0.770 0.114 0.250 0.355
0.91 LN 0.303 0.353 0.392 0.329 0.663 0.831
0.95 FN 0.321 0.609 0.792 0.138 0.314 0.454
1 EXP 0.409 0.587 0.677 0.306 0.629 0.808
Table 2.5: Empirical power of the tests based on S4 and S5 for a variety of density functions
and sample sizes.
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an estimated type-I error rate of 0.082 for a sample of size n = 30 from a Normal population
and 0.075 for a substantial sample of size n = 70 from a Cauchy distribution.
For the classical test of skewness S4 the test has nominal power for the symmetric distribu-
tions, although the test appears to be overly conservative for the Cauchy case. Again, for the
asymmetric distributions the test fails to capture the asymmetry present in the most asymmetric
distributions. For example, in Table 2.5 when n = 70 the test has empirical power 0.792 for
the Folded Normal distribution, but has much less power (0.677) to detect asymmetry for the
Exponential distribution.
As with the previous tests S5 achieves nominal empirical power for the symmetric Normal and
Cauchy distributions. There is also a steady increase in power through the asymmetric Normal
mixtures and Skew Normal distributions. Once again, however, the empirical power does not
perfectly reflect the size of asymmetry. For example, when n = 70 the test has empirical powers
of 0.831 and 0.454 for the Log-Normal and Folded Normal distributions.
Hence, we have demonstrated that the tests considered here all fail to generate power that is
representative of the quantity of asymmetry in the underlying distribution. In the next section
we investigate the effectiveness of several tests that are optimal for a certain class of asymmetric
distributions.
2.2.4 Other tests for symmetry
There are many other methodologies for testing symmetry and for further details on these
different methods refer to Hollander [56] and the references therein. For the tests that are under
investigation here, we demonstrated that the tests do not have power which is reflective of the size
of asymmetry. That is, while the tests have good rejection levels for non-symmetric distributions
their power does not increase as asymmetry increases. This is because the primary rationale for
the test statistics that are proposed in the literature to test for symmetry is to detect departure
from symmetry, rather than the quantification of asymmetry. It is not practical to demonstrate
this point, through simulations or otherwise, for all other tests of symmetry. However, based
on the discussion given in section 2 of Patil, Patil and Bagkavos [88] one can conclude that the
tests of symmetry proposed in Butler [16], Rothman and Woodroofe [105] and Boos [10] will
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also fail to have power, which is an increasing function of the amount of asymmetry. That is, it
is shown that the population versions of the test statistics do not effectively quantify asymmetry
in a certain class of distributions. The reason for this, as mentioned above, is that these test
statistics are also designed primarily to capture the departure from symmetry as opposed to the
dual purpose of capturing and quantifying the departure from symmetry. Recent research has
led to the development of new measures aimed at quantifying the size of asymmetry and the main
subject of the rest of this chapter is to explore the use of one such measure to test symmetry,
and investigate whether this new test has power which is superior to the tests discussed here.
2.3 Measuring asymmetry
2.3.1 A recently proposed measure of asymmetry
Intuitively it is believed that asymmetry is something that can be measured. When presented
with two similar density curves, most people are able to provide some rationale on why one is
more or less asymmetric than the other density curve (it was precisely this type of reasoning
that generated our <a orderings in the previous section.) Despite this, it is a challenge to find
a mathematical expression to effectively calibrate or quantify the amount of asymmetry.
Several measures of asymmetry have been proposed and we introduced some examples in
Chapter 1, however, we identified that each of these limits the class of density functions in
one way or another. For further details, see MacGillivray [76] and Boshnakov [11] and the
references therein. For a more general discussion on measuring asymmetry refer to Patil, Patil
and Bagkavos [88] (hereafter referred to as PPB). In PPB [88] their proposal is to measure
asymmetry using
η(X) =
 −Corr(f(X), F (X)) if 0 < Var(f(X)) <∞0 if Var(f(X)) = 0,
where X is a continuous random variable, with continuous function f as its probability density
function and F as its distribution function. Note that η is appropriately defined to avoid division
by zero when Var(f(X)) = 0, as is the case for the symmetric uniform distribution. PPB [88]
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show that this user-friendly measure effectively quantifies asymmetry in a number of different
distributions. The measure is based on the fact that, for a symmetric random variable X with
continuous probability density function f and cumulative distribution function F ,
Cov(f(X), F (X)) = 0.
We present the proof of this result below.
Theorem 2.1 If X is a symmetric random variable with probability density function f and
cumulative distribution function F then η(X) = 0.
Proof. It is sufficient to prove that Cov(f(X), F (X)) = 0, or that
E[f(X)F (X)] = E[f(X)]E[F (X)].
Now, since F (X) ∼ U(0, 1),
E[F (X)] =
1
2
.
Once again, we take the centre of symmetry to be zero without loss of generality. Because X
is a symmetric random variable we have F (−x) = 1− F (x) and f(x) = f(−x) for all x. Using
these identities gives
E[f(X)F (X)] =
∫ ∞
−∞
F (x)f2(x)dx
=
∫ 0
−∞
F (x)f2(x)dx+
∫ ∞
0
F (x)f2(x)dx
=
∫ ∞
0
F (−y)f2(−y)dy +
∫ ∞
0
F (x)f2(x)dx
=
∫ ∞
0
[1− F (y)]f2(y)dy +
∫ ∞
0
F (x)f2(x)dx
=
∫ ∞
0
f2(x)dx
=
1
2
∫ ∞
−∞
f2(x)dx
= E[f(X)]E[F (X)].
35
Hence, for a symmetric random variable X we have η(X) = 0. 
Table 2.6 gives some examples of the measure η applied to some commonly encountered
distributions, including some of the distributions discussed earlier in the chapter. In particular,
the table gives the value of η for the Normal, Uniform, t, Log-Normal, Folded Normal and
Exponential distributions. Firstly, observe that η = 0 for the symmetric distributions. Second,
the amount of asymmetry in the Folded Normal and Exponential distributions is independent
of the location and scale parameters that are used. On the other hand, for the Log-Normal
distribution (which is a transformation of the Normal (µ, σ2) random variable), both parameters
influence the amount of asymmetry.
Distribution η
Normal (µ, σ2) 0
Uniform (a, b) 0
t (k) 0
Log-Normal (µ, σ2)
3
(
2eµ+
1
4σ2 ·Dσ − e 14σ2
)
√
2
√
3e
2
3
σ2 − 3e 12σ2
Folded Normal (µ, σ2)
3pi − 12 tan−1(12
√
2)
pi
√
2
√
3− 3
≈ 0.95
Exponential (λ) 1
Table 2.6: The measure of η for a variety of commonly encountered distributions. The asym-
metry in the Log-Normal distribution depends on both parameters µ and σ2 as well as the
probability Dσ = P
[
−∞ < Z1 < Z2√2 −
1
2σ ,−∞ < Z2 <∞
]
.
It is not always simple or convenient to compute an exact solution for η. For example, an
exact expression for the Normal mixtures as a function of p is too long to be discussed here,
but for details see the appendix of PPB [88]. Figure 2.3 shows the numerical approximation
of η for a range of the parameters in the Normal mixtures (p), Skew Normal distribution (λ),
Sinh-arcsinh distribution (ε) and the Fernanadez and Steel distribution (γ). Observe that the η
identifies that the Normal mixtures are almost symmetric whenever p is close to either 0 or 1,
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Figure 2.3: The amount of asymmetry η as a function of the parameters in the Normal mixtures
(p), Skew Normal distribution (λ), Sinh-arcsinh distribution (ε) and the Fernandez and Steel
distribution (γ).
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and consequently the mixture is very close to N(0, 1) or N(2, 2). For the other distributions, as
one increases the skewness parameter, the amount of asymmetry η also increases appropriately.
In a recent article Patil, Bagkavos and Wood [89] discuss a stronger measure
ηs(X) = −1
2
sign(ρ1) max
0.5≤p≤1
∣∣ρp + ρ∗p∣∣ ,
where
ρp =
2
√
3
p
∫ ξp
−∞ f
2(x)F (x)dx− p2
∫ ξp
−∞ f
2(x)dx[
p
∫ ξp
−∞ f
3(x)dx−
(∫ ξp
−∞ f
2(x)dx
)2]1/2 ,
ρ∗p =
2
√
3
p
− ∫∞ξ1−p f2(x)F (x)dx+ p2 ∫∞ξ1−p f2(x)dx[
p
∫∞
ξ1−p f
3(x)dx−
(∫∞
ξ1−p f
2(x)dx
)2]1/2 ,
and F (ξp) = p. Now the condition ηs = 0 is, both, necessary and sufficient for the symmetry.
Unfortunately, a drawback of the stronger measure ηs is a loss of the ‘user-friendly’ aspect of η.
Thus we propose to use η to devise a test for symmetry. But before that, the next subsection
gives a brief description regarding the estimation of η.
2.3.2 Estimating η
PPB [88] construct three competing estimates of η. These are based upon calculating the sample
correlation using different estimates for f and F . For example f(Xi) is estimated using kernel
smoothing,
f̂(i)(Xi) =
1
n− 1
1
h
n∑
j 6=i
K
(
Xj −Xi
h
)
,
where K is a kernel density and h is the bandwidth. Now F (Xi) is estimated by
F̂(i)(Xi) =
1
n− 1
n∑
j 6=i
I[Xj < Xi].
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Note that the estimates f̂(i) and F̂(i) are dependent on i, but for brevity this is suppressed
f̂(i)(Xi) = f̂(Xi) and F̂(i)(Xi) = F̂ (Xi). We will use the following estimator of η,
η̂ = −
∑n
i=1 f̂(Xi)F̂ (Xi)− n
(
f̂
)(
F̂
)
√(∑n
i=1(f̂(Xi))
2 − nf̂
2
)(∑n
i=1(F̂ (Xi))
2 − nF̂
2
) , (2.2)
where f̂ = 1n
∑
i f̂(Xi) and F̂ =
1
n
∑
i F̂ (Xi). It was shown via simulation that η̂ is the most
effective estimator of η considered by PPB [88]. Furthermore, PPB state that standard methods
can be used to show the consistency of this estimate.
When calculating η̂ in practice it is helpful to note that the correlation is unchanged by
altering the order of the data, so suppose that the random sample X1, · · · , Xn is ordered from
smallest to largest. Further, let X = (X1, · · · , Xn). Now, we have
F̂ (X) =
(
0,
1
n− 1 ,
2
n− 1 , · · · , 1
)
.
Moreover, because η̂ is invariant under transformations of location and scale, the measure is
equivalent to the sample correlation between f̂(X) and U = (1, 2, 3, · · · , n). Figure 2.4 shows
the four Normal mixtures NM1, NM2, NM3 and NM4, which are associated with values of η
equal to 0.1, 0.2, 0.3 and 0.4. Figure 2.5 demonstrates how the measure works by showing a
scatter-plot of f̂(X) against U , along with a line of best fit. In this setting η̂2 is equivalent to
the coefficient of determination r2, where r is the sample correlation coefficient. It is clear from
Figure 2.5 that as the amount of asymmetry increases, r2 increases. Furthermore, the direction
of the asymmetry has a direct effect on the slope of the line of best fit. As a result, asymmetry
to the right results in a negative gradient and hence, a positive value of η̂. On the other hand,
asymmetry to the left results in a positive slope and hence, a negative value for η̂.
2.3.3 A new test statistic Tn and its asymptotic distribution
Since η has already been shown to be an effective measure of asymmetry it seems only natural
to suggest using η̂ as test statistic for testing symmetry. Therefore we extend the work of PPB
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[88] to investigate the use of η̂ as a test statistic. For example, the standardised test statistic
would be
Tn :=
√
n
η̂√
σ̂2
,
where σ̂2 is the estimate of the variance of
√
nη̂. Before we conduct a power analysis of Tn, we
first derive the asymptotic distribution of η̂.
The asymptotic distribution of η̂ is established in Theorem 2.3 below. For that, we require
the following assumptions:
A1 Assume that E[f2(X)] <∞.
A2 The kernel function K is smooth, has bounded support and is of bounded variation.
A3 The bandwidth h ∼ n−γ for 14 ≤ γ < 12 .
Theorem 2.3 Let X1, · · · , Xn be a random sample from a continuous probability density func-
tion f(x) and distribution function F (x) and further suppose that assumptions A1,A2 and A3
all hold. Then as n→∞
√
n [η̂ − η] L−→ N(0, σ2),
where
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
,
(2.4)
where νf and νF denote Var(f(X)) and Var(F (X))
(
= 112
)
respectively, and µf = E[f(X)].
Note that, although η̂ uses non-parametric density estimates, one is able to obtain a para-
metric convergence rate n−1, similar to the estimation of integrated squared density derivatives
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discussed by Hall and Marron [45]. Below we present a detailed proof of Theorem 2.3, which is
based on determining the first order asymptotic linear expansion of η̂, before applying a general
result given by Gine´ and Mason [38]. The proof also requires repeated application of Slutsky’s
lemma [115].
Proof. Recall that
η̂ = −Ĉorr
(
f̂ , F̂
)
= −
∑
i
(
f̂i − f̂
)(
F̂i − F̂
)
√∑
i
(
f̂i − f̂ i
)2√∑
i
(
F̂i − F̂ i
)2 ,
where f̂i = f̂(Xi) and F̂i = F̂ (Xi). This is an estimate of the population correlation coefficient,
η = −Corr (f(X), F (X)) = −E[f(X)F (X)]− E[f(X)]E[F (X)]√
Var[f(X)]Var[F (X)]
.
To ease the notation, let
νfF = E[f(X)F (X)]− E[f(X)]E[F (X)]
ν̂fF =
1
n
∑
i
(
f̂i − f̂
)(
F̂i − F̂
)
=
1
n
∑
i
(
f̂i
)(
F̂i − F̂
)
=
1
n
∑
i
f̂i
(
F̂i − 1
2
)
νf = Var[f(X)]
ν̂f =
1
n
∑
i
(
f̂i − f̂
)2
νF = Var[F (X)] =
1
12
ν̂F =
1
n
∑
i
(
F̂i − F̂
)2
=
1
n
∑
i
(
F̂i − 1
2
)2
.
Then,
η̂ = − ν̂fF√
ν̂f ν̂F
and η = − νfF√
νfνF
.
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Firstly, observe
√
n(η̂ − η) = −√n
(
ν̂fF√
ν̂f ν̂F
− νfF√
νfνF
)
= −√n
(
ν̂fF√
ν̂f ν̂F
− νfF√
ν̂f ν̂F
+
νfF√
ν̂f ν̂F
− νfF√
νfνF
)
= −√n 1√
ν̂f ν̂F
(ν̂fF − νfF ) +
√
n
νfF√
ν̂f ν̂F
√
νfνF
(√
ν̂f ν̂F −√νfνF
)
. (2.5)
Ignoring the sign of the first term on the right handside of equation (2.5) rewrite
√
n
1√
ν̂f ν̂F
(ν̂fF − νfF ) =
√
n
1√
νfνF
(ν̂fF − νfF ) +
√
n
1√
ν̂f ν̂F
(ν̂fF − νfF )
−√n 1√
νfνF
(ν̂fF − νfF )
=
√
n
1√
νfνF
(ν̂fF − νfF )
+
√
n
1√
ν̂f ν̂F
√
νfνF
(ν̂fF − νfF )
(√
νfνF −
√
ν̂f ν̂F
)
.
Claim 1
√
n (ν̂fF − νfF ) converges in law to a Normal distribution with finite variance.
We shall return to the matter of proving Claim 1 later. First, observe that from Hall and
Marron [45] it follows that ν̂f and ν̂F converge in probability to νf and νF . Therefore, using
this fact and Claim 1 we have
√
n
1√
ν̂f ν̂F
(ν̂fF − νfF ) =
√
n
1√
νfνF
(ν̂fF − νfF ) + op(1). (2.6)
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Write the second term in equation (2.5) as
√
n
νfF√
ν̂f ν̂F
√
νfνF
(√
ν̂f ν̂F −√νfνF
)
=
√
n
νfF (ν̂f ν̂F − νfνF )√
ν̂f ν̂F
√
νfνF
(√
ν̂f ν̂F +
√
νfνF
)
=
√
nνfF
ν̂f ν̂F − νfνF
2νfνF
√
νfνF
+
√
nνfF (ν̂f ν̂F − νfνF )
2νfνF −
√
ν̂f ν̂F
(√
ν̂f ν̂F +
√
νfνF
)
2νfνF
√
νfνF
√
ν̂f ν̂F
(√
ν̂f ν̂F +
√
νfνF
)
=
√
nνfF
ν̂f ν̂F − νfνF
2νfνF
√
νfνF
+ op(1), (2.7)
again, using the fact that ν̂f and ν̂F converge in probability to νf and νF . Furthermore,
√
n (ν̂f ν̂F − νfνF ) =
√
n (νf (ν̂F − νF ) + νF (ν̂f − νf )) +
√
n (ν̂f − νf ) (ν̂F − νF )
=
√
n (νf (ν̂F − νF ) + νF (ν̂f − νf )) + op(1). (2.8)
Hence using equations (2.6), (2.7), and (2.8), rewrite (2.5) as
√
n(η̂ − η) = −√n
(
1√
νfνF
(ν̂fF − νfF )− νfF
2νfνF
√
νfνF
(νf (ν̂F − νF ) + νF (ν̂f − νf )
)
+ op(1)
= −√n
(
1√
νfνF
(ν̂fF − νfF )− νfF
2νF
√
νfνF
(ν̂F − νF )− νfF
2νf
√
νfνF
(ν̂f − νf )
)
+ op(1).
The leading order term in the expansion for
√
n(η̂ − η) is composed of three parts. We show
that the linear combination is asymptotically Normal by applying Theorem 1 given by Gine´ and
Mason [38]. The statement and assumptions of this Theorem are given in detail in Appendix
A. Firstly, observe that
√
nν̂f =
√
n
1
n
n∑
i=1
(
f̂i − f̂
)2
=
√
n
1
n
n∑
i=1
(
f̂i − µf
)2
+ op(1),
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where µf = E[f(X)]. Hence, defining
ν˜f =
1
n
n∑
i=1
(
f̂i − µf
)2
,
it is clear that
√
n(η̂ − η) = −√n
(
1√
νfνF
(ν̂fF − νfF )− νfF
2νF
√
νfνF
(ν̂F − νF )− νfF
2νf
√
νfνF
(ν˜f − νf )
)
+ op(1)
= −√nΘ̂ + op(1),
where
Θ̂ =
1√
νfνF
(ν̂fF )− νfF
2νF
√
νfνF
(ν̂F )− νfF
2νf
√
νfνF
(ν˜f ) .
Claim 2
√
nΘ̂
L−→ N(0, σ2).
The proof of the Theorem will be complete if we prove Claim 1 and Claim 2. Since the proof
of Claim 1 and 2 are similar we prove Claim 2, whilst Claim 1 follows similarly. Observe that
Θ̂ is in the form
1
n
n∑
i=1
φ̂
(
f̂(Xi), F̂ (Xi)
)
,
and is an estimator of
Θ =
∫ ∞
−∞
{
f(x)F (x)− 12f(x)√
νfνF
− νfF
2νF
√
νfνF
(
F (x)− 1
2
)2
− νfF
2νf
√
νfνF
(f(x)− µf )2
}
f(x)dx
= 0.
Therefore we can apply Theorem 1 of Gine´ and Mason [38] to show that Θ̂ is asymptotically
Normal once we have verified the conditions I-VIII of the theorem. Details of these conditions
can be found in Appendix A. Conditions I, VI, VII and VIII hold directly from the assumptions
A1,A2 and A3. Also, under assumption A3 condition II holds with H = f as the suitable mea-
surable function. To verify the remaining conditions note that, in Gine´ and Mason’s notation,
we have that
45
ψ(x, F (x), f(x)) =
f(x)F (x)− 12f(x)√
νfνF
− νfF
2νF
√
νfνF
(
F (x)− 1
2
)2
− νfF
2νf
√
νfνF
(f(x)− µf )2
ψ(x, y0, y1) =
y0y1 − 12y1√
νfνF
− νfF
2νF
√
νfνF
(
y0 − 1
2
)2
− νfF
2νf
√
νfνF
(y1 − µf )2.
Further,
ψm(x) =
∂
∂ym
ψ(x, y0, y1)
∣∣
(x,F (x),f(x))
.
Hence,
ψ0(x) =
∂
∂y0
ψ(x, y0, y1) =
y1√
νfνF
− νfF
νF
√
νfνF
(
y0 − 1
2
)
=
f(x)√
νfνF
− νfF
νF
√
νfνF
(
F (x)− 1
2
)
,
ψ1(x) =
∂
∂y1
ψ(x, y0, y1) =
y0 − 12√
νfνF
− νfF
νf
√
νfνF
(y1 − µf )
=
F (x)− 12√
νfνF
− νfF
νf
√
νfνF
(f(x)− µf ).
Therefore III and IV hold under the assumption A1. Further, define
ξ(Xi) = ψ(Xi)− E [ψ(X)]
=
f(X)F (X)− 12f(X)√
νfνF
− νfF
2νF
√
νfνF
(
F (X)− 1
2
)2
− νfF
2νf
√
νfνF
(f(X)− µf )2,
ξ0(Xi) =
∫ ∞
Xi
{
f(y)√
νfνF
− νfF
νF
√
νfνF
(
F (y)− 1
2
)}
f(y)dy − 1
2
µf√
νfνF
,
χ1(y) = ψ1(y)f(y)
=
F (y)f(y)− 12f(y)√
νfνF
− νfF
νf
√
νfνF
(f(y)− µf )f(y).
Hence, condition V is also satisfied.
ξ1(Xi) = χ1(Xi)− E [χ1(X)]
=
F (X)f(X)− 12f(X)√
νfνF
− νfF
νf
√
νfνF
(f(X)− µf )f(X).
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Finally, define
Y = ξ(X) + ξ0(X) + ξ1(X)
=
f(X)F (X)− 12f(X)√
νfνF
− νfF
2νF
√
νfνF
(
F (X)− 1
2
)2
− νfF
2νf
√
νfνF
(f(X)− µf )2
+
∫ ∞
X
{
f(y)√
νfνF
− νfF
νF
√
νfνF
(
F (y)− 1
2
)}
f(y)dy − 1
2
µf√
νfνF
+
F (X)f(X)− 12f(X)√
νfνF
− νfF
νf
√
νfνF
(f(X)− µf )f(X).
Hence, we conclude under the assumptions A1-A3, that
√
n
(
Θ̂−Θ
)
is asymptotically normally
distributed with mean zero and variance
σ2 := Var(Y ) = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy − 1
2
µf√
νfνF
− νfF
{(
F (X)− 12
)2
2νF
√
νfνF
+
(f(X)− µf )2
2νf
√
νfνF
+
∫ ∞
X
(
F (y)− 12
)
νF
√
νfνF
f(y)dy +
(f(X)− µf )f(X)
νf
√
νfνF
}]
= Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
− νfF√
νfνF
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
= Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
.

Therefore, in conclusion, we have shown that the test statistic,
Tn :=
√
n
η̂√
σ̂2
,
is approximately standard Normal, where σ̂2 is an appropriate estimate of the variance σ2. The
expression for the variance is generally a complicated one to evaluate in practice, but it simplifies
a great deal under the null hypothesis (η = 0). In the next section we discuss several procedures
to estimate σ2.
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2.3.4 Estimating the variance σ2
We now provide details of how to estimate the variance that appears in the test statistic Tn.
Recall,
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
,
One approach is to estimate using the Monte Carlo method replacing f and F with f̂ and F̂
respectively. Using this method the integrals in the variance expression can be calculated using
some numerical method.
One can also simplify matters by computing the null variance (i.e. assuming that the random
variable X is symmetric) where η = 0. In this case σ2 reduces to
σ20 =
1
νfνF
Var
(
2
{
f(X)F (X)− 1
2
f(X)
}
+
∫ ∞
X
f2(y)dy
)
.
To ease the notation somewhat let
Φ1(X) =
∫ ∞
X
f2(y)dy.
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Hence, for symmetric random variables we have
σ20 =
1
νfνF
Var
[
2
{
f(X)F (X)− 1
2
f(X)
}
+ Φ1(X)
]
=
1
νfνF
(
Var
[
2
{
f(X)F (X)− 1
2
f(X)
}]
+ Var [Φ1(X)]
+ 2Cov
(
2
{
f(X)F (X)− 1
2
f(X)
}
,Φ1(X)
))
=
1
νfνF
(
E
[
4
{
f(X)F (X)− 1
2
f(X)
}2]
+ Var [Φ1(X)]
+ 4E
[{
f(X)F (X)− 1
2
f(X)
}
Φ1(X)
])
=
1
νfνF
(
4E
[
f(X)2F (X)2
]
+ E
[
f(X)2
]− 4E [f(X)2F (X)]+ E [Φ1(X)2]− [EΦ1(X)]2
+ 4E [f(X)F (X)Φ1(X)]− 2E [f(X)Φ1(X)]
)
.
Further, observe that by a simple change of variables
E [Φ1(X)] = E
[∫ ∞
u=X
f2(u)du
]
=
∫ ∞
y=−∞
f(y)
∫ ∞
u=y
f2(u)dudy
=
∫ ∞
u=−∞
f2(u)
∫ u
y=−∞
f(y)dydu
=
∫ ∞
u=−∞
f2(u)F (u)du
= E [f(X)F (X)] ,
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and
E [f(X)Φ1(X)] = E
[
f(X)
∫ ∞
u=X
f2(u)du
]
=
∫ ∞
y=−∞
f2(y)
∫ ∞
u=y
f2(u)dudy
=
∫ ∞
u=−∞
f2(u)
∫ u
y=−∞
f2(y)dydu
=
∫ ∞
u=−∞
f2(u)
{∫ ∞
y=−∞
f2(y)dy −
∫ ∞
y=u
f2(y)dy
}
du
=
∫ ∞
u=−∞
f2(u)
{
E[f(X)]−
∫ ∞
y=u
f2(y)dy
}
du
= E[f(X)]2 − E [f(X)Φ1(X)] .
Thus, under the null hypothesis
E [Φ1(X)] =
1
2
E [f(X)] = E [f(X)F (X)] ,
2E [f(X)Φ1(X)] = [Ef(X)]
2 = 4 [Ef(X)F (X)]2 .
Hence,
σ20 =
1
νfνF
{4m22 +m20 − 4m21}+ 4
{
E [f(X)F (X)Φ1(X)]−m211
}
+
{
E[Φ1(X)
2]−m211
}
,
where
mij = E
[
f(X)iF (X)j
]
.
For a random sample we can readily estimate mij using
m̂ij =
1
n
n∑
k=1
f̂(Xk)
iF̂ (Xk)
j .
Even in this greatly reduced form, the presence of the terms involving Φ1(X) means that the
expression for the variance is a complex one to evaluate in practice. In general, one could carry
out a numerical integration technique using the estimated density function f̂(x) in place of f(x).
Alternatively, in most situations one is primarily interested in whether samples are taken from
a Normal population. If we add the additional assumption (under the null hypothesis) that X
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is a normally distributed random variable we obtain
∫ ∞
x
f2(y)dy =
1
4
√
piσX
cerf
(
x− µX
σX
)
,
where µX and σX are the mean and variance of the random variable X respectively and
cerf(z) =
2√
pi
∫ ∞
z
e−t
2
dt,
is the complementary error function. This allows for an additional simplification to the null
variance and removes the need to carry out a potentially computationally expensive numerical
integration technique. More generally, one can define
Yi =
[
2√
ν̂f ν̂F
(
f̂(Xi)F̂ (Xi)− 1
2
f(Xi)
)
+
1√
ν̂f ν̂F
Φ̂1(Xi)
+ η̂

(
F̂ (Xi)− 12
)2
2ν̂F
+
(
f̂(Xi)− f̂
)2
2ν̂f
+ Φ̂2(Xi) +
(
f̂(Xi)− f̂
)
f̂(Xi)
ν̂f

 ,
where Φ̂1(x) is a numerical approximation of the integral Φ1(x) estimating f with f̂ , and Φ̂2(x)
is a numerical approximation of
∫ ∞
x
(
F (y)− 12
)
νF
f(y)dy,
estimating f and F by f̂ and F̂ . It is then possible to estimate σ2 using
σ̂2 = V̂ar(Y ) =
1
n− 1
n∑
i=1
(Yi − Y )2. (2.9)
Hence, in summary, for large n the distribution of
Tn =
√
n
η̂√
σ̂2
,
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is approximately standard Normal, where, σ̂2 is an appropriate estimate of
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
.
In the next section we analyse the empirical power of Tn through the use of a simulation study.
2.3.5 Power analysis of Tn
Methods
We subject the new test statistic to a similar simulation study as detailed in section 2.2. Once
again, the test statistic is generated m = 10, 000 times from samples of size n = 30, 50 and 70.
In each case the density and distribution function is estimated using a Normal kernel and the
bandwidth is estimated using the simple rule of thumb given by Silverman [114]. The asymptotic
variance σ2 is estimated from the sample using σ̂2 defined in equation (2.9), where the numerical
integration of Φ1 and Φ2 is carried out using a simple rectangle approximation with a grid of 512
points. Therefore Tn is asymptotically standard Normal and, thus, we reject the null hypothesis
at level 0.05 if the absolute value of the test statistic is greater than Z0.975 ≈ 1.96. As before,
the empirical powers (the proportion of rejections) of each of the tests are reported. Table 2.7
summarises the simulation procedure.
Step 1 Simulate samples of size n = 30, 50 and 70 from each of the distributions.
Step 2 Calculate the test statistic Tn based on these samples, estimating σ
2
using equation (2.9).
Step 3 If |Tn| > Z0.975 then the null hypothesis of symmetry is rejected at the
5% level.
Step 4 Repeat Steps 1-3 10, 000 times and report the proportion of rejections
(empirical power).
Table 2.7: Step by step guide to the simulation study for the newly proposed test Tn.
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η Dist.
Tn
n = 30 n = 50 n = 70
0 N 0.040 0.037 0.038
0 C 0.037 0.036 0.035
0.1 NM1 0.049 0.055 0.059
0.2 NM2 0.075 0.113 0.147
0.3 NM3 0.128 0.229 0.321
0.4 NM4 0.202 0.392 0.573
0.1 SN1 0.046 0.054 0.060
0.2 SN2 0.068 0.100 0.127
0.3 SN3 0.105 0.179 0.261
0.4 SN4 0.167 0.296 0.425
0.5 SN5 0.251 0.446 0.591
0.6 SN6 0.359 0.574 0.737
0.7 SN7 0.443 0.681 0.841
0.8 SN8 0.506 0.757 0.883
0.1 SAS1 0.044 0.050 0.061
0.2 SAS2 0.069 0.096 0.130
0.3 SAS3 0.109 0.186 0.257
0.4 SAS4 0.170 0.311 0.436
0.5 SAS5 0.270 0.477 0.655
0.6 SAS6 0.408 0.671 0.833
0.7 SAS7 0.581 0.838 0.948
0.8 SAS8 0.738 0.936 0.987
0.1 FAS1 0.047 0.046 0.063
0.2 FAS2 0.070 0.098 0.128
0.3 FAS3 0.103 0.172 0.247
0.4 FAS4 0.170 0.281 0.402
0.5 FAS5 0.242 0.405 0.556
0.6 FAS6 0.326 0.541 0.687
0.7 FAS7 0.409 0.645 0.794
0.8 FAS8 0.482 0.729 0.866
0.91 LN 0.908 0.991 0.999
0.95 FN 0.550 0.790 0.910
1 EXP 0.866 0.981 0.998
Table 2.8: Empirical power of the test based on Tn for a variety of density functions and sample
sizes.
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Results
The results of the simulation are detailed in Table 2.8. For the test based on Tn we observe
a steady increase in power for the asymmetric families, whilst for the remaining asymmetric
distributions (Log-Normal, Folded Normal, Exponential) the test achieves a high level of power.
Furthermore, whilst not perfect, the amount of power is more closely related to the amount of
asymmetry. This is to be expected since the tests are based on η, which has previously been
identified as a more effective measure of the magnitude of asymmetry. For example, for n = 70
the empirical power of Tn for the Log-Normal and Folded Normal distribution is 0.999 and
0.910 respectively. Comparing this with the respective power of the existing tests, reported in
Table 2.4 and Table 2.5, it is apparent that Tn is considerably more powerful than S1 (0.976 and
0.552), S2 (0.704 and 0.309), S4 (0.392 and 0.792) and S5 (0.831 and 0.454), and is comparable
to S3 (1.000 and 0.936).
In fact, Tn consistently out performs the existing tests S1, S2, S4 and S5 in terms of power.
Further, whilst S3 has marginally higher power than Tn, recall that S3 is not conservative.
Indeed, for a Normal sample, Tn has an estimated type-I error of 0.040 for n = 30 compared
to 0.082 for S3. For a sample of n = 30 from the Cauchy distribution this difference is even
more stark with a type-I error estimate of 0.037 for Tn compared to 0.108 for S3. Hence, the
additional power achieved by S3 is somewhat artificial if the test is unable to maintain the level
α under the null hypothesis.
In the next section we provide a short worked example to demonstrate the usefulness of Tn
when applied to a real data set.
2.4 Real data example
We now evaluate the usefulness of our test in a more practical setting by applying it to a real
data set. We consider a reasonably large set of data collected for a randomised trial investigating
hypertension (one of several trials collated by Wang et al. [125]), which we will introduce in the
next chapter. For example, we consider the EWPH trial, which consists of 172 patients [2]. The
main focus of this study was to investigate the effect of an antihypertensive treatment versus
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placebo at reducing mortality rates in elderly patients (above the age of 60). However, a number
of covariates were also collected. For example, every patient had their age recorded and 164
had their body mass index (BMI) recorded. After pooling the treatment and control groups
together the BMI data appears predominantly symmetric. In contrast, the age data appears
significantly skewed to the right. This is unsurprising, since this specific trial focused on elderly
patients and therefore we observe an abrupt cut-off in age at 60 on the left-hand tail, with a few
outliers above 90 in the right-hand tail. This can be seen visually in Figure 2.6, which shows
the density estimate of the BMI and age data. However, testing for symmetry will allow us to
make an objective judgement with regards to the asymmetry inherent in the data.
Suppose that our principle interest is to test whether the BMI data are being drawn from
a symmetric population. Pooling the treatment and control groups let X1, X2, · · · , X164 denote
the BMI readings, and let ηb denote the value η for the BMI in this population. The null
hypothesis is
H0 : ηb = 0,
which is indicative of symmetry in the BMI readings, whilst the alternative hypothesis is
H1 : ηb 6= 0,
which implies asymmetry. It is readily calculated using equation (2.2) that the estimate of ηb
for the BMI data is
η̂b = 0.077.
Recall that a value of η = 0 indicates symmetry, thus this small value suggests that the BMI
data are being drawn from a near-symmetric population. This supports the visual evidence in
the left-hand plot of Figure 2.6, which shows the density estimate of the data.
Using equation (2.9) we estimate the variance of
√
nbη̂b to be
σ̂2b = 3.41,
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Figure 2.6: Density estimate of the BMI and age data in the EWPH trial.
where nb = 164. Recall, by Theorem 2.3 we have
√
n (η̂ − η) L−→ N (0, σ2) .
Hence,
η̂ ∼ N
(
η,
σ2
n
)
,
approximately. Thus, under the null hypothesis we have
η̂b ∼ N
(
0,
σ2b
nb
)
,
approximately. From this it is readily determined that the probability (p-value) of obtaining a
value of η̂b at least as large as we did (0.077) under the null hypothesis is 0.30. Hence, as one
should expect, there is not significant evidence to reject the null hypothesis of symmetry at the
5% level.
We can also obtain a confidence interval by observing that
P
[
Z−α
2
<
√
n
η − η̂
σ
< Zα
2
]
≈ 1− α.
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Therefore, the approximate 100(1− α)% confidence interval for η is given by
η̂ ± Zα
2
σ̂b√
nb
.
The standard error of η̂b is
s.e.(η̂b) =
σ̂b√
nb
=
1.85√
164
= 0.144.
Therefore, the 95% confidence interval of ηb is given by
(−0.206, 0.360) .
Observe that this interval contains the null value of 0, backing up the p-value conclusion that
we cannot reject the null hypothesis of symmetry.
Now consider the problem of testing whether the age data are being drawn from a symmetric
population. This time, let ηa denote the value η for the distribution of ages in this population.
Once again, using equation (2.2), it is readily calculated that the estimate of ηa for the age data
is
η̂a = 0.594.
As expected, this is a much larger estimate of ηa, which is indicative of a more asymmetric
population. The estimated variance of
√
naη̂a using (2.9) is given by
σ̂2a = 4.25,
where na = 172. Under the null hypothesis of symmetry
η̂a ∼ N
(
0,
σ2a
na
)
,
approximately, which gives a p-value of < 0.0001 indicating there is considerable evidence against
the null hypothesis of symmetry. Once again, this supports the visual evidence in the right-hand
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plot of Figure 2.6, which shows the density estimate of the age data. It is clear that the age data
shows moderate skewness to the right, which is confirmed by η̂a = 0.594. Also, on this occasion
we determine the 95% confidence interval for ηa to be
(0.286, 0.902),
indicating that there is substantial evidence that the age data are drawn from a population
which is asymmetric to the right.
2.5 Discussion
In this chapter some of the existing tests of symmetry have been appraised and shown to per-
form well at detecting departure from symmetry. However, an undesirable feature was identified,
which seems to have been overlooked in the existing tests of symmetry. Namely, that the tests
failed to reject the symmetry hypothesis with greater power for the most visually asymmetric dis-
tributions. This trait was exhibited though visual inspection and a simulation study. The reason
for this feature is principally because, until recently, there was no measure of asymmetry which
adequately measured the size of asymmetry. However, a recently proposed measure η, which
has been shown to effectively measure the size of asymmetry, was introduced and discussed. By
considering sample estimates of η, a new test for symmetry was proposed. Furthermore, the
asymptotic properties of this test were determined and the test was compared with the existing
tests in a simulation study. Finally, we discussed a short worked example, applying the new test
to set of real data.
In conclusion, it was shown that η provides a useful test for symmetry, improving on the
other tests discussed in this chapter. While the test did not achieve the initial aim of always
achieving greater power in the most asymmetric cases, it did improve upon the performance of
the existing tests of symmetry. Indeed, for most cases, the test based on η̂ rejects most often
for the most asymmetric distributions. Moreover, it was demonstrated that the test achieves a
greater power than most of the existing tests, whist maintaining the set level of 0.05 under the
null hypothesis. In fact, the only test to outperform the newly proposed test was the ‘triples’
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test proposed by Randles et al. [95] and this particular test failed to maintain the set level for
the symmetric random variables.
Another advantage of the test based on η̂ is the flexibility afforded by the smoothing involved
in the estimate of f(x). For the simulation study in this chapter we have only considered using
a simple kernel density estimate with the most basic data-based estimate of h, however, one can
readily tailor the choice of the kernel function K and the bandwidth estimate h to the particular
problem in question. For example, one possibility is to account for known boundaries in the
support of f(x) using a boundary modification to the kernel density estimate. Indeed, if the
support of f(x) does not consist of the whole real line then the usual kernel density function
estimate (employed throughout this chapter) is biased near the boundary [98]. For example,
the density estimates of the Log-Normal, Folded Normal, and Exponential distribution are all
subject to this boundary bias in the region of zero. This bias is particularly serious for the
Folded Normal and Exponential distributions, where the density function is not continuous at
zero. This naturally leads to bias in the estimate η̂ and has consequences for the resulting test
for symmetry. In fact, it is likely that this bias is the main cause of the lower than expected
power in the Folded Normal and Exponential distributions. Provided that the location of the
boundary is known, this boundary bias can be reduced through the use of boundary kernel
density estimation [63]. Hence, appropriately used in the estimate of f(x), this can lead to
improvements in the estimate of η̂ and power of the test.
Up to this point we have only discussed estimating the variance of η̂ through the use of the
derived asymptotic distribution, however, other methods can be employed to obtain an estimate
of the variance. For example, bootstrapping can be used to make inferences, such as estimating
the variance or generating confidence intervals, for almost any test statistic [31]. This will be
explored in more detail in Chapter 4 when we investigate applying η̂ in smaller samples, where
the asymptotic distribution may be inappropriate.
Moreover, recent research by Patil, Bagkavos and Wood [89] has given rise to a new stronger
measure of asymmetry ηs, which is based on an analogous necessary and sufficient condition for
symmetry. This stronger measure also has the property that |ηs(X)| ≥ |η(X)| and so a test
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based on ηs could potentially improve upon the power of the test discussed here.
In summation, the test based on η̂ provides a valid alternative to the existing tests. In the
next chapter we discuss the potential applications of the measure η in more detail, including
applying η̂ to inform the analysis of randomised control trials.
N.B. The content of this chapter is the subject of a research paper by Partlett and
Patil, which has been accepted for publication in the Annals of the Institute of Sta-
tistical Mathematics.
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Chapter 3
Applying η̂ to inform the analysis
of randomised trials
3.1 Introduction
The results of Chapter 2 established how to use η̂ as a test statistic for testing symmetry.
Indeed, when dealing with a reasonably large data set we are able to approximate the sampling
distribution of η̂ as discussed in the previous chapter. This allows us to use the measure η̂ as a
test statistic as well as a summary statistic that measures asymmetry. The focus of this chapter
is to consider the application of η̂ in both contexts, for the analysis of randomised trials. This
is illustrated by using the hypertension trials collated by Wang et al. [125], which we introduce
in detail in section 3.2.
We discuss the possible applications of η̂ in three separate contexts. Firstly, we apply η̂ to
test and measure for baseline imbalance between the treatment and control arms of a randomised
control trial. This is an important assumption when carrying out analyses of randomised trials
and, when violated, it may lead to misleading inferences regarding the treatment effect. Secondly,
we apply η̂ to test for symmetry in the residuals of the analysis of covariance (ANCOVA) model,
used to estimate a treatment effect in a trial. Symmetry is a simple prerequisite for normality
and as such, any departure from symmetry indicates a departure from normality. Hence, we
discuss the benefits of applying η̂ to validate normality assumptions alongside more conventional
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methods, such as the QQ-plot [129]. Thirdly, we consider how η̂ can provide an aid for carrying
out transformations of the covariate or response variable. For example, if the residuals do not
appear to be coming from a Normal population, one reason could be that the covariate or
response data itself is non-Normal. In this case, a possible remedy is to transform the response
or covariate data to obtain a sample which conforms more closely to the normality assumption.
We show that the coefficient η̂ has a role in identifying which variables to transform, objectively
determining whether the transformation has been successful, and even providing an indication
as to what sort of transformation may be most appropriate.
The chapter is outlined as follows. In section 3.2 we introduce randomised control trials,
discuss how they are set up, and what they aim to achieve. We also introduce a collection of
data comprising of ten randomised control trials investigating hypertension treatment, collated
by Wang et al. [125]. In section 3.3 we use η̂ as an additional summary statistic to test the
homogeneity of the treatment and control arms of the hypertension data. In section 3.4 we
apply η̂ to test the symmetry of the residuals in several ANCOVA models. Section 3.5 examines
the use of η̂ to influence and appraise the effect of variable transformation on the residual
distribution in cases where the residuals show a significant departure from symmetry. In section
3.6 we briefly discuss some of the limitations of η̂ in this context, before offering some concluding
remarks in section 3.7.
Aims of the chapter:
• Investigate the use of η̂ to aid in the analysis of randomised control trials.
• Demonstrate that η̂ can be a useful measure in all stages of the transformation of
skewed data:
- Identifying whether a transformation is necessary (and for which variables).
- Deciding what type of transformation to apply.
- Determining whether the transformation has be successful at reducing the
amount of asymmetry.
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• An in depth appraisal of η̂, including its advantages and limitations in this context.
3.2 Randomised control trials
A randomised control trial is very much the gold standard for clinical trials. Firstly, patients
which are representative of the population at risk are recruited randomly into two or more
groups. The separate groups are subject to identical conditions and undergo the same follow
up, save for the treatment (or treatments) under consideration. The aim of randomisation is to
ensure that the only difference between the groups is the intervention of interest. That is, for
a sufficiently large sample size, randomisation eliminates the effect of confounding factors. The
patients in the groups are followed up to determine whether there is a significant difference in
the outcome of interest between the groups. For example, suppose we are interested in testing
the effect of a new treatment on blood pressure. Firstly, we randomly allocate patients into two
groups, one of which receives the new treatment and one of which receives a placebo. At the
end of follow-up the patients have their blood pressure recorded and the mean blood pressure
is compared between the two groups, to estimate the effect of the treatment.
Wang et al. [125] collated data from ten such randomised control trials. In the original paper
the authors used individual patient data (IPD) to perform a quantitative overview of trials in
hypertension to investigate the effect of lowering of systolic blood pressure (SBP) and diastolic
blood pressure (DBP) on cardiovascular outcome. They selected randomised control trials that
tested antihypertensive drugs against a placebo or no treatment. Information was collected about
28, 581 patients from 10 different studies. The study measured a range of different covariate
factors, including age, sex, and body mass index (BMI). In the later chapters we consider this
collection of data as a meta-analysis, however, here it is convenient for our illustrations to
consider each of the trials individually.
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3.3 Comparing the distribution of control and treatment sam-
ples
When analysing a randomised control trial, it is important that the control and treatment
samples are representative of the same population and that they are similar in terms of baseline
characteristics (apart from treatment) to minimise the effect of confounding factors. If there
are baseline differences between the control and treatment groups then the estimated treatment
effect may be misleading or biased. Indeed, it may simply be a reflection of baseline imbalance,
rather than a genuine treatment effect. An advantage of η is that it is characteristic which can
be readily compared between two populations. Hence, its estimate η̂ can be used to compare
two samples.
For example, consider the effect of hypertensive treatments at lowering blood pressure. We
can use η̂ to determine whether the initial blood pressures in the control and treatment groups
are distributed similarly. Indeed, to evaluate the treatment effect the initial blood pressure data
in the control and treatment samples should be drawn from the same population. As a result,
we expect that that the amount of asymmetry will be the same (along with other features,
such as the mean and variance). Moreover, because the two samples are independent and η̂ is
approximately normally distributed, we can test whether η is the same in the two samples in a
statistically rigorous framework.
Our null hypothesis is, for a given trial, that the initial blood pressure (either systolic or
diastolic) in the treatment and control samples are both drawn out of the same population with
density function f and cumulative distribution F . In this case the population has an unknown
quantity of asymmetry measured by η. Let ηT and ηC denote the values of η in the treatment
and control populations respectively.
Suppose that the treatment and control arms contain nT and nC individuals respectively.
Under null, ηT = ηC and one should expect that the estimate of η in the control sample η̂C and
the estimate in the treatment sample η̂T will be very similar. Hence, we set up a test of
H0 : θ = ηT − ηC = 0,
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against
H1 : θ 6= 0.
Under null, η̂T and η̂C are independent and approximately normally distributed with variances,
σ2
nT
and σ
2
nC
respectively where, using the results of the previous chapter,
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
,
where νf and νF denote Var(f(X)) and Var(F (X))
(
= 112
)
respectively, and µf = E[f(X)].
It is important to note that we are implicitly assuming that the variance of η̂ is equal in both
groups (a stronger assumption is that f(x) and F (x) are the same in both groups), however, this
assumption may be unnecessarily restrictive. Indeed, the variance of θ̂ can be readily calculated
when this assumption is relaxed. For this particular setting, and under the null hypothesis, we
expect the two groups to be relatively homogeneous and so this assumption is plausible in this
case. Indeed, additional calculations (not included here) show that the results are not sensitive
to this assumption for this example.
Hence, we can conclude that
θ̂ = η̂T − η̂C ∼ N
(
0,
{
1
nT
+
1
nC
}
σ2
)
,
approximately. We estimate the variance σ2 using the pooled estimate,
σ̂2 =
(nT − 1)σ̂2t + (nC − 1)σ̂2c
nT + nC − 2 ,
where σ̂2t and σ̂
2
c are the estimates of σ
2 using equation (2.9) in the treatment and control groups
respectively.
It is important to note that some authors warn against the testing for baseline imbalance,
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because there is no guarantee that the study is sufficiently powered to detect a difference and,
theoretically, randomisation should be adequate to avoid an imbalance anyway [109]. In any
case, imbalance is better resolved by adjusting for potential confounders in the analysis. Here,
we discuss tests for baseline imbalance to illustrate a potential application of η̂ which may
sometimes be useful, even if it is not recommended for routine use.
Trial
Systolic Diastolic
θ p-value n θ p-value n
ANBP 0.008 0.455 1542 0.017 0.417 1542
COOP −0.028 0.431 349 −0.084 0.310 349
EWPH 0.026 0.454 172 −0.060 0.422 172
HDFP 0.008 0.019 4797 0.016 0.338 4798
MRC1 −0.003 0.469 6991 −0.005 0.455 6991
MRC2 −0.049 0.295 2651 −0.026 0.285 2651
SHEP −0.005 0.426 4736 −0.123 0.004 4736
STOP 0.001 0.498 268 −0.047 0.450 268
SYCH −0.074 0.098 2391 0.045 0.196 2391
SYSE 0.057 0.082 4695 0.044 0.158 4695
Pooled −0.018 0.080 28592 0.013 0.148 28593
Table 3.1: Testing for a difference in η for initial blood pressures between treatment and control
groups (θ = η̂T − η̂C).
Table 3.1 gives the results of the test of ηC = ηT in each of the 10 hypertension trials. We
see that in most of the cases there isn’t a significant difference between ηC and ηT . There are
a couple of exceptions, however, in most cases there are relatively low levels of significance. In
two out of 20 tests we find a significant result at the 5% level, which is perhaps not surprising.
Also, observe that these ‘significant’ results both occurred in trials with over 4000 individuals,
where there is power to detect even a slight difference in the value of η.
This shows that there is very little difference in the amount of asymmetry between the treat-
ment and control groups, which suggests there is homogeneity between the two arms. Figures
3.1 - 3.10 show the density estimates of the systolic and diastolic blood pressure data in the
treatment and control data. Note that there appears to be substantial asymmetry in the ma-
jority of studies, and also a reasonable amount of variability between studies. For example,
the diastolic blood pressure in HDFP trial (in both groups) displays a reasonable amount of
asymmetry to the right, whereas the same diastolic blood pressure in the MRC2 trial displays a
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large degree of asymmetry to the left. However, crucially, in each trial the density estimates of
the treatment and control appear to be very similar, which ratifies the conclusion of the tests.
In the next section we apply η̂ to test for symmetry in the residuals of the ANCOVA model.
3.4 Testing for symmetry in the residuals of the ANCOVA model
Section 3.3 compared asymmetry between two randomised groups to verify that they were bal-
anced in terms of baseline characteristics. Another key component of randomised trials is to
estimate the treatment effect (the difference in outcome response between treatment and control
groups) at the end of the trial, using a statistical model. Such models often make normality
assumptions, for example, it is commonly assumed that the variables or residuals of the model
are normally distributed.
When handling data in practice, it is extremely unlikely that the variables (and as a con-
sequence, model residuals) are sampled from a truly symmetric Normal population. Indeed,
when collecting data in practice the number of error-inducing factors can be so numerous and
complex that in reality we fully expect that the data are drawn from a population which is
not strictly Normal. This discrepancy between theory and practice motivated Geary [37] to
suggest that, “Normality is a myth; there never has, and never will be, a Normal distribution.”
For the most part this is not a serious issue, as for many commonly used tests, such as the
t-test for testing the equality of means, the tests are robust to small departures from normality
[93]. This presents the discerning statistician, who wants to validate normality or symmetry
assumptions of their model, with a problem. This is because, when dealing with large data sets,
tests for normality (or symmetry) will often produce significant results (i.e. those indicating
departure from the model assumptions). However, this doesn’t mean that the underlying data
are not ‘close to’ normality or ‘nearly symmetric’. This demonstrates the value of simple visual
evidence, such as Q-Q plots or histograms, which instantly give a good idea of how closely the
data conforms to a Normal population. The downside with this approach of course, is the fact
that interpretation of the visual evidence is inherently subjective. We propose a less subjective
‘test’ for symmetry by placing ourselves somewhere between these two approaches. The mea-
sure of asymmetry η̂ introduced in the previous chapter gives an impression of the amount of
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Figure 3.1: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the ANBP study.
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Figure 3.2: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the COOP study.
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Figure 3.3: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the EWPH study.
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Figure 3.4: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the HDFP study.
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Figure 3.5: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the MRC1 study.
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Figure 3.6: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the MRC2 study.
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Figure 3.7: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the SHEP study.
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Figure 3.8: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the STOP study.
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Figure 3.9: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the SYCH study.
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Figure 3.10: Comparing the treatment and control samples for initial systolic and diastolic blood
pressure in the SYSE study.
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asymmetry in the underlying sample. Therefore, it can be used to inform just how closely the
sample conforms to normality. Also, using the distributional properties of η̂ outlined in Chapter
2 one can construct an approximate confidence interval for η̂. Hence, using the measure one can
make a more objective decision as to whether the sample displays acceptable departure from
symmetry. Alongside a Q-Q plot this provides a reasonable method for deciding whether or not
there is excessive violation of the model assumptions.
We consider implementing this idea for the analysis of the hypertension trials using AN-
COVA. Using the hypertension data included in the meta-analysis by Wang et al. [125] we
propose the following ANCOVA model for each of the ten trials i = 1, 2, · · · , 10,
YFij = αi + β1iYBi + β2iXij + eij , j = 1, · · · , ni,
where ni is the sample size in study i, YFij is the final blood pressure in millimetres of mercury
(mm Hg) for patient j in study i. Similarly, YBi denotes the initial blood pressure (in mm Hg),
Xij represents an indicator variable equal to 1 for the treatment group and 0 for the control
group, while eij denotes the residual associated with patient j in study i. Furthermore, β1i
denotes the average effect of a unit increase in the baseline blood pressure on the resultant
blood pressure in study i and β2i denotes the treatment effect in trial i, correcting for the initial
blood pressure. That is, the average effect of the treatment on the resultant blood pressure in
study i, holding the initial blood pressure fixed. Table 3.2 shows the treatment effect estimates
β̂2i and the 95% confidence interval for the treatment effect in the ANCOVA model. For example,
in the EWPH trial the estimated treatment effect on systolic blood pressure is −12.88. This
implies that the average effect of the treatment is to reduce blood pressure by 12.88 mm Hg.
It is clear that the treatment effect is consistently below zero across all studies, which indicates
that the treatment is effective at reducing blood pressure.
When conducting an analysis of covariance one makes a number of fundamental assump-
tions, including the assumption that the residuals of the model are normally distributed. One of
the most common methods of validating this assumption involves the use of QQ-plots, that is,
plotting the sample quantiles of the residuals against the theoretical quantiles that one would
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Trial
Systolic Diastolic
TE 95% CI TE 95% CI
ANBP −6.66 [−8.33;−4.99] −2.99 [−4.01;−1.97]
COOP −14.17 [−18.44;−9.89] −7.87 [−10.23;−5.52]
EWPH −12.88 [−19.22;−6.54] −6.01 [−8.64;−3.38]
HDFP −8.71 [−9.77;−7.64] −5.11 [−5.74;−4.48]
MRC1 −8.70 [−9.44;−7.97] −4.64 [−5.08;−4.20]
MRC2 −10.60 [−12.10;−9.10] −5.56 [−6.40;−4.73]
SHEP −11.36 [−12.43;−10.29] −3.98 [−4.51;−3.44]
STOP −17.93 [−22.68;−13.18] −6.54 [−8.79;−4.28]
SYCH −6.55 [−7.81;−5.29] −2.08 [−2.72;−1.44]
SYSE −10.26 [−11.12;−9.39] −3.49 [−3.90;−3.09]
Table 3.2: ANCOVA results including mean treatment effect (TE) and 95% confidence intervals
(CI).
expect from a Normal sample. A QQ-plot of a normally distributed sample would be approx-
imately linear. However, this approach relies on the subjective opinion of the researcher as to
what constitutes ‘approximately linear’. We propose using η̂, alongside a QQ-plot, to test for
the symmetry of the random sample and thus, we can establish a quantification of how far the
sample departs from a symmetric Normal population.
In Table 3.3 we report the value of η̂ for the residuals in each trial, along with the approximate
95% confidence interval in each case. We also report the p-value, that is, the probability of
observing such a value (or one at least of extreme) if the data were in fact perfectly symmetric.
In the vast majority of cases it is shown that it is highly unlikely that the residuals are coming
from a completely symmetric population, as the p-values are often less than 0.05. This is
precisely what one should expect in such large randomised control trials, where such a large
sample size means that the test based on η̂ has the power to detect even modest departures
from symmetry. For example, most studies have over 1000 patients in total. The important
thing to observe is that the value of η̂ is small in most of the cases, indicating only a small
departure from symmetry (and hence only a slight violation of the normality assumption).
Figures 3.11 and 3.12 show the QQ-plots for the residuals from the models for systolic and
diastolic blood pressures respectively. The QQ-plots compare the sample quantiles of the ob-
served standardised residuals with the theoretical quantiles of the standard Normal distribution.
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It is apparent that the majority of QQ-plots display a near linear trend indicating a reasonable
agreement between the quantiles of the observed residuals with the Normal residuals. In the
studies where η̂ is unusually large, with absolute value greater than 0.2 (HDFP and STOP for
systolic blood pressure, and EWPH and SYSE for diastolic blood pressure), we see that the
QQ-plots also identify asymmetry in the form of a non-linear trend between the sample quan-
tiles and the theoretical Normal quantiles. It is also worthy of note that the QQ-plots for the
diastolic and systolic blood pressure in the ANBP trial also display a small anomaly in the form
of a vertical kink in the lower tail. This is evidence of a bimodal structure in the underlying dis-
tribution, which may go undetected by the measure of asymmetry η̂. Figures 3.13 and 3.14 show
the density estimates of the residuals in the the models of systolic and diastolic blood pressures
respectively. These figures provide further evidence of the small departures from symmetry in
some of the trials, as well as confirming the presence of a bimodal residual distribution for the
ANBP data.
As we have already identified, there are four trials which contain residuals which display
potentially important asymmetry (an absolute value of η̂ > 0.2). These are the HDFP and
STOP trials in the systolic case and EWPH and SYSE in the diastolic case. When residuals
fail to conform to a Normal distribution it is common practice to transform the dependent
or independent variables to rectify this problem. In the next section we discuss the potential
applications of η̂ to conducting transformations of asymmetric data.
3.5 Correcting for asymmetry
As we have already alluded to, violations of the normality assumption can potentially com-
promise the estimation of coefficients and the calculation of confidence intervals when analysing
linear models [13]. It is sometimes the case that the error distribution is ‘skewed’ by the presence
of outliers in the data. Whilst it is common practice to remove outliers from the data, one should
be careful not to throw away meaningful data. Since parameter estimation is typically based
on the minimization of squared error, a few extreme observations can exert a disproportionate
influence on parameter estimates, as noted by Huber [57]. Furthermore, exact inference, such as
the calculation of confidence intervals and various significance tests for coefficients are based on
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Figure 3.11: QQ-plots of the residuals for the ANCOVA model (systolic blood pressure).
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Figure 3.12: QQ-plots of the residuals for the ANCOVA model (diastolic blood pressure).
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Figure 3.13: Density estimate of the residuals for the ANCOVA model (systolic blood pressure).
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Figure 3.14: Density estimate of residuals for the ANCOVA model (diastolic blood pressure).
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the assumption that the errors are normally distributed. If the error distribution is significantly
non-Normal, confidence intervals may be too wide or too narrow [108]. The assumption of nor-
mality in residuals is often violated because the distributions of the dependent or independent
variables are themselves significantly non-Normal, and in such cases it is common practice to
transform the dependent or independent variables to rectify this problem.
One of the advantages of η̂ is that it can play a role in selecting an appropriate transfor-
mation, because the sign indicates the direction of the asymmetry. When η̂ > 0 this implies
the data are skewed towards the right and so we must apply a transformation which ‘pulls in’
the extreme values. Examples of such transformations include the logarithmic and square root
transformations. On the other hand, if η̂ < 0 then this indicates the data are skewed to the
left and so there is a need to ‘pull up’ the smaller values. Such transformations could involve
performing an exponential or power transformation.
We now illustrate this using the hypertension data once more, and examine whether trans-
formation of the final blood pressure data improves the normality of the residuals from the
ANCOVA model. Our first step is to select an appropriate transformation for the response
variable, based on the value of η̂. After attempting a number of different transformations on the
final blood pressure data it appears that for positive η̂ the logarithmic transform have the most
appreciable effect on the asymmetry, whilst for the negative η̂ squaring the data appears most
effective. Table 3.4 shows the effect of applying the appropriate transformation to the response
variable. It is clear that the measure of asymmetry η̂ is markedly reduced, particularly in the
HDFP, STOP, and EWPH trials. In fact applying a logarithmic transform to the systolic blood
pressure data in the HDFP trial reduces the value of η̂ from 0.22 to 0.10. Figures 3.15 to 3.18
show the visual improvement in the symmetry of the residuals.
The results of this section clearly demonstrate that η̂ can be a useful tool in governing
transformation of the covariate or response data in our ANCOVA model. Indeed, η̂ has a role to
play in all stages of the data transformation process. Firstly, it provides an objective measure
of whether data display inordinate departure from symmetry. Secondly, it provides a useful
guide as to what sort of transformation might be the most effective. Finally, it can be used to
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Figure 3.15: Density estimation of the raw residuals in the HDFP trial and the residuals after
carrying out a logarithmic transform on the response variable (systolic blood pressure).
−100 −50 0 50
0.
00
0
0.
00
5
0.
01
0
0.
01
5
0.
02
0
No transform
D
en
si
ty
−30000 −20000 −10000 0 10000 20000 30000
0e
+0
0
1e
−0
5
2e
−0
5
3e
−0
5
4e
−0
5
5e
−0
5
Transformed
D
en
si
ty
Figure 3.16: Density estimation of the raw residuals in the STOP trial and the residuals after
squaring the response variable (systolic blood pressure).
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Figure 3.17: Density estimation of the raw residuals in the EWPH trial and the residuals after
squaring the response variable (diastolic blood pressure).
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Figure 3.18: Density estimation of the raw residuals in the SYSE trial and the residuals after
squaring the response variable (diastolic blood pressure).
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Trial
Residual η̂
Transformation
η̂ after response
pre-transform transformation
HDFP
0.22 (0.18, 0.26) Log 0.10 (0.05, 0.15)
(systolic)
STOP −0.23 (−0.44, 0.01) Square −0.10 (−0.32, 0.14)
(systolic)
EWPH −0.24 (−0.57, 0.04) Square −0.09 (−0.43, 0.20)
(diastolic)
SYSE −0.26 (−0.30,−0.22) Square −0.18 (−0.22,−0.13)
(diastolic)
Table 3.4: Effect of applying an appropriate transformation to the response variable on the
asymmetry of the residuals in the ANCOVA model.
objectively determine whether the transformation has been successful by providing a numerical
value to quantify the difference in asymmetry before and after the transformation.
3.6 Limitations of testing for normality with η̂
It is important to note that the Normal distribution of η̂ described in Chapter 2 is asymptotic.
As a result, we are reliant on large samples to accurately conduct tests and report p-values based
on η̂. For small samples, the actual value of η̂ remains a reasonable measure of the asymmetry
of the data, but because we are estimating f and F we do require a reasonable number of
data points to build an accurate description of the underlying density and distribution function.
Further, one must be mindful of the fact that η̂ is a measure of asymmetry, not normality.
Hence, even if η̂ is close to zero the sample need not represent a Normal population. We can
use the hypertension data once again to demonstrate this fact. In the hypertension data some
of the studies specifically include more elderly patients, for example MRC2 and STOP. On the
other hand, some studies are interested in younger patients, for example, ANBP and HDFP. As
a result when we pool together all of the studies we can see that the age data are described by a
clearly bimodal population. This can be seen in Figure 3.19, which shows the density estimate
of the pooled age data. Interestingly however, due to the incidental symmetry of this bimodal
sample, η̂ is actually very small, and the results can be seen in Table 3.5. In fact, we are unable
to reject the null hypothesis of symmetry even with such a large sample size. This example
demonstrates that η̂ alone is not a suitable indicator of the normality of a set of data. Rather,
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one should also consult a histogram and QQ-plot before jumping to the conclusion that a given
sample is Normal just because η̂ is small. Figure 3.20 shows the QQ-plot for this set of data
and it is immediately clear that the age data are not Normal.
Treatment Control
η̂ p-value n η̂ p-value n
Age 0.01 0.25 14459 0.01 0.36 14122
Table 3.5: Testing symmetry of age data pooled across studies.
3.7 Discussion
In this chapter it was shown that, for a reasonably large data set, η̂ has a number of useful
applications as a test statistic, as well as a summary statistic. Using the hypertension data set
collated by Wang et al. [125] one is able to test for baseline imbalance between the treatment
and control samples in each trial. Furthermore, η̂ can also be used to test the symmetry of
residuals in ANCOVA models, which is an important assumption of the model. Furthermore, it
was shown that η̂ can play a crucial role in identifying when to transform the data, what type
of transformation is likely to be effective, and evaluating whether the transformation has been a
success. In conclusion, it appears that η̂ has the potential to be a very useful tool in a number
of different important applications.
Of course, while we have exclusively considered using η̂, there are many other measures of
skewness or asymmetry that would be viable for the applications discussed here. For example,
in Chapter 1 we discussed measures of asymmetry proposed by MacGillivray [76], Boshnakov
[11], and Li and Morris [73], as well as the multiple measures of skewness proposed by Pearson
[91] and the quantile measure of skewness proposed by David and Johnson [22]. However, each
of these measures have a number of shortcomings when compared with η̂. For example, the
method given by MacGillivray [76] disregards a certain amount of the probability mass in the
tails of the random variable. This is a significant drawback when measuring the asymmetry
of a random variable, as the tails obviously provide crucial information in that regard. More-
over, the measures of asymmetry proposed by Boshnakov [11] are only applicable to unimodal
distributions, and so are only valid for a reduced class of random variables.
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Figure 3.19: Density estimate of pooled age data.
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Figure 3.20: QQ-plot of age data.
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Furthermore, the measures of skewness discussed here all fail to effectively calibrate asym-
metry in comparison with η. This is demonstrated in Chapter 2 where we consider two tests of
symmetry based on Pearson’s skewness coefficients. For example, the test proposed by Cabilio
and Masaro [17] is based on the sample version of γ1, while the test detailed by Gupta [43] is
based on the sample version of γ3. It was established in Chapter 2 that each of these tests have
power which is inferior to the test based on η̂.
It was also established that one of the shortcomings of η̂ is that the distribution given in
Chapter 2 is asymptotic. As a result, one requires a reasonably large sample to apply the Normal
approximation. Large samples were available in the hypertension trials, but other situations (e.g.
observational studies of rare diseases) may involve small numbers of patients. In the subsequent
chapter we demonstrate that it is not appropriate to assume a Normal distribution for η̂ in small
samples, before proposing a new estimation procedure which is more robust for small samples.
In summary,
• η̂ can be used to compare the baseline characteristics of a randomised control trial,
either as an additional summary statistic or to statistically test for a difference in the
distributions (though such routine testing is not advised).
• η̂ can provide a helpful insight in guiding and evaluating the transformation of skewed
data.
• η̂ can also be used to assess the normality of a set of data, provided it is used alongside
an appropriate visual aid, such as a QQ-plot.
• Small samples may compromise the accuracy of confidence intervals and p-values, but
η̂ still provides a helpful measure of asymmetry provided there are sufficient samples
to accurately estimate the density or distribution function.
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Chapter 4
An investigation into the small
sample properties of η̂
4.1 Introduction
Up to this point, we have only considered using η̂ to measure asymmetry or test for symmetry
in large samples. As we have previously identified, the distribution of η̂ calculated in Chapter 2
is asymptotic and so requires a reasonably large sample to apply the Normal approximation. In
this chapter we demonstrate that it is not appropriate to assume a Normal distribution for η̂ for
small samples, before proposing a new estimation procedure which is theoretically more robust
for small samples. We then compare the performance of this new procedure with η̂ in small and
large samples by way of a simulation study, as well as two examples using real data.
In section 4.2 we estimate the sampling distribution of η̂ for small samples and reveal the
limitations of applying η̂ in this case. This is the motivation for a transformed measure which
is shown to have better distributional properties for small samples. In section 4.3 we derive
the asymptotic distribution of this new measure and demonstrate that this distribution is more
accurate for small samples. In section 4.4 we introduce and discuss the bootstrap, to assist
in the calculation of the standard error of the new measure and thereby allow us to construct
accurate confidence intervals. In section 4.5 we use a simulation study to compare the raw
and transformed measure by assessing the accuracy the confidence intervals for η obtained by
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using the two methods, where the variance is estimated using both bootstrapping and asymptotic
theory. In section 4.6 we compare the effectiveness of the two measures at quantifying asymmetry
using two real data examples. Finally, section 4.7 summarises the results of this chapter.
Aims of the chapter:
• Demonstrate the limitations of η̂ in small samples.
• Develop a new measure ζ̂ that has better small sample properties.
• Compare the performance of the two measures using real and simulated data.
4.2 The sampling distribution of η̂ for small data sets
Recall that η is defined as the correlation coefficient between f(X) and F (X). Likewise, η̂
can be regarded as the corresponding sample estimate of this correlation coefficient. Tjostheim
[120] notes that the small sample estimation of the sample correlation coefficient is somewhat
problematic. Indeed, Tjostheim states that it is “well established that the sampling distribution
of the sample correlation coefficient is appreciably skewed” even for quite substantial sample
sizes. Soper et al. [116] previously carried out an extensive investigation into the distribution
of the sample correlation coefficient in small samples. They conclude that the distribution is
substantially non-Normal for samples of 25 and 50, irrespective of the value of the true correlation
coefficient ρ. Further, while there is a better approximation for n = 100 when ρ < 0.4, there is
still a substantial deviation for larger values of ρ.
Therefore, for small samples the Normal approximation that was derived in Chapter 2 is
invalidated, as are the proposed estimates of the variance. To clarify, whilst the estimated value
of η is not significantly compromised, small samples present a barrier to calculating accurate
confidence intervals. As a result, small samples will also have an adverse effect on the perfor-
mance of our test based on η̂, proposed in Chapter 2. In particular, we can no longer guarantee
the accuracy of the calculated p-values. One suggestion is to apply the asymptotic theory with
the t distribution in place of the Normal distribution, to account for the uncertainty in the
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estimate of the variance of η̂. However, the variance estimate proposed in Chapter 2 (equation
(2.9)) is generally already conservative, as we will show in section 4.5. Also, the t distribution
fails to account for asymmetry in the small sample distribution of η̂.
Figures 4.1 and 4.2 show the estimated sampling distribution of η̂ based on 10, 000 small
samples (n = 15) from several random variables. It is clear that the sampling distribution of
η̂ is particularly non-Normal when the samples are taken from asymmetric random variables
(when η is closer to the extreme value of 1). In particular, the sampling distribution is heavily
skewed to the left as η̂ cannot take values larger than one. In the next section we propose how
to transform η̂ to reduce the skewness in the sampling distribution.
4.3 ζ - The Fisher Z-transformation of η
The Fisher Z-transform of the sample correlation coefficient r,
Z(r) =
1
2
log
(
1 + r
1− r
)
,
is known to be a better approximation to normality.
Fisher [35] proposed the Z-transformation to stabilise the variance of the sample correlation
coefficient r. That is, the transformation ensures that the variance of Z(r) is similar for all values
of r. Moreover, Fisher [36] showed that for small samples Z(r) follows a Normal distribution
more closely than r. Fisher comments that for just 8 observations “when these correlations are
distributed over the scale of r, the (density) curves are far from Normal even when (the true
correlation coefficient) ρ is equal to 0, and when ρ = 0.8 they become extremely skew.” By con-
trast, Fisher observes that in the Z-transformed scale the density curve “appears symmetrical”
and furthermore, “the entire curve is identical for all values of ρ.”
Indeed, simulations appear to suggest that the finite sample behaviour of Z(η̂) is better
than η̂, that is, Z(η̂) appears to follow a Normal distribution more closely than η̂ for small
samples. Figures 4.3 and 4.4 show the estimated sampling distribution of Z(η̂) based on 10, 000
small samples (n = 15) from several random variables. In this case the sampling distribution
is significantly improved compared to η̂ in Figures 4.1 and 4.2, despite still showing some slight
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Figure 4.1: Density estimate of the sampling distribution of η̂ based on 10, 000 small samples of
size n = 15 from Normal and Cauchy random variables.
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Figure 4.2: Density estimate of the sampling distribution of η̂ based on 10, 000 small samples of
size n = 15 from the Log-Normal and Folded Normal distributions.
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Figure 4.3: Density estimate of the sampling distribution of the Fisher Z-transformed measure
Z(η̂) based on 10, 000 small samples of size n = 15 from Normal and Cauchy distributions.
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Figure 4.4: Density estimate of the sampling distribution of the Fisher Z-transformed measure
Z(η̂) based on 10, 000 small samples of size n = 15 from the Log-Normal and Folded Normal
distributions.
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skewness to the left for the asymmetric random variables.
Therefore, let
ζ = Z(η),
and
ζ̂ = Z(η̂).
The asymptotic distribution of ζ̂ is outlined in the following theorem.
Theorem 4.1 Let X1, · · · , Xn be a random sample from a continuous probability density func-
tion f(x) and distribution function F (x). Then, under the assumptions of Theorem 2.3, as
n→∞
√
n ·
[
ζ̂ − ζ
]
L−→ N(0, τ2),
with
τ2 =
σ2
(1− η2)2 ,
and
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
,
where νf and νF denote Var(f(X)) and Var(F (X))
(
= 112
)
respectively, and µf = E[f(X)].
The proof follows almost directly from Theorem 2.3.
Proof. Recall that from Theorem 2.3,
√
n · [η̂ − η] L−→ N(0, σ2).
Also, it is readily calculated that
Z ′(r) =
1
1− r2 .
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The delta method [86] states that, if there is a sequence of random variables Xn such that
√
n · [Xn − θ] L−→ N(0, ς2),
then
√
n · [g(Xn)− g(θ)] L−→ N
(
0,
[
g′(θ)
]2
ς2
)
,
for any function g with at least one continuous derivative and g′(θ) 6= 0.
Hence, an application of the delta-method gives
√
n ·
[
ζ̂ − ζ
]
L−→ N(0, τ2). 
One can readily estimate τ2 by simply transforming a suitable estimate of σ2, for example, σ̂2
given in equation (2.9) in Chapter 2. In this case, the estimate of τ2 is
τ̂2 =
σ̂2
(1− η̂2)2 . (4.2)
Therefore the standard error of ζ̂ is given by
s.e.
(
ζ̂
)
=
τ̂√
n
. (4.3)
Now, instead of calculating a confidence interval for η directly, we can instead calculate a
confidence interval for ζ and transform back using
Z−1(x) =
exp(2x)− 1
exp(2x) + 1
= tanh(x),
to obtain confidence interval for η. Now, the advantage of this approach is that it ensures that
we do not obtain any confidence intervals for η which include values outside of [−1, 1]. However,
it is worth noting that the distribution outlined in Theorem 4.1 is also asymptotic and, in fact,
carrying out the delta-method creates another source of error. Therefore the estimate of the
variance of ζ̂, given in equation (4.2), is more imprecise than the variance estimate of η̂. We
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demonstrate this in section 4.5 when we compare the effectiveness of the two approaches using
simulated data. Hence, although we are able to reduce the skewness in the sampling distribution
of the measure, it comes at a price. Namely, that estimating the variance by conventional
methods becomes more difficult. This motivates an alternative procedure, bootstrapping, to
estimate the variance. The next section is dedicated to introducing bootstrapping and discussing
how to apply it to help in estimating the variance of ζ̂.
4.4 Bootstrapping
As noted by Efron and Tibshirani [31], the bootstrap is a data based simulation method for
statistical inference, which can be used to make inferences about almost any test statistic, such
as estimating the variance and generating confidence intervals. The use of the term bootstrap
derives from the phrase to pull oneself up by one’s bootstrap. The simple principle behind the
bootstrap is to re-sample from the available data and thus approximate the sampling distribution
of the statistic of interest.
In the context of testing for symmetry or measuring asymmetry non-parametric bootstrap-
ping proceeds as follows. Given a random sample from an unknown population with an unknown
amount of asymmetry η, draw with replacement another sample from it and repeat until the
same sample size is obtained. Repeating this process a large number of times, say 1000 times,
one can obtain 1000 bootstrap samples. Then η can be estimated in each replicate and the
1000 estimates provide an approximate sampling distribution of η̂, which can be used to make
inferences about η.
Our interest is to construct accurate confidence intervals for η and ζ, which can be asymmet-
ric for small samples. Suppose that X0 = (X1, X2, · · · , Xn) is the random sample of interest,
which is drawn from a population with an unknown quantity of asymmetry η0. Further, let
η̂ = η(X0) be the observed estimate of η in the original sample X0. Let X˜1, X˜2, · · · , X˜R be
the surrogate data sets that are re-sampled from the original data X0. Further, suppose that
η˜1, η˜2, · · · , η˜R are the corresponding estimates of η in the surrogate data sets. This collection of
estimates can then be used to make inferences about η. For example, one can obtain an estimate
of the variance of η̂ or construct an approximate 95% confidence interval.
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Approximate confidence intervals based on bootstrapping were pioneered by Efron [28]. The
basic 100(1− α)% bootstrap confidence interval for η is given by
[
2η̂ − η˜(1−α2 ); 2η̂ − η˜α2
]
, (4.4)
where η˜α is the α quantile of the bootstrap sample, η˜1, η˜2, · · · , η˜R [23]. Similarly, the corre-
sponding 100(1− α)% confidence interval for ζ is
[
2ζ̂ − ζ˜(1−α2 ); 2ζ̂ − ζ˜α2
]
, (4.5)
where ζ˜α is the α quantile of the bootstrap sample, ζ˜1, ζ˜2, · · · , ζ˜R.
In fact, since their first implementation a number of other competing methods for generating
bootstrap confidence intervals have been developed [30]. Aside from the basic confidence interval
defined in equation (4.4) other methods include: the percentile bootstrap (based directly on the
quantiles of the surrogate estimates η˜i); the bootstrap-t; and the bias corrected bootstrap [29].
Efron and Tibshirani [31] state that “the Normal and t percentage points are symmetric about
zero, and as a consequence the resulting intervals are symmetric about the point estimate. In
contrast, the bootstrap-t percentiles can be asymmetric about 0, leading to intervals which are
longer on the left or right.”
However, it is widely known that the sample correlation coefficient is problematic to handle
with the ordinary bootstrap. In fact, Hall [44] goes as far as describing the problem of con-
structing a confidence interval for a correlation coefficient as the “smoking gun” of bootstrap
methods. Indeed, Hall comments that “when used without a variance-stabilizing transforma-
tion, percentile-t fails spectacularly, producing intervals that have poor coverage accuracy and
fail to respect the range of the coefficient. This seems to be case regardless of the choice of the
variance estimate.”
For this reason, we construct rough bootstrap confidence intervals for η̂ and ζ̂ using equations
(4.4) and (4.5). In the next section we apply this method to generate 95% confidence intervals
for η using η̂ and ζ̂ and compare their accuracy with the confidence intervals constructed under
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the asymptotic theory, with particular focus on the small sample case.
4.5 Simulation study comparing the estimation procedures
4.5.1 Methods
We compare the bootstrap approach with the asymptotic theory by generating confidence in-
tervals for η using simulated data from a range of distributions and determining the coverage
of these confidence intervals. In particular, we consider data sampled from Normal, Cauchy,
Uniform, Normal mixtures, Skew Normal, Log-Normal, Folded Normal and Exponential popu-
lations. For both η and ζ we simulate data from each distribution with a relatively small sample
size (n = 15) and a more substantial sample size (n = 100). In each case we calculate the 95%
confidence intervals using the asymptotic theory given in Theorem 2.3 and Theorem 4.1 (using
a Normal distribution), and calculate a competing confidence interval using bootstrapping with
1000 replicates by applying equations (4.4) and (4.5). For each of these approaches we repeat
the process 10, 000 times to determine the coverage, that is, the number of confidence intervals
that contain the true value. Table 4.1 summarises the simulation procedure.
Step 1 Simulate samples of size n = 15 and n = 100 from each of the distribu-
tions.
Step 2 Calculate confidence intervals for η and ζ using the asymptotic theory in
Theorem 2.3 and Theorem 4.1 and bootstrap confidence intervals using
equations (4.4) and (4.5).
Step 3 For each method, determine whether the confidence interval contains
the true value of η and ζ.
Step 4 Repeat Steps 1-3 10, 000 times and report coverage for each method.
Table 4.1: Step by step guide to the simulation study comparing the coverage of the confidence
intervals.
4.5.2 Results
Table 4.2 shows the coverage results for η and ζ with sample size n = 100. In this case it appears
that the Normal asymptotic theory using η̂ does a reasonable job of capturing the distribution
of η̂, with the coverage not deviating too far from the expected value of 0.95 in the conventional
cases. That is, the coverage is close to 0.95 for the Normal and Normal mixtures and is still
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reasonably close for the Cauchy distribution and even the Exponential distribution. However,
the confidence intervals based on η̂ do perform poorly for several of the more pathological cases,
with a very low coverage of 0.88 and 0.85 for the Uniform and Folded Normal distributions and
a very high coverage of 0.99 for the Log-Normal distribution. Furthermore, it is clear that the
confidence intervals are not improved when using ζ̂ with asymptotic theory. It is also worthy
of note that in this case, when the data are exponentially distributed, the confidence intervals
constructed using ζ̂ never contain the true value of η = 1. This is because, when the confidence
intervals are constructed in this fashion, the confidence intervals are always entirely between −1
and 1.
Using bootstrapping to construct the confidence intervals for η̂ produces confidence intervals
which are too small with coverage around 0.91 for most cases. This reflects the concerns raised
by Hall and Efron regarding the use of the bootstrap to estimate the sampling distribution of
the correlation coefficient. On the other hand, using the variance stabilising Z-transformation
and considering ζ̂ along with bootstrapping appears to produce very good results in most cases.
Indeed, the coverage is very close to 0.95 on the whole, with the exception of the uniform
distribution and the heavily skewed distributions.
Table 4.3 reports the coverage of the 95% confidence interval for η and ζ using a much smaller
sample of n = 15. At first glance it appears a similar story to the large sample case. Indeed,
using η̂ with asymptotic theory seems to perform reasonably well on the whole, particularly
for the Normal and Cauchy distributions and mildly skewed Normal mixtures. In the other
cases the confidence intervals are generally overly conservative, with the exception of the Folded
Normal distribution. By contrast, using ζ̂ with bootstrapping produces confidence intervals
which are too small, with coverage around 0.91 for most of the conventional distributions. An
advantage of the confidence intervals generated by ζ̂, which goes undetected by only considering
the coverage, is that it produces suitably asymmetric confidence intervals for the asymmetric
distributions and will never produce a confidence interval containing impossible values outside
of the range of [−1, 1].
Unsurprisingly, using the asymptotic variance of ζ̂ generates very poor confidence intervals
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in every case considered here. Also, using bootstrapping with η̂ generates extremely erratic
confidence intervals which are frequently too short.
The results of this section show that, even for rather small samples, applying the asymptotic
theory η̂ produces the best approximate confidence intervals in terms of coverage. However, these
confidence intervals have two notable disadvantages. Firstly, the confidence intervals constructed
using asymptotic theory are necessarily symmetric and therefore fail to capture the asymmetry
in the small sample distribution. Secondly, it is possible to construct confidence intervals which
include values outside the range of [−1, 1]. In these cases we have shown that confidence intervals
constructed using ζ̂ and bootstrapping resolve these issues, but do not attain the same level of
coverage and generally appear to be too short.
For the symmetric populations under consideration here, the best coverage results are ob-
tained by using the asymptotic variance for η̂, irrespective of sample size. Hence, it is rec-
ommended to use this approach to test for symmetry in small or large samples, however, it is
imperative that the sample is large enough to provide an accurate estimate of the underlying
density or distribution function.
However, when η is close to the −1 or 1 the sampling distribution of η̂ is appreciably skewed,
therefore, more care should be taken when constructing confidence intervals. Nevertheless, when
the sample size is reasonably large (n > 30), one can still apply the asymptotic theory directly
on η̂. For smaller samples, based on the coverage results in Table 4.3, it is still recommended to
apply the asymptotic theory for η̂, truncating the confidence intervals at −1 or 1 if necessary.
However, in these cases, one should also check how discrepant the results are to the ζ̂ approach
using bootstrapping. If the two approaches are excessively disparate then one might conclude
that there is insufficient data to accurately assess the asymmetry and, thus, further research
with bigger samples is necessary. In the next section we reinforce these ideas by considering a
couple of examples of calculating ζ̂ using real data.
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η Distribution
Asymptotic Bootstrapping
η̂ ζ̂ η̂ ζ̂
0 Normal 0.959 0.971 0.896 0.936
0 Cauchy 0.966 0.973 0.924 0.950
0 Uniform 0.883 0.957 0.643 0.763
0.1 NM1 0.959 0.971 0.906 0.944
0.2 NM2 0.958 0.968 0.909 0.944
0.3 NM3 0.964 0.972 0.918 0.946
0.4 NM4 0.969 0.969 0.918 0.941
0.5 SN5 0.961 0.951 0.904 0.918
0.6 SN6 0.964 0.937 0.902 0.899
0.7 SN7 0.962 0.917 0.906 0.869
0.8 SN8 0.953 0.870 0.915 0.811
0.91 Log-Normal 0.990 0.920 0.970 0.783
0.95 Folded Normal 0.850 0.365 0.887 0.245
1 Exponential 0.969 0.000 0.907 0.000
Table 4.2: Coverage of 95% confidence intervals for η based on 10, 000 samples of size n = 100.
Confidence intervals are constructed using η̂ and ζ̂, estimating the variance using asymptotic
theory and bootstrapping with R = 1000 replicates.
η Distribution
Asymptotic Bootstrapping
η̂ ζ̂ η̂ ζ̂
0 Normal 0.953 1.000 0.766 0.911
0 Cauchy 0.960 1.000 0.826 0.952
0 Uniform 0.906 1.000 0.571 0.769
0.1 NM1 0.954 0.999 0.771 0.913
0.2 NM2 0.963 0.997 0.780 0.913
0.3 NM3 0.971 0.993 0.785 0.905
0.4 NM4 0.974 0.987 0.789 0.903
0.5 SN5 0.951 0.961 0.759 0.882
0.6 SN6 0.943 0.937 0.755 0.865
0.7 SN7 0.942 0.904 0.768 0.845
0.8 SN8 0.926 0.832 0.819 0.822
0.91 Log-Normal 0.979 0.866 0.950 0.846
0.95 Folded Normal 0.885 0.553 0.855 0.550
1 Exponential 0.959 0.000 0.952 0.000
Table 4.3: Coverage of 95% confidence intervals for η based on 10, 000 samples of size n = 15.
Confidence intervals are constructed using η̂ and ζ̂, estimating the variance using asymptotic
theory and bootstrapping with R = 1000 replicates.
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4.6 Real data example
4.6.1 A small data set
We begin by considering a small set of data from an observational study investigating the use of
parathyroid hormone (PTH) to predict the onset of hypocalcemia after a thyroidectomy. This is
part of a collection of studies on the topic collated by Noordzij et al. [85], which we will introduce
in the next chapter. In particular, we consider the preoperative PTH levels in patients who did
not go on to develop hypocalcemia in the study by Lam and Kerr [71]. Figure 4.5 shows the
histogram of the data, which appears to demonstrate some asymmetry to the right.
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Figure 4.5: Histogram of the preoperative PTH levels in patients who did not go on to develop
hypocalcemia in the study by Lam and Kerr [71].
Now, suppose that the main interest is to measure the asymmetry in this particular set
of data, for example, one might require an estimate of the asymmetry to inform or guide a
normalising transformation. For this particular set of data there are only 27 individuals so we
may expect that the confidence interval for η is not likely to be especially precise. Let ηs be the
measure of asymmetry η in this case. If we estimate ηs for this particular data set we obtain
η̂s = 0.69,
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which suggests quite substantial asymmetry to the right. However, the confidence interval for
ηs constructed using the asymptotic theory given in Theorem 2.3, is given by
[−0.09; 1.47].
The first thing to observe is that this confidence interval is very wide but, more than that, the
confidence interval includes numbers outside the range [−1, 1]. As we have already mentioned
ηs is a correlation coefficient, therefore, it is impossible that the value of ηs could fall outside
[−1, 1]. Thus, it is clear in this case that asymptotic theory has broken down and that the
constructed confidence interval has lost some of its meaning. By truncating the interval at 1 we
obtain the approximate confidence interval
[−0.09; 1].
However, if we apply the new small sample approach we find that
ζ̂s = Z (η̂s) = 0.84,
and the confidence interval for ζs = Z(ηs), constructed using equation (4.4) and 1000 bootstrap
replicates, is
[0.05; 1.63].
Now, transforming back using the inverse transformation Z−1(x) = tanh(x) we obtain the
following confidence interval for ηs,
[0.05; 0.93].
Hence, by using the transformed measure ζ̂ along with a bootstrap estimate of the variance
we have produced a slightly shorter approximate confidence interval. However, recall that the
confidence intervals constructed using this method are generally too short. Since the result is not
overly dissimilar to the truncated confidence interval constructed using the asymptotic theory,
and appealing to the results of the simulation study, we conclude that [−0.09; 1] is a reasonably
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Figure 4.6: Density estimate of the initial diastolic blood pressure (IDBP) in the treatment
group of the COOP trial.
accurate 95% confidence interval. Clearly, however, there is large uncertainty in the findings
and further research with larger samples is required to produce more precise results.
4.6.2 A large trial
We now revisit the hypertension data collated by Wang et al. [125] to investigate the effectiveness
of ζ̂ for measuring asymmetry in larger data sets. In particular, we focus on the initial diastolic
blood pressure in the treatment group of the COOP trial (n = 150). Figure 4.6 shows the
density estimate of the data, which this time demonstrates asymmetry to the left.
In this case, as the sample size is larger, we expect that the asymptotic theory will be more
effective at approximating the confidence interval for η. Let ηl denote the measure of asymmetry
in the underlying population. It is readily calculated that
η̂l = −0.83,
which indicates substantial asymmetry to the left. Moreover, the confidence interval for ηl is
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given by
[−0.99;−0.66].
On the other hand, by applying the transformed method we obtain ζ̂l = −1.2 and the confidence
interval for ζl = Z(ηl), constructed using bootstrapping with 1000 bootstrap replicates, is
[−1.42;−0.98].
Once again, if we transform back to acquire a confidence interval for ηl then we obtain
[−0.89;−0.75].
Hence, even in the large sample case we obtain a much tighter confidence interval. However, this
is certainly due in part to the fact that the coverage of the 95% confidence intervals constructed
using the ζ̂ approach is lower than 0.95. Regardless, it is clear from either confidence interval
that large asymmetry exists in this data.
4.7 Discussion
In this chapter we revealed the limitations of applying η̂ to small samples. Principally, we
showed that the asymptotic Normal distribution does not provide a good approximation. This
was the motivation for a transformed measure ζ̂ which appeared to follow a Normal distribution
more closely for small samples. We also introduced and discussed the bootstrap to facilitate the
construction of confidence intervals for this new measure, which appear to be fairly accurate
for the more conventional distributions considered here. We carried out a simulation study
to compare the accuracy of the confidence intervals for η using bootstrapping and asymptotic
theory. It was shown that, on the whole, confidence intervals constructed directly using η̂ with
variance estimation based on the asymptotic theory provide the best the confidence intervals
in terms of coverage. On the other hand, ζ̂ can be used to generate confidence intervals for η
which are more meaningful, in the sense that they are suitably asymmetric and do not extend
beyond the interval [−1; 1]. We proposed an effective compromise, namely, to generate the
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confidence intervals using η̂, but truncate the confidence limits at −1 or 1. This approach
attains reasonable accuracy in terms of coverage. However, it is constructed by assuming that the
sampling distribution of η̂ is approximately Normal, an untenable assumption when η is close to
−1 or 1 and the sample size is small. Finally, we compared the effectiveness of the two procedures
using two real data sets, one small and one large. It was shown that, despite discrepant upper
and lower bounds, the conclusions about asymmetry were very similar irrespective of which
approach was used to derive the confidence intervals. In the first, both confidence intervals
revealed substantial uncertainty indicating the need for more data; in the second, both gave
strong evidence of a large degree of asymmetry.
In summary, for the symmetric populations the best coverage results are obtained by using
the asymptotic variance for η̂, irrespective of sample size. If the principal interest is to test
for symmetry, then one is only really concerned with the sampling distribution under the null
hypothesis of symmetry. Hence, for testing symmetry it is recommended to use η̂ with the
asymptotic variance estimate, regardless of the sample size. Nonetheless, to ensure an accurate
estimate of η it is imperative that the sample is large enough to provide an accurate estimate
of the underlying density or distribution function.
However, it was shown that when η is close to the −1 or 1 the sampling distribution is
appreciably skewed, therefore more care should be taken when constructing confidence intervals.
When the sample size is reasonably large (n > 30), it is recommended that one applies the
asymptotic theory directly on η̂. For smaller samples, it is suggested to apply the asymptotic
theory for η̂, truncating the confidence intervals at −1 or 1 if necessary. However, one should
also check how discrepant the results are to the ζ̂ approach using bootstrapping, and, if the two
approaches are unreasonably incongruent then one can conclude that there are too few samples
to accurately assess the asymmetry in the population.
In conclusion, the methods discussed in this chapter provide a useful alternative for small
samples, however, there are a number of limitations which must be addressed. Indeed, the
problem of constructing accurate confidence intervals for η in the small sample setting has not
been satisfactorily resolved. In particular, the issues encountered are similar to those identified
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by Hall [44] in the context of constructing bootstrap confidence intervals for the correlation
coefficient. Hence, the problem of drawing inferences from small samples remains something of
a ‘smoking gun’ for η, and something that merits further research. It was shown that, while
using bootstrapping with ζ̂ succeeds in producing asymmetric confidence intervals, they are
generally too narrow. As a result, for small samples, the recommendation is to prioritise the
original asymptotic approach, truncating the confidence intervals at −1 or 1 if necessary.
Another limitation is the fact that we have only considered using non-parametric bootstrap-
ping with the simple confidence intervals given in equation (4.4). In fact, there are a huge
variety of methods for performing bootstrapping, as well as the subsequent calculation of confi-
dence intervals. For instance, other bootstrap methods include the parametric bootstrap or the
smoothed bootstrap [27]. Additionally, it is also possible to construct confidence intervals that
adjust for bias [29]. However, these procedures are often more computationally intensive and,
consequently, their implementation is not so widespread.
In the next chapter we discuss how one can apply η̂ and ζ̂ to carry out a meta-analysis of η
with the aim of comparing the distribution of data across several studies.
Recommendations for applying η̂:
• For large samples (n ≥ 30) the asymptotic theory for η̂ seems to produce accurate
confidence intervals across a range of distributions.
• Even for small samples (n < 30) the asymptotic theory for η̂ seems to produce the most
accurate confidence intervals in terms of coverage, despite the fact that the sampling
distribution of η̂ is somewhat more skewed than ζ̂.
• Confidence intervals for η, which are constructed using ζ̂, allow for asymmetry in the
sampling distribution of η̂ when η is close to −1 or 1. Further, they are guaranteed to
be between [−1, 1], but do not perform as well in terms of coverage.
• On balance, it is recommended to calculate confidence intervals using the asymptotic
theory of η̂ and appropriately crop the confidence intervals that extend beyond the
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range [−1, 1].
• For symmetric distributions the sampling distribution of η̂ appears to be approximately
Normal, even for samples as small as n = 15. Therefore, in the context of testing for
symmetry, p-values should not be too badly compromised when the sample size is
small.
• Irrespective of what method we use, it is imperative that there are enough sample
points to reasonably estimate the density function f and the distribution function
F . The requisite number of points for this will vary depending on the shape of the
underlying population.
• If confidence intervals are very wide then it indicates that further data collection is
required to enable more precise inferences.
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Chapter 5
Analysing the asymmetry of data
across several studies
5.1 Introduction
As shown in the previous chapter, a common problem when dealing with small samples is that
it can often be difficult to assess the distributional properties of the data. For example, for
small samples the data may appear to be considerably asymmetric or fail to conform to a
Normal distribution, but this could be due to chance. This, in turn, leads to uncertainty about
whether or not it is appropriate to transform the data. Indeed, in medical statistics it is not
uncommon that, for a number of small studies which are investigating the same treatment or
intervention, different authors come to disparate conclusions about the appropriate scale [54].
When individual patient data are available, one might be tempted to pool the data across
all studies to assess the underlying distribution. However, in this chapter we show that this
approach can produce misleading results, and propose alternative methodologies.
In this chapter we consider how to examine and combine asymmetry estimates of a particular
distribution, when multiple studies are available. In section 5.2 we introduce the fixed effect and
random effects meta-analysis models before conducting a brief review of the existing literature on
the meta-analysis of correlation studies. In section 5.3 we investigate measuring the asymmetry
of data across several studies with the aim of obtaining an ‘overall’ measure of the asymmetry
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in the underlying population. In particular, we explore the potential pitfalls of simply pooling
the data from every study, before proposing a meta-analysis of the asymmetry measure η to
combat this problem. In section 5.4 we examine employing the meta-analysis of η on a much
smaller data set, a collection of comparatively small observational studies. In this case, we show
that a meta-analysis of ζ can be used to obtain more meaningful conclusions. In section 5.5 we
extend this technique to identify distributional differences between the treatment and control
arms across several studies. In section 5.6 we summarise the results of the chapter.
Aims of the chapter:
• Investigate the problem of measuring the asymmetry in a population with several
samples from heterogeneous studies.
• Identify the dangers of simply pooling studies together to investigate asymmetry.
• Develop a meta-analysis approach to solve this problem using the measures of asym-
metry, η̂ and ζ̂.
• Explore the possible applications of these techniques in small and large data sets.
5.2 Meta-analysis
5.2.1 Fixed effect meta-analysis
As the name suggests, a meta-analysis is an analysis of analyses. Glass [40] defines a meta-
analysis as “the statistical analysis of a large collection of analysis results from individual studies
for the purpose of integrating the findings.” In essence, a meta-analysis seeks to combine the
results of several independent studies that are considered to be similar enough to be synthesised
in a meaningful manner. In the medical literature it is commonplace for a number of different
studies to investigate the effect of the same treatment or intervention. This provides something
of a dilemma to a clinician as studies can often give different or even contradictory results. A
meta-analysis provides a way to collate the results of a number of studies in a systematic way
109
and provide a single overall treatment effect estimate, which is of practical use to a clinician. An
obvious advantage of carrying out a meta-analysis is that it increases the available sample size,
which reduces the uncertainty in the treatment effect estimate and increases statistical power.
It also allows for investigation of the similarities and differences between individual studies and
their effect sizes.
Suppose there are k studies investigating a specific treatment or intervention. Further,
suppose that each study reports the treatment effect estimate θ̂i and its variance σ
2
i for i =
1, · · · , k. The fixed effect model assumes homogeneity across studies and, more specifically, that
each study is estimating the same effect θ. Therefore, in the parametric framework detailed by
Whitehead and Whitehead [127], the fixed effect model has the form
θ̂i ∼ N(θ, σ2i ).
The first challenge when synthesising treatment effect estimates from multiple studies is to
account for the different levels of uncertainty in each study. Typically, some studies will have
a larger sample size than others and so the each individual estimate has a different standard
error. The inverse-variance method provides greater weighting to the estimates with a smaller
variance,
wi =
1
σ2i
,
where σ2i is the variance of θ̂i. The maximum likelihood estimate of the overall effect estimate
is the following weighted average of the individual treatment effect estimates θ̂i,
θ̂ =
∑k
i=1wiθ̂i∑k
i=1wi
.
The overall effect estimate θ̂ has variance
Var
(
θ̂
)
=
1∑
iwi
.
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Hence, an approximate 100(1− α)% confidence interval for θ is given by
θ̂ ± Zα
2
√
1∑
iwi
.
As we have mentioned, θ̂ is the maximum likelihood estimate of the treatment effect and
as such, it is asymptotically unbiased and asymptotically Normal. In this way, θ̂ provides the
best possible unbiased estimate of the treatment effect θ, using the evidence from all studies.
However, the estimate θ̂ is based on the assumption that all of the studies are estimating the
same underlying treatment effect θ.
Many consider the fixed effect model to be an over-simplification. For example, DerSimonian
and Laird [25] identify that, given the many potential sources of heterogeneity between trials (e.g.
location, dosage, characteristics of the patients), it is unlikely that all the trials are measuring
the same treatment effect. A more realistic assumption is that each of the trials are estimating
a slightly different treatment effect, which itself is randomly drawn from a Normal population.
This gives rise to random effects meta-analysis.
5.2.2 Random effects meta-analysis
When there is evidence of between study heterogeneity, one can modify the meta-analysis to
account for the variability between studies. A random effects meta-analysis assumes that the
underlying treatment effects θi vary across studies, following a Normal distribution with mean
θ and variance τ2. The model can be expressed as
θ̂i ∼ N(θi, σ2i ),
where
θi ∼ N(θ, τ2).
Now, to estimate the overall effect one must account for the within study variances σ2i and the
between study variance τ2. Hence the maximum likelihood estimate of θ in the random effects
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model is
θ̂r =
∑k
i=1w
∗
i θ̂i∑k
i=1w
∗
i
,
where
w∗i =
1
σ2i + τ
2
.
A number of methods have been proposed to estimate the between study variance τ2. For
example, the most common approach is given by DerSimonian and Laird [25]. They propose
the following unbiased, method of moments estimate for τ2,
τ̂2 =
Q− (k − 1)∑
iwi −
∑
i w
2
i∑
i wi
,
where
Q =
k∑
i=1
wi
(
θi − θ̂
)2
,
where θ̂ is the overall effect estimate from the fixed effect meta-analysis. Another useful measure
for assessing the amount of between study variation is
I2 = 100%× Q− (k − 1)
Q
.
The measure, proposed by Higgins and Thompson [53], describes the percentage of the total
variation which is due to between study heterogeneity. This can be observed by noting that
I2 = 100%× τ̂
2
τ̂2 + σ̂2
,
where τ̂2 is the DerSimonian and Laird estimate of τ2 and
σ̂2 =
(k − 1)∑iwi
(
∑
iwi)
2 −∑iw2i ,
is an estimate of a ‘typical’ within study variance,
The overall effect estimate θ̂r has variance
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Var
(
θ̂r
)
=
1∑
iw
∗
i
.
Hence, an approximate 100(1− α)% confidence interval for θ is given by
θ̂r ± Zα
2
√
1∑
iw
∗
i
.
The random effects approach assumes a distribution of true treatment effects across studies
and θ̂ provides an estimate of the average treatment effect across all studies. One must be
mindful of the amount of heterogeneity between studies when interpreting this ‘average’ effect,
as individual studies may have a true treatment effect which is far from the average value. As
a result, some authors also suggest reporting a prediction interval for a new study treatment
effect [100, 55]. The 100(1− α)% prediction interval is given by
θ̂r ± tk−2;α
2
√
τ̂2 + Var
(
θ̂r
)
,
where τ̂2 is the estimate of the between study heterogeneity.
5.2.3 Meta-analysis of a correlation coefficient
Our interest is to conduct a meta-analysis of η̂, which is effectively a sample correlation coeffi-
cient. Indeed, recall that
η = Cor(f(X), F (X)),
while the estimate η̂ is the corresponding sample correlation coefficient. There is a wealth of
literature on the meta-analysis of correlation coefficients, something which is particular relevant
in psychology studies. For example, Hunter and Schmidt [58] propose carrying out a meta-
analysis on the raw correlation coefficient. As noted by Pigott et al. [92], it is common practice
to assume that the variance of the study specific correlation ri is known and is given by
vi =
(1− r2i )2
ni
,
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where ni is the within study sample size. However, as observed by Hedges and Olkin [51],
the more conventional approach is to carry out a meta-analysis after applying the Fisher Z-
transformation to the correlation coefficients. In this case the within study variance of the
Z-transformed correlations is given by
vi =
1
ni − 3 .
Field [34] carries out an extensive Monte Carlo comparison of these meta-analysis approaches
and concludes that both methods break down for a small number of studies and sample sizes.
In particular, the Schmidt-Hunter method underestimates the summary correlation, whilst the
Hedges-Olkin method tends to over estimate the summary correlation when the true correlation
is greater than 0.5.
In the next section we investigate the problem of measuring asymmetry in data across several
studies with the aim of obtaining an ‘overall’ measure of asymmetry in the underlying population.
In particular, we explore the potential pitfalls of simply pooling data across all studies, before
proposing a meta-analysis on the asymmetry measure η̂ to combat this problem.
5.3 Meta-analysis of η̂ to quantify asymmetry of a random vari-
able across multiple studies
When testing for symmetry, for example, in a covariate or response variable across multiple
studies it is important to note that it is not sufficient to pool the data and test for symmetry
assuming the data are all from a single trial. Rather, one should evaluate the symmetry in
each of the trials separately. The reason for this is that, even when the data are sampled from
several asymmetric populations, the pooled samples can appear to be symmetric, and thus give a
misleading impression of symmetry. This phenomena is exhibited by revisiting the hypertension
data. In particular, we determine the value of η̂ for the initial diastolic blood pressure data in
the treatment group for each trial separately as well as the value of η̂ obtained after naively
pooling the data from all trials. The values of η̂ can be seen in Table 5.1.
What we observe seems somewhat counter intuitive. The data are asymmetric in the majority
114
0 50 100 150
0.
00
0.
01
0.
02
0.
03
0.
04
0.
05
W
e
ig
ht
ed
 d
en
sit
y
Figure 5.1: Density estimates of individual trials weighted with respect to their sample size
(coloured) and the density estimate of pooled data (black-dashed) naively assuming all the data
are from one ‘mega’ trial.
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Trial η̂ 95% CI s.e. n
ANBP 0.27 [0.16; 0.38] 0.06 780
COOP −0.83 [−0.99;−0.66] 0.08 150
EWPH 0.84 [0.44; 1.24] 0.20 90
HDFP 0.81 [0.75; 0.86] 0.02 2427
MRC1 0.51 [0.45; 0.58] 0.03 3546
MRC2 −0.80 [−0.87;−0.73] 0.03 1314
SHEP −0.63 [−0.69;−0.57] 0.03 2365
STOP −0.51 [−0.88;−0.13] 0.19 137
SYCH −0.50 [−0.57;−0.43] 0.04 1252
SYSE −0.59 [−0.66;−0.53] 0.03 2398
Naive
−0.08 [−0.10;−0.07] 0.01 14459pooled
result
Table 5.1: The value of η̂ with 95% confidence intervals (CI) for initial diastolic blood pressure
data in the treatment group, along with the standard error (s.e.) of η̂. The results are given for
each trial separately and also by pooling all the trials together assuming all the data are from
one ‘mega’ trial.
of individual cases, for example, for the COOP and MRC2 trials η̂ = −0.83 and η̂ = −0.80
respectively, signifying these trials are highly skewed to the left. On the other hand, for the
EWPH and HDFP trials η̂ = 0.84 and η̂ = 0.81 respectively, indicating these trials are highly
skewed to the right. However, upon pooling the data we obtain a very symmetric set of data with
η̂ = −0.08. This apparent ‘paradox’ is resolved in Figure 5.1, which shows the individual study
specific density estimates as well as the density estimate obtained by naively pooling all the
data together. Further, the individual density estimates have been weighted according to their
respective sample size so that one obtains an appreciation of how much each trial contributes to
the overall pooled data set. We observe that, because the different skewed trials have different
means, when the data are pooled we observe a near symmetric density curve. That is to say, the
asymmetry inherent in individual trials is masked when pooling the data together. The upshot
of this is that when evaluating the symmetry or normality of the data, it is insufficient to pool
the data and test for symmetry. Instead, it is better practice to evaluate each trial separately.
For further details on why it is inappropriate to ignore clustering when pooling data across
multiple studies refer to Abo-Zaid et al. [1].
This motivates a more formal, more statistically rigorous, meta-analysis of η̂ using the meth-
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ods detailed in section 5.2.1 and 5.2.2, with the aim of determining the size of asymmetry in the
underlying distribution. The meta-analysis methods in section 5.2.1 and 5.2.2 require, for each
study, an estimate of the measure of interest along with its variance.
Recall from Theorem 2.3 in Chapter 2 that
√
n · [η̂ − η] L−→ N(0, σ2),
where n is the sample size and
σ2 = Var
[
2√
νfνF
(
f(X)F (X)− 1
2
f(X)
)
+
∫ ∞
X
f(y)2√
νfνF
dy
+ η
{(
F (X)− 12
)2
2νF
+
(f(X)− µf )2
2νf
+
∫ ∞
X
(
F (y)− 12
)
νF
f(y)dy +
(f(X)− µf )f(X)
νf
}]
,
where νf and νF denote Var(f(X)) and Var(F (X))
(
= 112
)
respectively, and µf = E[f(X)].
Hence, we have that approximately
Var (η̂) =
σ2
n
.
Further, recall that one can estimate σ2 from the data using
σ̂2 = V̂ar(Y ) =
1
n− 1
n∑
i=1
(Yi − Y )2, (5.1)
where
Yi =
 2√
ν̂f ν̂F
(
f̂(Xi)F̂ (Xi)− 1
2
f(Xi)
)
+
1√
ν̂f ν̂F
Φ̂1(Xi)
+ η̂

(
F̂ (Xi)− 12
)2
2ν̂F
+
(
f̂(Xi)− f̂
)2
2ν̂f
+ Φ̂2(Xi) +
(
f̂(Xi)− f̂
)
f̂(Xi)
ν̂f

 ,
where f̂ and F̂ are the kernel density estimate and the empirical distribution function estimate
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respectively. Moreover, recall that Φ̂1(x) is a numerical approximation of the integral
Φ1(x) =
∫ ∞
x
f2(y)dy,
using f̂(x) as an estimate of the curve f(x), and Φ̂2(x) is a numerical approximation of
∫ ∞
x
(
F (y)− 12
)
νF
f(y)dy,
estimating f and F by f̂ and F̂ .
Hence, provided each study has a sufficiently large sample size we can approximate the
standard error using
s.e. (η̂) =
σ̂√
n
.
As a result, when we have a number of different trials which are composed of samples from the
same population, one can conduct a meta-analysis of η̂ to identify whether there is a common η to
describe the underlying population. In Chapter 4 it was shown that this Normal approximation
is only valid for reasonably large samples (n > 30). Therefore, ideally we need every study in the
meta-analysis to be sufficiently large, however, generally smaller samples will be given a lower
weighting.
Suppose we have k independent studies of size ni from the random variables X
(i), for i =
1, · · · , k. That is, let X(i)1 , X(i)2 , · · · , X(i)ni be a random sample from X(i). Then each study has
a study specific quantity of asymmetry
η(i) = Corr
(
fi
(
X(i)
)
, Fi
(
X(i)
))
,
where fi and Fi are probability density function and cumulative distribution function for X
(i)
respectively. The study specific measure of asymmetry η(i) is readily estimated from the data
using
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η̂(i) = −
∑ni
j=1 f̂i
(
X
(i)
j
)
F̂i
(
X
(i)
j
)
− nif̂ iF̂ i√(∑ni
j=1
(
f̂i
(
X
(i)
j
))2 − nif̂2i)(∑nii=1 (F̂i (X(i)j ))2 − niF̂ 2i)
, for i = 1, · · · , k.
where f̂ i =
1
ni
∑
j f̂i
(
X
(i)
j
)
, F̂ i =
1
ni
∑
j F̂i
(
X
(i)
j
)
and f̂i and F̂i are the study specific ker-
nel density estimate and empirical cumulative distribution function respectively. The optimal
bandwidth for the kernel density estimate f̂i can be estimated using the the data from study i.
Then, using Theorem 2.3 in Chapter 2 it is readily verified that
η̂(i) ∼ N
(
ηi,
σ2i
ni
)
approximately, where σ2i is estimated using equation (5.1) using the data in study i. Hence, we
have defined the study specific estimate of η and its within study variance. Now, let us specify
the meta-analysis model.
The fixed effect model assumes that the σ2i are known and that every estimate η̂
(i) is esti-
mating the same underlying measure of asymmetry. That is
η(i) = η, for i = 1, · · · , k.
Therefore, the fixed effect meta-analysis model is given by
η̂(i) ∼ N
(
η,
σ2i
ni
)
, (5.2)
where η denotes the overall measure of asymmetry in the underlying population. The random
effects meta-analysis model assumes that the study specific η(i) are randomly drawn from a
Normal population with mean ηo and variance τ21 . That is, we assume
η̂(i) ∼ N
(
η(i),
σ2i
ni
)
η(i) ∼ N (ηo, τ21 ) , (5.3)
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Study η̂ 95% CI %Wf %Wr s.e. n
ANBP 0.27 [0.16; 0.38] 4.94 10.12 0.06 780
COOP −0.83 [−0.99;−0.66] 2.26 10.05 0.08 150
EWPH 0.84 [0.44; 1.24] 0.37 9.40 0.20 90
HDFP 0.81 [0.75; 0.86] 21.47 10.17 0.02 2427
MRC1 0.51 [0.45; 0.58] 15.62 10.16 0.03 3546
MRC2 −0.80 [−0.87;−0.73] 12.95 10.16 0.03 1314
SHEP −0.63 [−0.69;−0.57] 16.58 10.16 0.03 2365
STOP −0.51 [−0.88;−0.13] 0.41 9.47 0.19 137
SYCH −0.50 [−0.57;−0.43] 12.03 10.16 0.04 1252
SYSE −0.59 [−0.66;−0.53] 13.38 10.16 0.03 2398
Overall (fixed) −0.10 [−0.12;−0.07]
Overall (random) −0.15 [−0.59; 0.29]
Table 5.2: Meta-analysis of η̂ for initial diastolic blood pressure data in the treatment group
(I2 = 99.7%). %Wf and %Wr denote the percentage weights of each study in the fixed and
random effects meta-analysis respectively.
where ηo denotes the overall measure of asymmetry in the underlying population and τ21 is the
between study variance in the measure of asymmetry.
Table 5.2 shows the results of a meta-analysis on the values of η̂ for initial diastolic blood
pressure data in the treatment group, whilst the results are displayed graphically in a forest plot
in Figure 5.2. In this case the majority of the trials have a large number of patients, with all
but one study having sample size greater than 100.
Unsurprisingly, the studies display a vast amount of heterogeneity. Indeed, the Q statistic
rejects homogeneity between studies with a p-value < 0.0001 and the I2 statistic reveals that
99.7% (with CI [99.6%; 99.8%]) of the variability in the values of η̂ can be attributed to between
study heterogeneity. Therefore the fixed effect model (5.2), which gives an overall estimate of
η̂ = −0.10 (with CI [−0.12;−0.07]) is not appropriate here. It is more accurate to conclude
that different studies are drawing diastolic blood pressure data from different populations (with
different values of η). Fitting the random effects model (5.3) suggests that these separate values
of η are normally distributed about a mean value, estimated as −0.15 (with CI [−0.59; 0.29]).
The between study variance (estimated using DerSimonian and Laird’s method of moments) is
τ̂21 = 0.49 (with I
2 = 99.7% [99.6%; 99.8%]). In fact, the amount of between study variability
is so extreme that the approximate 95% prediction interval for the value of η for a new study
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is [−1.85, 1.55]. This ‘prediction interval’ includes the entire range of possible range of η, which
can only take values between −1 and 1.
It could be argued, after observing the forest plot, that the values of η can be split into two
distinct clusters. Indeed, there is a cluster of studies with asymmetry to the left (η̂ < 0) and
another cluster with asymmetry to the right (η̂ > 0), but there are few samples which appear
to be symmetric (with η̂ close to 0). This demonstrates that the amount of asymmetry could
be drastically different from one setting to another. This motivates further analyses, such as
meta-regression and subgroup analyses, to determine the source of this apparent heterogeneity
between the studies.
In the next section we investigate applying a meta-analysis of η̂ on a much smaller data
set, a collection of comparatively small observational studies. In this case, we show that a
meta-analysis of ζ̂ can be useful for obtaining more meaningful conclusions.
5.4 Meta-analysis of η̂ for small samples
As we have already discussed, a meta-analysis of η̂ is of particular interest when individual
studies have small sample sizes, as it can be particularly difficult to determine the underlying
distribution in these cases. However, there is a problem with applying a meta-analysis of η̂ in
this setting. Indeed, the distribution of η̂ calculated in Chapter 2 is asymptotic and so requires a
reasonably large sample to apply the Normal approximation. In Chapter 4 it was demonstrated
that, for a single trial, the Normal approximation breaks down for small samples. In this section
we investigate the implications for a meta-analysis of η̂.
In order to demonstrate this problem we consider a set of much smaller studies. Rather than
dealing with large randomised control trials, we consider a meta-analysis of smaller observa-
tional studies. In particular, we use the parathyroid hormone (PTH) data collated by Noordzij
et al. [85]. Noordzij et al. gathered data from nine observational studies investigating the use of
PTH to make early predictions about the onset of hypocalcemia after a thyroidectomy. Postop-
erative hypocalcemia is a common complication following a thyroidectomy, but, unfortunately
hypocalcemia is not usually present until 24 to 48 hours after surgery. As result, it is common
practice to keep patients under observation for this time. However, 70% of these patients will
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not go on to develop hypocalcemia. As noted by Noordzij et al., this puts unnecessary strain on
healthcare resources if a simple laboratory test is able to accurately classify patients at an early
stage. Thus, there is an appreciable interest in the accurate early prediction of hypocalcemia.
In the original paper the authors obtained individual patient data (IPD) for 457 patients across
the nine studies. All nine studies reported the preoperative PTH level along with the PTH level
during at least one of three time periods: 0-20 minutes, 1-2 hours, and 6 hours.
Figure 5.3 shows the histograms of the preoperative PTH levels for patients who did not go on
to develop hypocalcemia. Two things are clear from the histograms. Firstly, as we have already
mentioned, the number of individuals in each group is very small. Secondly, it is very difficult
to tell whether the data are sampled from a symmetric distribution, or a Normal distribution,
or indeed whether they are drawn from the same distribution. To attempt to answer these
questions we conduct a meta-analysis of η̂ to compare and synthesise information about the
amount of asymmetry in these studies.
The results of the meta-analysis for η̂ on the preoperative PTH data are shown in the top half
of Table 5.3 and the forest plot is given in Figure 5.4. The first thing to note is that there appears
to be homogeneity in the asymmetry across the studies, with between study variance estimated
as τ̂21 = 0 using DerSimonian and Laird’s method of moments. However, there is a problem
applying a meta-analysis of η̂ in this case. As we have already mentioned, the distribution of
η̂ determined in Chapter 2 is asymptotic. In Chapter 4 it was demonstrated that, for a single
trial, the Normal approximation breaks down for small samples. This has implications for a
meta-analysis of η̂ and this can lead to erroneous results. Indeed, observe that some of the
confidence intervals calculated in Table 5.3 extend beyond the range [−1, 1]. For example, for
the studies by Lam and Kerr [71] (Lam2003) and Lombardi et al. [74] (Lombardi2004) the 95%
confidence interval for η is given by [−0.03; 1.40] and [−0.36; 1.20] respectively. However, as
we have already discussed, η is a correlation coefficient and therefore it is certainly bounded
between −1 and 1. In this case, the sample sizes are so small that the Normal approximation is
simply not appropriate.
In the previous chapter it was recommended to construct approximate confidence intervals
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Figure 5.2: Forest plot of the meta-analysis of η̂ for initial diastolic blood pressure data in the
treatment group (I2 = 99.7%).
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Figure 5.3: Histograms of the preoperative PTH levels in patients who did not go on to develop
hypocalcemia for each of the six studies.
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Study η̂ 95% CI %Wf %Wr s.e. n
Warren2002 −0.17 [−0.89; 0.54] 11.6 11.6 0.36 12
Lo2002 0.34 [−0.12; 0.81] 27.33 27.33 0.24 89
Lam2003 0.69 [−0.03; 1.40] 11.48 11.48 0.37 27
Warren2004 0.32 [−0.29; 0.92] 16.1 16.1 0.31 23
Lombardi2004 0.42 [−0.36; 1.20] 9.69 9.69 0.40 35
McLeod2006 0.40 [−0.10; 0.90] 23.8 23.8 0.25 46
Overall (fixed) 0.34 [0.10; 0.58]
Overall (random) 0.34 [0.10; 0.58]
Study ζ̂ 95% CI %Wf %Wr s.e. n
Warren2002 −0.17 [−1.19; 0.84] 5.77 5.77 0.52 12
Lo2002 0.36 [−0.10; 0.82] 28.27 28.27 0.23 89
Lam2003 0.84 [0.06; 1.63] 9.68 9.68 0.40 27
Warren2004 0.33 [−0.24; 0.89] 18.57 18.57 0.29 23
Lombardi2004 0.44 [−0.30; 1.18] 10.81 10.81 0.38 35
McLeod2006 0.43 [−0.04; 0.90] 26.91 26.91 0.24 46
Overall (fixed) 0.40 [0.15; 0.64]
Overall (random) 0.40 [0.15; 0.64]
η 0.38 [0.15; 0.56]
Table 5.3: Meta-analysis of η̂ and ζ̂ on preoperative PTH levels in patients who did not go on to
develop hypocalcemia (I2 = 0%). %Wf and %Wr denote the percentage weights of each study
in the fixed and random effects meta-analysis respectively. For the meta-analysis of ζ̂, the table
also displays the overall estimate of η (and the corresponding confidence interval) obtained by
applying the inverse Z-transformation.
using η̂ using an estimate of the asymptotic variance. However, when the number of observations
was small (n < 30) it was suggested to suitably truncate any confidence intervals that extended
beyond the endpoints −1 and 1. However, this truncation method cannot be easily generalised
to a meta-analysis involving these offending studies, as the meta-analysis methods use standard
errors (and not upper and lower confidence interval bounds) to determine the weights. Thus,
when attempting to synthesise information about the amount of asymmetry η using a meta-
analysis, it is especially important to check how the results compare to a corresponding small
sample approach, which utilises a standard error estimate appropriate for small samples. Hence,
for small samples we propose validating the meta-analysis result for η using a meta-analysis for
ζ.
Recall from Theorem 4.1 in Chapter 4 that
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√
n ·
[
ζ̂ − ζ
]
L−→ N(0, υ2),
where
υ2 =
σ2
(1− η2)2 .
Let ζ(i) denote the study specific Z-transformed measure of asymmetry for study i. Further,
let ζ̂(i) denote the estimate of ζ(i) in study i. Then, the fixed effect model for ζ is given by
ζ̂(i) ∼ N
(
ζ,
υ2i
ni
)
, (5.4)
where ζ denotes the overall measure of symmetry in the underlying population and υ2i denotes
the study specific variance.
The analogous random effects meta-analysis model assumes that the study specific ζ(i) are
randomly drawn from a Normal population with mean ζ and variance τ22 . That is, we assume
ζ̂(i) ∼ N
(
ζ(i),
υ2i
ni
)
ζ(i) ∼ N (ζ, τ22 ) , (5.5)
where ζ denotes the overall measure of asymmetry in the underlying population and τ22 is the
between study variance in the measure of asymmetry.
Recall from equation (4.3) in Chapter 4 that the standard error can be approximated using
s.e.
(
ζ̂
)
=
σ̂√
n (1− η̂2) .
However, in the previous chapter we also demonstrated that this estimate is generally very poor.
As a result, we may alternatively estimate the variance of ζ̂ using bootstrapping, which was
shown to be more effective. We now redo the analysis for the PTH data using the meta-analysis
of ζ̂, estimating the within study variance
υ2i
ni
using bootstrapping with R = 1000 replications.
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The bottom half of Table 5.3 shows the meta-analysis of ζ̂ for the preoperative PTH levels in
individuals who did not go on to develop hypocalcemia, whilst Figure 5.5 shows the forest plot.
Once again, there is little evidence of heterogeneity with τ̂22 = 0 using DerSimonian-Laird, and
the overall fixed effect ζ̂ is given by 0.40 with confidence interval [0.15, 0.64]. Transforming back
gives an overall asymmetry measure of η̂ = 0.38 with confidence interval [0.15, 0.56]. Comparing
this with the meta-analysis directly on η̂ in Table 5.3, the confidence interval is slightly narrower.
This is not surprising, since in the simulation study in Chapter 4 the confidence intervals were
found to be tighter when using ζ̂ with bootstrapping.
Table 5.4 summarises the results of the two meta-analysis approaches. As expected, the
summary confidence interval constructed by carrying out the meta-analysis of ζ̂ is asymmetric
and tighter than the confidence interval constructed using a meta-analysis of η̂. There is only a
very slight difference in the summary result. Indeed, the summary η̂ is lower when based on a
meta-analysis of η̂ compared to ζ̂. There are a number of possible explanations for this. First, the
meta-analyses use different variance estimates and consequently assign different weights to each
study. Indeed, we estimated the variance of η̂ using the asymptotic theory, whilst the variance
of ζ̂ was determined via the bootstrap. Generally speaking, the variance of the study specific
ζ̂ will be greater than the variance of the study specific than η̂. On top of this, because of the
random sampling involved in calculating the bootstrap estimate of the variance, there are likely
to be differences in the weights induced by chance. All of these factors contribute to the slight
difference in the summary estimate of η̂ but, crucially, the results are not radically disparate.
In particular, we conclude that there is statistically significant asymmetry to the right in the
underlying population. In particular, the magnitude of asymmetry is fairly moderate and is not
likely greater than η = 0.6. The advantage of applying a meta-analysis of ζ̂ is that the study
specific confidence intervals will be interpretable and, as a result, the final summary confidence
interval is guaranteed to be contained within the interval [−1, 1].
Hence, taking into consideration the coverage results in Chapter 4, there is once again a
tension regarding which approach to take. Similar to Chapter 4, we generally recommend that
the meta-analysis be performed directly on η̂ using the asymptotic variance. However, if there
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Figure 5.4: Forest plot of the meta-analysis of η̂ for preoperative PTH levels in patients who
did not go on to develop hypocalcemia (I2 = 0%).
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Figure 5.5: Forest plot of the meta-analysis of ζ̂ for preoperative PTH levels in patients who did
not go on to develop hypocalcemia (I2 = 0%).
M-a method Overall η̂ [ 95% CI] I2
η 0.34 [0.10; 0.58] 0
ζ 0.38 [0.15; 0.56] 0
Table 5.4: Comparing the fixed effect summary results for η using the meta-analysis of η̂ and ζ̂
on preoperative PTH levels in individuals who did not go on to develop hypocalcemia.
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are several studies with a relatively small number of observations (ni < 30), which could be
influential in the meta-analysis result, then it is suggested to compare the meta-analysis of η̂
with a meta-analysis of ζ̂, estimating the variance of ζ̂ via bootstrapping. If the two approaches
do not differ by an excessive margin then, as with the example given above, we can be relatively
confident in the accuracy of the meta-analysis of η̂. On the other hand, if the two approaches
provide vastly disparate results, then we are forced to conclude that there are simply too few
studies or observations within studies to accurately assess the asymmetry in the underlying
population. Thus, in such a situation, further studies with larger sample sizes are required to
accurately determine the distribution of the underlying population.
In the next section we return to the hypertension data and extend this technique to assess
whether there are distributional differences between the treatment and control arms of the trials.
5.5 Using η̂ to examine the distributional differences between
treatment and control arms
Up to this point, this chapter has focused on summarising and quantifying heterogeneity in
the asymmetry of a random variable with samples across multiple studies. In this section we
apply the meta-analysis of η̂ to identify distributional differences between the treatment and
control arms of a randomised control trial across several studies. In particular, suppose we are
interested in comparing the systolic blood pressure of the patients. More specifically, we shall try
to ascertain whether there is a significant difference between η for systolic blood pressure in the
treatment and control groups at two times, before and after the intervention. As the trials are
randomised we should expect, prior to treatment, the two populations of systolic blood pressure
to be relatively similar. As a result, the amount of asymmetry η̂ should be similar between the
two groups. In section 3.3 of Chapter 3 we investigated applying η̂ to test this hypothesis for
individual trials. We now apply the meta-analysis methods outlined in the previous sections to
perform this analysis across every study simultaneously and thereby synthesise and compare the
results. By contrast, we have no reason to suspect that the two samples (and indeed η̂) will be
homogeneous post-treatment.
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Now suppose that we have k studies comprising of two arms, treatment and control, each
containing the same continuous outcome measure. Let η
(i)
T and η
(i)
C denote the amount of asym-
metry in the continuous variable for the treatment and control arms of study i respectively.
Further, let θ(i) = η
(i)
T −η(i)C denote the difference in the amount of asymmetry between the arms
in study i. We estimate θ(i) using
η̂
(i)
T − η̂(i)C ,
where η̂
(i)
T and η̂
(i)
C are the estimates of η in the treatment and control groups of study i respec-
tively. Then, using Theorem 2.3 in Chapter 2 it is readily verified that
θ̂(i) = η̂
(i)
T − η̂(i)C ∼ N
(
θ(i),
{
1
nT ;i
+
1
nC;i
}
σ2i
)
,
approximately, where nT ;i and nC;i are the sample sizes in the treatment and control groups
respectively. We estimate the variance σ2i using the pooled estimate,
σ̂2i =
(nT ;i − 1)σ̂2t;i + (nC;i − 1)σ̂2c;i
nT ;i + nC;i − 2 ,
where σ̂2t;i and σ̂
2
c;i are the estimates of σ
2
i using equation (5.1) in the treatment and control
groups of study i respectively.
It is important to note that we are implicitly assuming that the variances of η̂
(i)
T and η̂
(i)
C
are equal. This is perhaps a reasonable assumption provided that η̂ is similar in both groups
across all studies, but otherwise may be overly restrictive. Indeed, the variance of θ̂(i) can
be readily calculated when the assumption of equal variances is relaxed. However, additional
calculations show that, for the examples considered here, the results are not overly sensitive to
this assumption even when there are some small differences in η̂ between the treatment and
control groups in some studies.
In this case, the fixed effect model assumes that the within study variances are known
and that every estimate of the difference in asymmetry θ̂(i) is estimating the same underlying
difference. That is
θ(i) = θ, for i = 1, · · · , k.
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Therefore, the fixed effect meta-analysis model for the difference in asymmetry is given by
θ̂(i) ∼ N (θ, ω2i ) , (5.6)
where θ denotes the overall difference in the measure of asymmetry between the treatment and
control populations and
ω2i =
{
1
nT ;i
+
1
nC;i
}
σ2i
The random effects meta-analysis model assumes that the study specific θ(i) are randomly drawn
from a Normal population with mean θ and variance τ23 . That is, we assume
θ̂(i) ∼ N
(
θ(i), ω2i
)
θ(i) ∼ N (θ, τ23 ) , (5.7)
where θ denotes the overall difference in the measure of asymmetry between the treatment and
control populations, and τ23 is the between study variance.
Table 5.5 shows the results of the meta-analysis of θ prior to treatment, whilst Table 5.6
shows the results of the meta-analysis after treatment. There is no evidence of between study
heterogeneity in the value of η̂ prior to treatment with, τ̂23 = 0. Figure 5.6 shows the forest plot
obtained by fitting the fixed effect model (5.6) on the difference in η̂ between the treatment and
control groups for pre-treatment systolic blood pressure. The average difference in the amount
of asymmetry θ is 0 (with CI [−0.03; 0.04]). In conclusion, we see that there is no evidence of
any difference in η̂ between the treatment and control groups pre-treatment. This reaffirms the
results of our tests in Chapter 3, that prior to treatment the two arms are homogeneous, at least
in terms of asymmetry.
Conversely, after treatment there is a substantial amount of between study variability in θ
with I2 as high as 78.8% (with CI [61.3%; 88.3%]). This implies that 78% of the total variability
in the effect estimates can be attributed to between study heterogeneity. Figure 5.7 shows the
forest plot obtained by fitting the random effects meta-analysis model (5.7) on the difference in η̂
between the treatment and control groups for post-treatment systolic blood pressure. The 95%
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Study η̂T − η̂C 95% CI %Wf %Wr s.e. n
ANBP 0.010 [−0.14; 0.16] 4.98 4.98 0.08 1530
COOP −0.023 [−0.36; 0.31] 1.01 1.01 0.17 350
EWPH 0.035 [−0.46; 0.53] 0.45 0.45 0.26 172
HDFP 0.008 [−0.07; 0.08] 19.62 19.62 0.04 4797
MRC1 −0.003 [−0.09; 0.08] 14.93 14.93 0.04 6991
MRC2 −0.040 [−0.21; 0.13] 3.71 3.71 0.09 2651
SHEP 0.001 [−0.06; 0.06] 28.8 28.8 0.03 4736
STOP 0.004 [−0.36; 0.37] 0.84 0.84 0.19 268
SYCH −0.075 [−0.19; 0.04] 8.79 8.79 0.06 2391
SYSE 0.049 [−0.03; 0.13] 16.87 16.87 0.04 4695
Overall (fixed) 0.00 [−0.03; 0.04]
Overall (random) 0.00 [−0.03; 0.04]
Table 5.5: Meta-analysis of the difference between η̂ in the treatment and control arms for systolic
blood pressure data prior to treatment (I2 = 0%). %Wf and %Wr denote the percentage weights
of each study in the fixed and random effects meta-analysis respectively.
Study η̂T − η̂C 95% CI %Wf %Wr s.e. n
ANBP 0.141 [−0.02; 0.30] 4.88 10.18 0.08 1530
COOP −0.017 [−0.33; 0.30] 1.31 5.30 0.16 349
EWPH 0.029 [−0.48; 0.54] 0.50 2.55 0.26 172
HDFP 0.063 [−0.02; 0.14] 20.66 13.76 0.04 4798
MRC1 −0.007 [−0.08; 0.07] 22.59 13.89 0.04 6991
MRC2 0.232 [0.11; 0.36] 8.6 11.94 0.06 2651
SHEP 0.213 [0.12; 0.31] 14.64 13.17 0.05 4736
STOP 0.282 [−0.10; 0.66] 0.90 4.08 0.19 268
SYCH 0.148 [0.02; 0.28] 7.50 11.56 0.07 2391
SYSE 0.324 [0.24; 0.41] 18.41 13.58 0.04 4695
Overall (fixed) 0.14 [0.11; 0.18]
Overall (random) 0.15 [0.06; 0.24]
Table 5.6: Meta-analysis of the difference between η̂ in the treatment and control arms for systolic
blood pressure data after treatment (I2 = 78.8%). %Wf and %Wr denote the percentage weights
of each study in the fixed and random effects meta-analysis respectively.
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Study
Fixed effect model
ANBP
COOP
EWPH
HDFP
MRC1
MRC2
SHEP
STOP
SYCH
SYSE
−0.4 −0.2 0 0.2 0.4
Mean difference
Difference in eta (ED)
ED
 0.00
 0.01
−0.02
 0.03
 0.01
 0.00
−0.04
 0.00
 0.00
−0.07
 0.05
95%−CI
[−0.03; 0.04]
[−0.14; 0.16]
[−0.36; 0.31]
[−0.47; 0.54]
[−0.07; 0.08]
[−0.09; 0.08]
[−0.21; 0.13]
[−0.06; 0.06]
[−0.36; 0.37]
[−0.19; 0.04]
[−0.03; 0.13]
W (fixed)
100%
 5.0%
 1.0%
 0.4%
19.6%
14.9%
 3.7%
28.8%
 0.8%
 8.8%
16.9%
Figure 5.6: Fixed effect meta-analysis conducted on the difference in η̂ (ED) between the treat-
ment and control of pre-treatment systolic blood pressure (I2 = 0%).
Study
Random effects model
ANBP
COOP
EWPH
HDFP
MRC1
MRC2
SHEP
STOP
SYCH
SYSE
−0.6 −0.4 −0.2 0 0.2 0.4 0.6
Mean difference
Difference in eta (ED)
ED
 0.15
 0.14
−0.02
 0.03
 0.06
−0.01
 0.23
 0.21
 0.28
 0.15
 0.32
95%−CI
[ 0.06; 0.24]
[−0.02; 0.30]
[−0.33; 0.30]
[−0.48; 0.54]
[−0.02; 0.14]
[−0.08; 0.07]
[ 0.11; 0.36]
[ 0.12; 0.31]
[−0.10; 0.66]
[ 0.02; 0.28]
[ 0.24; 0.41]
W (random)
100%
10.2%
 5.3%
 2.5%
13.8%
13.9%
11.9%
13.2%
 4.1%
11.6%
13.6%
Figure 5.7: Random effects meta-analysis fit using DerSimonian-Laird on the difference η̂ (ED)
between the treatment and control of post-treatment systolic blood pressure (I2 = 78.8%).
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confidence interval for the average post-treatment difference θ̂ is [0.06; 0.24], which suggests that
η is larger in the treatment arm than in the control arm post-treatment. Intuitively, perhaps
this is what one should expect, as there is likely to be little or no change in the control group
after treatment, whilst it is plausible that the treatment not only reduces blood pressure, but
also alters the distribution in terms of the amount of asymmetry. Indeed, variations in an
individual’s response to treatment can induce changes in the sampling distribution of the blood
pressure readings. The 95% prediction interval for the post-treatment difference θ for a new
study is [−0.14; 0.44], which suggests that it is also plausible that the post-treatment difference
in η̂ may be zero or even negative in a future study.
5.6 Discussion
In this chapter we introduced the fixed effect and random effects meta-analysis models before
conducting a brief review of the existing literature on the meta-analysis of correlation studies.
This provided the foundation for investigating the problem of measuring asymmetry in a pop-
ulation based on several studies, with the aim of obtaining an ‘overall’ measure of asymmetry
in the underlying population and determining a prediction interval for the asymmetry in a new
study. Initially, we explored the potential pitfalls of naively pooling data across all studies and
analysing it as if it were a single data set. This was the motivation for proposing a meta-analysis
on the asymmetry measure η̂ to combat this problem. We also applied the technique using a
much smaller data set and, in this case, we show that ζ̂ can be used to obtain suitably asymmet-
ric confidence intervals. Next, we extended this technique to identify distributional differences
between the treatment and control arms of a randomised control trial across several studies. In
particular, we demonstrated that the method can be used to assess the baseline similarity in
η̂ across multiple studies simultaneously, as well as investigating the change in the distribution
post-treatment.
To summarise, when every study is reasonably large (say, n > 30), it is recommended
that meta-analyses be performed directly on η̂. However, if there are a number of studies
with insufficient sample sizes to ensure the accuracy of the asymptotic distribution of η̂, it is
recommend that the meta-analysis results be compared to the small sample procedure based on
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ζ̂. That is, it was shown that η̂ may still produce meaningful results (especially if the offending
studies receive a lower weighting in the meta-analysis), but the results should be the subject of
a sensitivity analysis, by additionally considering a meta-analysis of ζ̂. In general, caution is
advised when applying either method if there are a small number of samples or studies, as the
investigations of Field [34] into meta-analyses of correlation coefficients attest. In this situation
neither method is ideal and, therefore, further research studies with large sample sizes are the
priority.
In conclusion we have shown that a meta-analysis of η̂ is a useful technique for determining
the overall asymmetry in a population, when we have access to a number of different studies from
that population. It also provides a platform to compare and contrast the distribution of different
groups over several studies on the same treatment. In the next chapter we perform a simulation
study to assess the effect of ignoring violations of the symmetry or normality assumption on the
inferences one draws from several statistical models.
Key findings and recommendations
• When every study is reasonably large (say, n > 30), it is recommended that meta-
analysis be performed directly on η̂.
• If there are a number of studies with insufficient sample sizes to ensure the accuracy of
the asymptotic theory, then the results should be the subject of a sensitivity analysis
by alternatively considering a meta-analysis of ζ̂.
• If the majority of studies have small sample sizes, further research is required to obtain
larger sample sizes across the population of interest.
• To ensure accurate estimation of η every study must have a sufficiently large sample
size to construct a reasonable estimate of the density function f and the distribution
function F . The requisite number of points for this will vary depending on the shape
of the underlying population.
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Chapter 6
The effect of violating symmetry
and normality assumptions in
statistical models
6.1 Introduction
As we have previously identified, there are a number of statistical tests which assume that the
data are sampled from a symmetric population. For example, the Wilcoxon signed-rank test,
used to test for differences between two samples with unknown distribution functions, relies
on the assumption that the data are drawn from a symmetric population [128]. Many other
commonly used statistical tests or models rely on the assumption of symmetry implicitly, via the
normality assumption. For example, the t-test assumes that the data are drawn from a Normal
distribution [119], while linear models assume that the residuals are sampled from a normally
distributed population [82]. Furthermore, the random effects meta-analysis model introduced
in the previous chapter assumes a Normal distribution on two levels. That is, it assumes that
the study specific treatment effect estimates θ̂i are each normally distributed about a ‘true’
study specific effect θi, and that these random effects are also normally distributed about an
overall treatment effect. In these cases assessing the symmetry of the distribution is an essential
step towards evaluating the normality. In this chapter we analyse to what extent some of the
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commonly used statistical methods are robust to departures from symmetry or normality.
The outline of the chapter is as follows. In section 6.2 we investigate to what extent violations
of the normality assumption impinge the inferences we are able to draw from linear models. In
the context of clinical trials, we discuss the effect on the sampling distribution of the treatment
effect estimate, as well as the corresponding confidence intervals. Further, we investigate the
impact of asymmetric or skewed data on the predictive capabilities of the linear model. In
section 6.3 we extend this investigation to meta-analyses and determine how the presence of
asymmetry in the random effects distribution impacts the accuracy of confidence and prediction
intervals. In section 6.4 we also include an example to illustrate the effect that asymmetry in
the random effects has on the construction of prediction intervals in this context. In section 6.5
we summarise the results of the chapter and provide some recommendations regarding the use
of linear models and meta-analyses when there is asymmetry present in the residual or random
effects distribution respectively.
Aims of the chapter:
• Investigate the effect of asymmetric data on the accuracy of common inferences made
from linear models.
• Explore the impact of asymmetry in the random effects on the inferences drawn from
meta-analyses.
• Propose a number of recommendations regarding the use of linear models and meta-
analyses when there is asymmetry present in the residual or random effects distribution
respectively.
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6.2 The effect of asymmetric data on linear models used to anal-
yse randomised control trials
6.2.1 Introduction
Recall from Chapter 1 the following simple linear model applied to two groups of data,
Yj = β0 + β1Xj + ej , j = 1, · · · , n,
ej ∼ N(0, σ2),
(6.1)
where Yj is some continuous response and Xj is the group identifier and can be equal to 0 or 1.
It is assumed that
1. The residuals ej are normally distributed.
2. The variances are homogeneous in both groups.
3. The errors are independent.
In practice it is common for one or more of the assumptions are violated. For example, the
number of error inducing factors can be so numerous and complex that in reality we should not
expect the data to reflect a perfectly Normal sample. As a result, in reality the residuals of
model (6.1) are rarely going to follow a Normal distribution exactly. For the most part this is
not a serious issue, as it is well established that linear models are robust to small departures
from normality [82]. As a result, the inferences that one draws from the model should not be
too badly biased by the existence of some slight skewness. However, for more serious departures
from normality (e.g. heavily skewed data) the usual inferences that one draws from the model
(e.g. treatment effect estimates or confidence intervals) may well be seriously compromised.
Previous work by Lumley et al. [75] has shown that t-test approach is surprisingly robust
to even extreme departures from normality. In this section we conduct a similar analysis in the
context of linear models that are used to estimate a treatment effect estimate of a randomised
trial. In particular, we analyse the effect of asymmetric data on the sampling distribution of the
treatment effect estimate, as well as investigating the accuracy of the corresponding confidence
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intervals for the treatment effect. Further, we also investigate the effect of asymmetric data on
the predictive power of linear models by examining the the accuracy of prediction intervals for
future patients.
6.2.2 Methods
The sampling distribution of the treatment effect
Firstly, we assess the effect of asymmetric residuals on the sampling distribution of β̂1, the
treatment effect estimate, by simulating two sets of data resulting in heavily skewed residuals
from the Log-Normal distribution. In particular, we generate two artificial Log-Normal samples
(Yj), each of size n, which have a difference in mean equal to one and fit the simple linear model
(6.1) using all 2n data points. Under the normality assumption we have that
β̂1 − β1
s
β̂
=
β̂1 − 1
s
β̂
∼ t2n−2,
where t2n−2 is the t distribution with 2n− 2 degrees of freedom, and sβ̂ is the standard error of
β̂1 given by
s
β̂
=
√
1
2n−2
∑
i e
2
i∑
i(xi − x)2
=
√
1
2n−2
∑
i e
2
i
2n14
=
√
1
n−1
∑
i e
2
i
2n
,
and ei are the residuals of the model. By repeatedly simulating the asymmetric Log-Normal
data and fitting the above linear model we obtain a random sample of β̂1. We also perform the
same analysis using normally distributed data and compare the results to assess the impact of
the asymmetric Log-Normal data.
Coverage of confidence intervals
On top of this, we investigate the effect of asymmetry on the confidence intervals obtained for
the treatment effect estimates using the linear model (6.1). Montgomery et al. [82] state that
the 100(1−α)% confidence interval for the treatment effect of a simple linear regression is given
by
β̂1 ± tα/2;n−2σ
√
1
n
+
x2
sxx
, (6.2)
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where n is the total sample size and sxx =
∑
i(xi − x)2.
We simulate 10, 000 replications of the simple linear model (6.1) with baseline β0 = 0 and
true treatment effect β1 = 1 with residuals drawn from a variety of distributions. In particular,
we consider residuals drawn from Normal, Normal mixtures, Skew Normal, Log-Normal, Folded
Normal and Exponential populations. We then construct the 100(1−α)% confidence interval for
the treatment effect using a range of levels α, namely, α = 0.5, 0.1, 0.05, 0.01. For each simulated
model we determine whether or not this confidence interval contains the true value and thereby
calculate the coverage.
Coverage of prediction intervals
Next, we consider the effect of asymmetric data on the accuracy of prediction intervals. Given
an observation for the independent variable X = x0 Montgomery et al. [82] give the 100(1−α)%
prediction interval for a simple linear regression as
ŷ0 ± tα/2;n−2σ
√
1 +
1
n
+
(x0 − x)2
sxx
, (6.3)
where ŷ0 = β̂0 + β̂1x0. Observe, that the form is very similar to the confidence intervals, but
with an additional term to account for the extra variability.
We assess whether the predictions from linear models are sensitive to the to the distribution
of the data by, firstly, constructing the fitted model using a random sample from a particular
distribution. Again, we consider residuals drawn from Normal, Normal mixtures, Skew Normal,
Log-Normal, Folded Normal and Exponential populations. Next, we generate a prediction in-
terval based on that model, before simulating a new random point from the distribution and
determine the predicted value for y,
ŷ0 = β̂0 + β̂1x0.
Finally, we determine whether or not the predicted value is contained within the constructed pre-
diction interval. For each distribution, we repeat this process m = 10, 000 times and determine
the coverage of the prediction intervals. The simulation study is outlined in Table 6.1.
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Step 1a For each given distribution, generate the ‘control’ sample by sim-
ulating n observations from the residual distribution.
Step 1b Generate the ‘treatment’ sample by simulating n observations
from the residual distribution and adding on the ‘true’ treatment
effect β1 = 1.
Step 2 Fit the linear model (6.1) using all 2n data points, naively assum-
ing that the residuals are normally distributed.
Step 3a Extract the estimate of the treatment effect β̂1. Also, construct
the confidence interval for β1 using equation (6.2), as well as the
prediction interval for a new individual (treatment and control)
using equation (6.3).
Step 3b Check to see whether the confidence intervals contain the true
overall treatment effect β1 = 1. Also, simulate a new observa-
tion for a new individual (either treatment or control) using the
‘true’ residual distribution and determine whether the correspond-
ing prediction interval contains the new observation.
Step 4 Repeat Steps 1-3b 10, 000 times and report the coverage of the
confidence and prediction intervals.
Table 6.1: Outline of the simulation study assessing the impact of asymmetry in the residuals
of linear models on the coverage of confidence and prediction intervals.
6.2.3 Results
The sampling distribution of the treatment effect
Figure 6.1 shows the density estimate for the values of β̂1s
β̂
obtained by fitting the linear model
(6.1) 10, 000 times with n = 5, 15, 30, 100 observations in each arm, using Normal residuals and
asymmetric Log-Normal residuals. The dotted line shows the t distribution with 2n− 2 degrees
of freedom, which is the distribution of β̂1 under the normality assumption. It is clear that
β̂1 does not conform exactly to this curve when the normality assumption has been violated,
however, the error is significantly reduced as the sample size increases. As a result, for small
sample sizes confidence intervals based upon this assumption will be compromised. On the other
hand, when the sample size is reasonably large β̂1 is approximately normally distributed by the
Central Limit Theorem, even when the normality assumption is violated. This can be seen in
the far right density in Figure 6.1 where n = 100.
Consequently, for small n it is clear that the sampling distribution of β̂1 is altered by viola-
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tions of the normality assumption, however, the pertinent question is ‘How seriously does this
effect the inferences that we draw from the model?’. To answer this question we investigate the
effect of asymmetric residuals on the coverage of the confidence intervals constructed under the
assumption of normality.
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Figure 6.1: The density estimate of β̂1s
β̂
for Log-Normal residuals (η ≈ 0.91) based on 10, 000
samples. The dotted line shows the hypothesised t distribution whilst the red line shows the
distribution of β̂1s
β̂
for Normal residuals.
Coverage of confidence intervals
Table 6.2 shows the coverage of the confidence intervals constructed using the linear model (6.1)
with residuals drawn from several different populations and a range of sample sizes. As expected,
for the symmetric Normal distribution roughly 100(1− α)% of the confidence intervals contain
the true value. For the most part, the coverage is not greatly altered when the residuals are
sampled from the the asymmetric distributions. However, when the residuals are drawn from
the heavy tailed Log-Normal samples the coverage deviates from the expected value of 1 − α.
This is most pronounced for the smaller samples (n < 30) and α = 0.5. Indeed, for a sample
of n = 15 from a Log-Normal population the 50% confidence interval for the treatment effect
has coverage of 0.452 and so is considerably shorter than expected. However, this disparity is
reduced as n increases. Moreover, it is also less noticeable for the more conventional confidence
intervals (α = 0.1, 0.05). For example, for a sample of n = 15 from a Log-Normal population the
95% confidence interval for the treatment effect has coverage of 0.9608, and is only marginally
too wide.
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Hence, we observe that when we have an extremely small sample drawn from an asymmetric
population, failure to account for this may produce confidence intervals which are too wide or
too short. However, in most cases the discrepancy is still small for 95% confidence intervals and,
moreover, this effect is reduced as the sample size increases. Indeed, the Central Limit Theorem
ensures that the sampling distribution of the treatment effect estimate will approach a Normal
distribution for sufficiently large n, regardless of the asymmetry inherent in the underlying data.
In summary, the results indicate that, generally speaking, the confidence intervals for the
treatment effect estimate are extremely robust to departures from symmetry. This is particu-
larly evident for the 95% confidence intervals (as opposed to the shorter unconventional 50%
confidence intervals). Indeed, even for the extremely asymmetric distributions considered here,
the coverage of the 95% confidence intervals only display minor departures from 0.95.
Further, it is important to note that some of the distributions considered here are extreme
examples (for example, the Log-Normal distribution). In reality, most clinical trials are unlikely
to contain such large departures from symmetry and, moreover, the majority of randomised
control trials do not contain fewer than 30 patients. As a result ‘realistic’ asymmetry will not
seriously effect the treatment effect estimate. The same may not be true if one’s interest is to
use the model to make predictions about future patients. Next, we present the corresponding
coverage results for the prediction intervals.
Coverage of prediction intervals
The coverage of the 100(1−α)% prediction intervals are given in Table 6.3. As one should expect,
when the residuals are sampled from the symmetric Normal distribution, roughly 100(1− α)%
of the prediction intervals contain the newly simulated value. Once again, for the asymmetric
distributions, the most striking departures occur for the 50% confidence intervals where the
residuals are sampled from a Log-Normal distribution. Indeed, for n = 15 the coverage of the
prediction interval is much too large (0.648). Moreover, this actually worsens as n increases and
for n = 100 the 50% confidence interval is far too large with coverage given by 0.739. This is
a trend emulated by the Normal mixtures which have reasonable coverage for small n, but this
coverage steadily grows as we increase the sample size. By contrast, for the Skew Normal data
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the coverage steadily declines away from 0.5 for increasing sample size. This seems to suggest
that, unlike the previous problem of constructing confidence intervals for the treatment effect,
one cannot guarantee that the prediction intervals will be suitable for large samples.
This is emphasised in Figure 6.2 which shows the appropriately centred and scaled density
functions for the Normal, SN5, SN8 and Log-Normal distributions. It also includes the location
−3 −2 −1 0 1 2 3
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Figure 6.2: Centred and scaled density functions of the Normal, SN5, SN8, and Log-Normal
distributions along with the location of the 100α2 and 100
(
1− α2
)
percentiles of the Normal
distribution for α = 0.5, 0.1, 0.05 and 0.01.
of the 100α2% and 100
(
1− α2
)
% percentiles of the Normal distribution for α = 0.5, 0.1, 0.05
and 0.01. If a new observation is sampled from a Normal distribution then these percentiles
correspond to the expected endpoints of the 100(1 − α)% prediction interval. If, however, the
new observation is not drawn from a Normal distribution, it is clear that a prediction interval
constructed under the assumption of symmetry will fail to adequately capture the variability
in the new observation. It just so happens that all of these distributions have approximately
95% of their mass between the 2.5% and 97.5% percentiles of the Normal distribution. By
contrast, there are large differences in the proportion of probability mass between the 25%
and 75% percentiles of the Normal distribution. For example, the Log-Normal distribution has
approximately 82% of its mass in this region, whilst the SN8 distribution has approximately
145
47% of its mass in this region. These differences explain the stark contrast in the coverage of
the 50% confidence interval in Table 6.3.
Again, it must be pointed out that this discrepancy is less exaggerated for the wider pre-
diction intervals, in particular the 95% and 99% prediction intervals, which only show mild
departures from 0.95 or 0.99 for very small samples. Indeed, even for the heavily asymmetric
Log-Normal distribution with a very small sample number of observations in each arm (n = 5)
the coverage of the 95% prediction interval is 0.916, which is only a slight deviation from the
expected value, whilst for n = 100 the 99% prediction interval has a coverage of 0.973.
In summary, although the coverage of the more conventional 95% and 99% prediction inter-
vals appears to be reasonable even when the residual distribution is asymmetric, the results for
the shorter prediction intervals highlight the fact that the impact on probabilistic inferences is
not yet clear. Indeed, it was shown that the 50% prediction intervals can be extremely sensitive
to asymmetric data. Moreover, in the context of clinical trials more care should be taken when
interpreting prediction intervals than confidence intervals, as one can no longer appeal to the
Central Limit Theorem for larger samples. In the next section we extend this investigation to
meta-analyses and we begin by reintroducing fixed effect and random effects meta-analysis.
6.3 The impact of asymmetry in the random effects of meta-
analyses
6.3.1 Introduction
Suppose that we have k studies investigating a specific treatment or intervention and that each
study reports the treatment effect estimate θ̂i and its variance σ
2
i , where i = 1, · · · , k. Recall
from section 5.2.2 in Chapter 5, that when there is evidence of between study heterogeneity, one
can perform a random effects meta-analysis to account for the variability between studies. A
random effects meta-analysis assumes that the treatment effects θi vary across studies, following
a Normal distribution with mean θ and variance τ2. In particular, the conventional parametric
approach to random effects meta-analysis, outlined by Whitehead and Whitehead [127] has the
form
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θ̂i ∼ N(θi, σ2i ), i = 1, · · · , k,
θi ∼ N(θ, τ2).
(6.4)
Recall, that the (1− α)100% confidence interval for θ is conventionally calculated by assuming
that the σ2i are known. In this case
θ̂ ± Zα
2
√
Var
(
θ̂
)
, (6.5)
where θ̂ is the maximum likelihood estimate of θ, and Zα
2
is the α2 quantile of the standard
Normal distribution. However, it was noted by Knapp and Hartung [67] that this form for the
confidence interval does not account for the uncertainty in the estimate of the variance of θ̂.
Instead, Knapp and Hartung suggest using
θ̂ ± tk−1;α
2
√
Varι
(
θ̂
)
, (6.6)
where tk−1;α
2
is the α2 quantile of the t distribution with k − 1 degrees of freedom and Varι
(
θ̂
)
is the appropriately modified variance estimate
Varι
(
θ̂
)
=
1
k − 1
∑n
i=1w
∗
i
(
θ̂i − θ̂
)2∑n
i=1w
∗
i
,
where w∗i =
1
σ2i+τ
2 [50]. This alternative variance estimate facilitates the use of the t distribution
in equation (6.6) because
θ̂√
Varι
(
θ̂
) = √∑ni=1w∗i · θ̂√
1
k−1
∑n
i=1w
∗
i
(
θ̂i − θ̂
)2 ,
where
√∑n
i=1w
∗
i · θ̂ is approximately standard Normal and
∑n
i=1w
∗
i
(
θ̂i − θ̂
)2
follows a chi-
squared distribution with k − 1 degrees of freedom.
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The (1− α)100% prediction interval, proposed by Higgins et al. [55], is
θ̂ ± tk−2;α
2
√
τ̂2 + Var
(
θ̂
)
, (6.7)
where τ̂2 is the estimate of the between study heterogeneity.
As we have already identified, the random effects meta-analysis model assumes symmetry
at two levels. Firstly, it assumes that the study specific estimate of the treatment effect θ̂i
is normally distributed about the ‘true’ study specific effect θi. Secondly, it is assumed that
these random effects are also normally distributed about an overall treatment effect. Baker and
Jackson [6] state that normality is “the default assumption made about unknown distributions...
having the merit of simplicity and often being motivated by the Central Limit Theorem (CLT).”
Indeed, the CLT unquestionably suggests that, for reasonably large studies, the estimated effect
θ̂i should be approximately normally distributed about the true study effect θi. However, as
noted by Baker and Jackson, “the CLT does not really imply anything about the distribution
of the random effects,” and that one can only appeal to the CLT in this case “with the vague
idea that the unknown source of variation between studies might be the sum of several factors.”
The results of the previous section exemplify the strength of the Central Limit Theorem in
the context of estimating the treatment effect from a linear model. Thus, in this section we
focus our investigation on asymmetry in the random effects distribution, and the impact this
can have on the results and interpretation of the meta-analysis.
6.3.2 Methods
In order to obtain the most accurate perspective of the impact of asymmetry on meta-analyses
we simulate data in two stages. Firstly, for a given treatment effect we first generate k random
effects from a particular distribution, which has variance τ2. This allows for the possibility of
generating asymmetry in the random effects distribution. Secondly, for each of the k studies,
we simulate Normal data (i.e. the continuous outcome response value) for the control and
treatment arms of the individual studies, with sample size n in each arm and a difference in
means determined by the random effects.
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Thus, in this case the treatment effects θi are the mean differences in each study, and the
‘known’ within study variances σ2i are estimated from the continuous response. We then fit the
random effects model (6.4) using restricted maximum likelihood estimation (REML), naively
assuming normality at both levels. We extract the model estimates of θ and τ and construct
confidence intervals for θ naively assuming that overall treatment effect is normally distributed,
using both equation (6.5) and equation (6.6). Similarly, we construct prediction intervals for a
new treatment effect by assuming that the random effects are normally distributed and using
equation (6.7).
The random effects are generated from a Normal distribution and a range of increasingly
asymmetric distributions. In particular, we consider random effects drawn from Normal, Normal
mixtures, Skew Normal, Log-Normal, Folded Normal and Exponential populations.
For every distribution we: vary the number of studies k; use a range of sample sizes n; use a
true overall treatment effect θ = 1; use a fixed baseline θ0 = 0; fix the variance of the continuous
response at σ2 = 1; and set the between study variance to be τ2 = 1. It is important to note
that the within study variance is given by
σ2i =
2σ2
n
,
hence τ2 >> σ2i . We also tested the sensitivity of the results to a range of different parameters for
θ, σ2, τ2 and found the results to be relatively consistent provided that τ2 >> σ2i . We generate
each meta-analysis 10, 000 times using the R package meta and extract the model estimates of
the overall treatment effect θ and the between study standard deviation τ . We also construct
the 100(1−α)% confidence intervals for the overall treatment effect (using Z and t quantiles), as
well as the prediction interval for the treatment effect of a new study. In particular, we consider
α = 0.5, 0.1, 0.05 and 0.01. At each iteration we check to see whether the constructed confidence
intervals contain the true treatment effect and thereby calculate the coverage (the proportion
of confidence intervals containing the true treatment effect). Similarly, for each iteration we
simulate a new treatment effect from the predictive distribution and determine whether the
prediction interval contains this new treatment effect. In this way we also calculate the coverage
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of the 100(1− α)% prediction interval. The simulation study is outlined in Table 6.4.
Step 1 For a given random effects distribution, simulate k random effects
with mean θ = 1 and variance τ2 = 1.
Step 2 For each study, simulate two normally distributed samples of size
n with equal variance σ2 = 1, and with a difference in means
determined by the random effect θi. In particular, the ‘control’
arm comprises a sample of size n from a Normal distribution with
mean 0 and variance σ2, whilst the ‘treatment’ arm consists of
a sample of size n from a Normal distribution with mean θi and
variance σ2.
Step 3 Fit the meta-analysis model (6.4) using the R package meta with
REML, naively assuming normality at both levels.
Step 4a Extract the estimates of the overall treatment effect θ and the
between study standard deviation τ . Also, construct confidence
intervals for θ using equations (6.5) and (6.6), as well as the pre-
diction interval for a new treatment effect using equation (6.7).
Step 4b Check to see whether the confidence intervals contain the true
overall treatment effect θ = 1. Also, simulate a new treatment
effect from the true random effects distribution and determine
whether the prediction interval contains the new treatment effect.
Step 5 Repeat Steps 1-4b 10, 000 times and report the coverage of the
confidence and prediction intervals.
Table 6.4: Outline of the simulation study assessing the impact of asymmetry in the random
effects of meta-analyses.
6.3.3 Results
Coverage of confidence intervals derived using the Normal distribution
Tables 6.5, 6.6 and 6.7 display the coverage of the 100(1−α)% confidence intervals for the treat-
ment effect, where the confidence intervals are constructed by assuming a Normal distribution
and using equation (6.5), for n = 30, 100 and 1000 respectively. It is apparent that, regardless of
the number of observations in each study, if k is small then the coverage of the confidence inter-
vals is uniformly poor across all distributions. Indeed, for each level α, the confidence intervals
are consistently too short when k < 10. There is some evidence that asymmetry in the random
effects may exacerbate this effect, as the coverage is especially poor when the random effects
are highly asymmetric. For example, in Table 6.7 (where n = 1000), the coverage of the 95%
confidence based on k = 7 studies with Log-Normal random effects is 0.817 compared to 0.903
150
for normally distributed random effects. Both fall some way short of the expected coverage of
0.95, but the discord is much greater in the asymmetric case.
On the other hand, this discrepancy is much smaller when there are a large number of studies
(k = 100), even if there are only a small number of observations n in each arm. For example, in
Table 6.5 (where n = 30) the coverage for every distribution is reasonably good when there are
k = 100 studies. Indeed, the 95% confidence interval almost every distribution achieves good
coverage, with coverage of 0.931 for Log-Normal random effects and 0.950 for Normal random
effects. Therefore, we conclude that, in the most commonly encountered situations, asymmetry
in the random effects does not have a major impact on the confidence intervals for the average
treatment effect. Whilst it is true that the confidence intervals are generally poor for k < 10,
this is also the case when the random effects are normally distributed and so this is more likely
to be a problem caused by having too few studies.
Coverage of confidence intervals derived using the t distribution
Tables 6.8, 6.9 and 6.10 display the coverage of the 100(1 − α)% confidence intervals for the
treatment effect, where the confidence intervals are constructed by assuming a t distribution
and using equation (6.6), for n = 30, 100 and 1000 respectively. In this case, even when the
number of studies k is small, then the confidence intervals have appropriate coverage. Once
again, when there are few studies, there is some evidence that the coverage is more seriously
effected when there is substantial asymmetry in the random effects. For example, in Table 6.10
(where n = 1000), the coverage of the 95% confidence interval based on k = 5 studies with
Log-Normal random effects is 0.856 compared to 0.950 for normally distributed random effects.
However, when there are a moderate number of studies, confidence intervals based on t are
reasonably accurate regardless of the random effects distribution. For example, in Table 6.8
(where n = 30) the coverage for every distribution is reasonably good when there are k = 10
studies. For example, the coverage of the 95% confidence interval for Folded Normal random
effects is 0.937, compared to 0.952 for normally distributed random effects. Therefore, once
again, it appears that asymmetry in the random effects does not have a major impact on the
confidence intervals for the average treatment effect.
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Figure 6.3: Comparing the coverage of 95% confidence intervals constructed using equation (6.5)
(based on the Normal distribution) and those using equation (6.6) (based on the t distribution),
using a random effects meta-analysis with k normally distributed random effects and k studies
consisting of n = 30 observations in each arm.
It is apparent, comparing the coverage of the confidence intervals constructed using the
Normal distribution and those using the Knapp and Hartung method based on the t distribu-
tion, that the latter consistently performs better in terms of coverage. Figure 6.3 compares
the coverage of the 95% confidence intervals constructed using the two methods for normally
distributed random effects. Using the Normal confidence intervals, it is clear that one requires
at least 10 studies before the coverage provides an acceptable approximation to 0.95 (namely,
0.921), and that the confidence intervals are consistently anti-conservative. On the other hand,
the Hartung-Knapp confidence intervals are generally much closer to 0.95, even for just k = 3
studies.
Coverage of prediction intervals
Tables 6.11, 6.12 and 6.13 display the coverage of the 100(1−α)% prediction intervals for a new
treatment effect, where the prediction intervals are constructed by assuming a t distribution and
using equation (6.7), for n = 30, 100 and 1000 respectively. It is clear that, when k is small,
constructing accurate prediction intervals is particularly problematic when there is asymmetry in
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the random effects. Indeed, when there are only k = 3 studies the prediction intervals are wildly
over conservative, to such a degree that for many of the symmetric or asymmetric random effects
distributions the 95% and 99% confidence intervals have coverage equal to 1. This is perhaps
not a surprise, as it difficult to make accurate predictions about a future treatment effect based
on only a few studies.
On the other hand, when the number of studies is large (k = 100) the coverage of the
prediction intervals is much better, in most cases. For example, as seen in Table 6.13 (where
n = 1000), if the meta-analysis is comprised of k = 100 studies then the coverage of the 50%
prediction intervals is equal to 0.494 for Normal random effects. For a Normal random effects
distribution with at least 30 individuals in each study, generally at least 5 studies are required
to ensure the prediction intervals have suitable coverage. However, for Log-Normal random
effects the prediction interval is too wide with coverage of 0.65. By contrast, for the highly
asymmetric SN8 distribution (η = 0.8) the prediction interval is too short with coverage of
0.462. Therefore, it is apparent that the prediction intervals are sensitive to the random effects
distribution, however, the differences are most marked when α = 0.5 and they are less obvious
for the 95% and 99% prediction intervals. Indeed, for these wider prediction intervals, the
coverage is relatively good, but there is still some slight deviation for the most asymmetric
random effects distributions. For example, when k = 7 and n = 1000 the coverage for the
95% prediction interval based on Log-Normal random effects is 0.925 compared to 0.958 for the
Normal distribution. However, this disparity is less noticeable when k = 100 as the coverage
of the 95% prediction interval is 0.953 and 0.950 for the Log-Normal and Normal distribution
respectively. Figure 6.4 displays these results graphically and compares the coverage of 50% and
95% prediction intervals constructed assuming normally distributed random effects, for Normal
and Log-Normal random effects.
Although the 95% prediction intervals display reasonable coverage even when the true distri-
bution was asymmetric, the results for the shorter prediction intervals highlight the fact that the
impact on probabilistic inferences is not yet clear. Next, we examine this problem in more detail
through the use of an example, and assesses the consequences for clinically relevant inferences.
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Figure 6.4: Comparing the coverage of 50% (left) and 95% (right) prediction intervals con-
structed using equation (6.7) (assuming Normal random effects) for Normal and Log-Normal
random effects, based on a random effects meta-analysis with k studies consisting of n = 30
observations in each arm.
6.4 Impact on probabilistic inferences
In the simulation study in the previous section we assessed the accuracy of confidence and predic-
tion intervals based on their coverage. It was shown that, provided there are a sufficiently large
number of studies with a reasonably large sample size (n ≥ 30), the 95% confidence and predic-
tion intervals perform well in terms of coverage, irrespective of the random effects distribution.
However, a 95% confidence (or prediction) interval can contain the overall (or predicted) treat-
ment effect roughly 95% of the time, but still fail to provide useful insight regarding the range of
possible values. If, for example, the underlying sampling distribution is appreciably skewed then
a symmetric confidence or prediction interval can provide adequate coverage without providing
a true reflection of the probable range of values. This is akin to the problem of selecting the
most suitable credible interval in a Bayesian framework. Indeed, the traditional equal-tail cred-
ible interval is only sensible when the underlying distribution is symmetric. When calculating
a credible interval for a skewed posterior density, it is recommended to consider the highest
posterior density (HPD) interval [12]. This ensures that the resultant interval will contain the
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region with the highest posterior probability.
For a random effects meta-analysis, this is more likely to be a problem for prediction intervals
than confidence intervals. Indeed, since estimation of the overall treatment effect is based on an
average across a number of studies, provided there are a reasonable number of studies, the CLT
ensures that the sampling distribution of the overall treatment effect is approximately Normal
even if the random effects are appreciably asymmetric. On the other hand, when predicting
a treatment effect for a future study, asymmetry in the random effects cannot be so easily
disregarded. Indeed, the results of the simulation study for the 50% prediction interval expose
the problems caused by a substantially asymmetric random effects distribution, even when there
are a large number of studies.
For example, recall Figure 6.2, which shows the centred and scaled density functions for the
Normal, SN5, SN8 and Log-Normal distributions. All of these distributions have approximately
95% of their mass between the 2.5% and 97.5% percentiles of the Normal distribution. Thus,
a prediction interval constructed by naively assuming a Normal distribution will have coverage
close to 95% even if the actual predictive distribution is given by one of the more heavily asym-
metric distributions. This is precisely what was observed in the simulation study in the previous
section. However, although the naive 95% prediction interval performs as expected in terms of
coverage, it is not particularly informative about the possible distribution of future treatment
effects. Indeed the symmetric prediction interval conceals the fact that a new treatment effect
is far more likely to be found in the right-hand side of the prediction interval.
In order to further emphasise the impact of incorrectly specifying the random effects dis-
tribution in this context we consider an example used by Lee and Thompson [72]. Lee and
Thompson suggest modelling the random effects using the flexible skewed distribution proposed
by Fernandez and Steel [33]. Recall from Chapter 2 that the Fernandez and Steel distribution
has density function
FAS(z; γ) =
2
γ + 1γ
{
f
(
z
γ
)
I[z ≥ 0] + f (γz) I[z < 0]
}
,
for any symmetric unimodal density function f and some γ ∈ (0,∞). When γ = 1 the dis-
164
tribution is symmetric, while γ > 1 and γ < 1 correspond to asymmetry to the right and left
respectively. In particular, Lee and Thompson suggest setting f to be a Normal probability den-
sity function to obtain the three-parameter skewed Normal distribution or, alternatively, setting
f to be the probability density function of the t distribution (with k degrees of freedom) to ob-
tain the even more flexible four-parameter skewed t distribution, which allows for the possibility
of heavier tails.
To illustrate their method Lee and Thompson apply it to a meta-analysis of 70 trials inves-
tigating the effectiveness of fluoride toothpaste conducted between 1954 and 1994, collated by
Marinho et al. [77]. In this instance the treatment effect is the ‘prevented fraction’ of decayed
and filled dental surfaces. That is, the difference in the mean change in the control and treatment
groups from baseline, divided by the mean change in the control group. The treatment effect
(and 95% confidence interval) obtained using the original analysis is given by 0.24 [0.21; 0.28].
Lee and Thompson demonstrate that there is clear evidence that the random effects distri-
bution is appreciably skewed. Indeed, Table 6.14 shows the parameter estimates obtained by
applying the flexible method given by Lee and Thompson to the meta-analysis. Firstly observe
that, for the flexible models that include a skewness parameter γ, this skewness parameter is
clearly non-zero. Moreover, there is a clear drop in the deviance information criterion (DIC), a
measure of the relative appropriateness of the model, for the more flexible models [117]. In par-
ticular, there is a drop of nearly 10 in the DIC for the skewed t compared to the skewed Normal
model, indicating a better fit in this case. Further, Figure 6.5 shows the estimated predictive
distributions for a new treatment effect by assuming several different parametric forms for the
random effects distribution. It is clear from the bottom two plots that introducing a skewness
parameter has greatly altered the predictive distribution, which suggests that the random effects
are not normally distributed.
Lee and Thompson [72] did not explicitly derive prediction intervals, and so we extend their
work by deriving equal-tail prediction intervals for a new treatment effect using the random
effects distributions described above. Table 6.15 compares the overall treatment effect and the
50%, 90%, 95% and 99% prediction intervals obtained by applying the flexible model proposed
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µ σ2 k γ DIC
Normal 0.242 (0.017) 0.015 (0.003) - - −139.2
t 0.224 (0.014) 0.012 (0.005) 3.332 (1.885) - −146.2
Skewed Normal 0.250 (0.015) 0.012 (0.003) - 2.219 (0.593) −143.5
Skewed t 0.238 (0.015) 0.012 (0.006) 4.005 (4.028) 1.951 (0.567) −148.7
Table 6.14: Parameter estimates (and standard errors) obtained by applying the flexible method
given by Lee and Thompson [72] to a meta-analysis of 70 trials investigating the effectiveness
of fluoride toothpaste by assuming several different parametric forms for the random effects
distribution.
Random effects Overall TE Prediction interval
distribution (95% CI) 50% 90% 95% 99%
Normal 0.24 [0.21; 0.28] [0.16; 0.33] [0.04; 0.44] [0.00; 0.48] [−0.07; 0.56]
t 0.22 [0.20; 0.25] [0.17; 0.28] [0.07; 0.38] [0.02; 0.43] [−0.14; 0.59]
Skewed Normal 0.25 [0.22; 0.28] [0.17; 0.32] [0.11; 0.46] [0.10; 0.51] [0.07; 0.61]
Skewed t 0.24 [0.21; 0.27] [0.17; 0.28] [0.12; 0.43] [0.11; 0.50] [0.06; 0.72]
Table 6.15: The overall treatment effect (TE) and 95% confidence interval (CI), as well as the
50%, 90%, 95% and 99% equal-tail prediction intervals for the effectiveness of fluoride toothpaste
obtained using the flexible parametric model proposed by Lee and Thompson [72] utilising
various assumptions for the random effects distribution.
Random effects
P[θ∗ > 0] P[θ∗ > 0.1] P[θ∗ > 0.2]
distribution
Normal 0.976 0.878 0.635
t 0.979 0.918 0.625
Skewed Normal 1.000 0.968 0.613
Skewed t 0.999 0.980 0.573
Table 6.16: The probability of a positive treatment effect θ∗ in a new trial investigating the
effectiveness of fluoride toothpaste by assuming several different parametric forms for the random
effects distribution.
167
by Lee and Thompson [72] and the results obtained by naively assuming that the random effects
are normally distributed. More specifically, we use the parameter estimates to derive equal-
tail prediction intervals for the flexible random effects distributions. It is apparent that, while
the estimate of the overall treatment effect (and its corresponding confidence interval) is not
altered dramatically, the prediction intervals are sensitive to the choice of the random effects
distribution. For example, if one assumes normality the 95% prediction interval is [0.00; 0.48],
however, if one assumes the skewed t distribution the 95% prediction interval is [0.11; 0.50]. This
reinforces the argument that, while the simulation study suggests that prediction intervals may
not be too adversely effected in terms of coverage, there are still repercussions for the inferences
that are drawn from the predictive distribution. This is particularly relevant in a Bayesian
framework, where one may be interested in making direct probability statements about the
treatment effect of a new study (e.g. finding the probability that the treatment might be
harmful in a new study, or determining the probability of a new treatment effect being clinically
meaningful).
Indeed, Table 6.16 reports the probability that a new treatment effect is greater than zero.
The probability that fluoride toothpaste will be effective in a new population (θ∗ > 0) is 0.976
when assuming normality, but 0.999 when assuming a skewed t distribution. The difference is
larger if more stringent clinical criteria for success are used. For example, the probability the
treatment effect is at least 0.1 in a new population is 0.878 when assuming normality, and 0.980
when assumed a skewed t distribution. Thus, it is clear that probabilistic inferences such as
these are sensitive to the random effects assumption.
6.5 Discussion
6.5.1 Key findings and recommendations
In this chapter we evaluated and discussed the effects of violating symmetry and normality
assumptions in several statistical models through the use of simulation studies. In particular,
we analysed how robust linear models and meta-analysis models are to violations of the normality
assumption by simulating data from a number of asymmetric probability distributions. The key
168
findings and recommendations are presented in the box below, and discussed in detail thereafter.
Key findings and recommendations
• For linear models
- Confidence intervals for the treatment effect estimate are not seriously effected
unless there are radical departures from symmetry in the residuals and there are
fewer than 8 individuals in each arm.
- Prediction intervals for the response value of a new patient are compromised for
asymmetric data even for substantial sample sizes, especially when considering
unusually narrow confidence intervals (e.g. 50%). On the contrary, conventional
intervals (95% and 99%) appear to be relatively robust to departures from sym-
metry.
- However, probability statements regarding a new individual are likely to be com-
promised.
• For random effects meta-analyses
- The number of studies is a far bigger contributor to the inaccuracy of confidence
intervals than asymmetry in the random effects.
- Confidence intervals for the average treatment effect constructed assuming nor-
mality (using Zα) are frequently too short for all distributions (irrespective of
whether the random effects are symmetric or asymmetric) when the number of
studies k is small (k < 10).
- Using the approach suggested by Knapp and Hartung [67] one obtains coverage
which is consistently close to 0.95, even when the number of studies is small.
- Prediction intervals for the treatment effect of a new study are generally overly
conservative when k = 3 irrespective of the asymmetry in the random effects
distribution.
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- Narrow prediction intervals (e.g. 50%) are inaccurate when there is substantial
asymmetry in the random effects distribution, even when k is large (k = 100).
However, in terms of coverage, the 95% and 99% prediction intervals are fairly
robust to asymmetry in the random effects distribution, especially when there
are at least 5 studies and the within study sample size is at least 30.
- Clinically relevant inferences, such as determining the probability of a new treat-
ment effect being above or below a specific value, are likely to be severely impinged
by the presence of asymmetry in the random effects. Such inferences are not un-
common in a Bayesian framework and are used to determine the probability of a
new treatment being harmful or having an effect which is clinically meaningful.
- Thus, when making probability statements or predictions about treatment effects
in a new population, greater attention is needed regarding the asymmetry in the
random effects distribution. This requires a reasonable number of studies, and in
situations where the normality distribution cannot be verified, prediction intervals
and probabilistic statements should be reported more cautiously.
Key findings for linear models
It was shown that, generally speaking, the conventional inferences that one draws from linear
models (e.g. treatment effect estimates and confidence intervals) are robust even to extreme de-
partures from symmetry. However, when the sample size is extremely small (n < 10) asymmetry
in the residuals of a linear model may lead to a skewed sampling distribution for the treatment
estimate, which impacts ones ability to draw accurate inferences from the model. Fortunately,
most randomised control trials do not contain so few patients and when n ≥ 30 this does not
appear to be a problem.
This was reflected in the coverage of the confidence intervals for the treatment effect, con-
structed using a linear model. Indeed, it was shown that the confidence intervals for the treat-
ment effect estimate are extremely robust to departures from symmetry. This is particularly
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evident for the 95% confidence intervals. Indeed, even for the extremely asymmetric distribu-
tions considered here, the coverage of the 95% confidence intervals only display minor departure
from 0.95. Indeed, the robustness of the t-test approach to departures from normality is well
established [9, 39, 108]. Further, the conclusions drawn from our investigation, that even ex-
treme asymmetry exerts very little influence on the coverage of confidence intervals, is in line
with existing research by Lumley et al. [75].
On the surface it appears that prediction intervals for future observations are similarly un-
affected for liner models. Indeed, the more conventional prediction intervals (95% or 99%) were
shown to be surprisingly robust to departures from symmetry in terms of coverage. However, it
was shown that shorter prediction intervals (50%) could be seriously erroneous with the coverage
actually worsening for larger sample sizes. Now, while it is unlikely that one would concerned
about a 50% prediction interval in practice, this discrepancy in coverage identifies that predic-
tive distribution is far from the assumed Normal distribution. This casts doubt of the apparent
validity of the 95% prediction intervals and, moreover, will have obvious ramifications if one is
interested in answering questions of a ‘Bayesian nature’ (i.e. finding the probability of a newly
treated individual displaying a clinically important difference in the response).
Key findings for meta-analyses
For a meta-analysis fitted using REML, it is apparent that asymmetry in the random effects dis-
tribution does not appear to be a substantial contributor to the accuracy of confidence intervals.
However, it was observed that the deviation from the expected coverage was worse if the random
effects displayed extreme asymmetry. In particular, confidence intervals had poor coverage when
the number of studies was small (k < 10) and this seemed to be the case irrespective of the
random effects distribution. Generally speaking, it was observed that for small numbers of stud-
ies, the confidence intervals tended to be too short using the Normal distribution. This finding
was also observed for meta-analyses fit using DerSimonian and Laird’s method of moments by
Brockwell and Gordon [14]. Brockwell and Gordon [14] suggest calculating confidence intervals
for the treatment effect using a ‘quantile approximation method’, that is, alternative quantiles
motivated by a simulation study. However, Jackson and Bowden [59] show that this approach
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is sensitive to the study parameters and the distribution of within study variances. Hence, for
meta-analyses with fewer than five studies, they advise using Normal quantiles for the primary
analysis, but to use the quantile approximation method as part of a sensitivity analysis.
In summary, the number of studies or the within study sample sizes are appeared to be
far bigger contributors to the inaccuracy that we observe in the confidence intervals. This
conclusion coincides with the findings of Kontopantelis and Reeves [68, 69] who conduct extensive
simulation studies comparing the performance of different meta-analysis methods when there is
asymmetry in the random effects. This finding is also concurrent with the results of McCulloch
et al. [80] who investigate the impact of incorrectly specifying the random effects distribution in
generalised linear mixed effects models. They conclude that the maximum likelihood approach
displays a “large degree of robustness . . . for a wide variety of commonly encountered situations.”
Moreover, it appeared that increasing the sample size did not significantly improve matters if
the number of studies was small.
In these cases the most suitable method appears to be the approach suggested by Knapp and
Hartung [67], which makes small sample adjustments to the variance estimates and constructs the
confidence interval based on the t distribution. This method produces a slightly wider confidence
interval than the conventional method, which reflects the uncertainty in the estimates of the
within study variance. However, this procedure generally produced confidence intervals that
were too wide in cases where there were a small number of studies (e.g. k = 3). This is in
line with the conclusions of Cornell et al. [20] who note that the method may overestimate the
amount of uncertainty in some cases, particularly when dealing with 5 or fewer studies.
Further, for a meta-analysis fitted using REML, the simulation study appeared to suggest
that asymmetry in the random effects doesn’t appear to be a serious problem for the construction
of 95% or 99% prediction intervals. By contrast, if one is interested in making predictions
over shorter intervals (50%), then asymmetry in the random effects distribution can seriously
compromise these inferences. These results suggest that the predictive distribution is far from the
assumed Normal distribution and, hence, this will have obvious consequences if one is interested
in determining the clinical significance of a new treatment effect or answering questions of a
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‘Bayesian nature’ (i.e. finding the probability of a new treatment effect being above or below a
certain value). Indeed, it was revealed that prediction interval coverage isn’t necessarily always
an informative measure, particularly if the interval fails to contain the highest probability mass
of the effect distribution. This was reaffirmed by an investigation into the impact of asymmetry
on probabilistic inferences, considering an example data set used by Lee and Thompson. Indeed,
to guarantee an informative prediction interval it is imperative to account for the asymmetry
in the random effects distribution. This conclusion is supported by Karabatsos et al. [65],
who propose a Bayesian non-parametric meta-analysis model, which can accommodate a wider
range of effects distributions. Indeed they state that the Normal random effects model may be
adequate for estimation of the overall effect size, but for prediction, “they surely are not if the
effect-size distribution exhibits non-normal behaviour.”
6.5.2 Limitations
It is worth noting that in this chapter we have exclusively considered the effect of asymmetry
on the treatment effect (in terms of the difference in the mean between control and treatment
groups) and the accuracy of confidence intervals and prediction intervals constructed about some
mean value. However, when there is a substantial amount of asymmetry in the underlying data,
it is debatable whether the mean provides the most informative measure of the centre of the
data. For example, in a heavily asymmetric population, a few extreme values will exert an
inordinate influence on the location of the mean. This may result in the mean being located
a long way from the majority of the data. Hence, while we may be able to construct accurate
confidence or prediction intervals about this mean, it may not be the best measure of the centre
of the data. For example, when there is extreme asymmetry in the data, it can be argued that
the median provides a better measure of the centre of the data (as a few extreme values in one
direction do not influence on the estimate of the median).
Also, our principle focus has been to assess the impact of asymmetry on the inferences of
statistical models. As a result, we neglected investigation of the impact of other departures
from the normality assumption, for example, excessively heavy tailed distributions. In fact,
these symmetric departures from the normality assumption have the potential to have equally,
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if not more, serious implications for the inferences drawn from statistical models [108].
Further, random effects meta-analysis simulation study has a number of specific limitations.
In particular, we only consider the situation where there is a large degree of heterogeneity. That
is, where the between study variability is much larger than the within study variability. Further,
we have also only considered the situation where the size of the studies is relatively balanced,
which means that there is very little variation in the within study variance across studies. Further
research is required to determine whether the key findings and recommendations discussed here
are sensitive to these features.
Also, in addition to the method suggested by Knapp and Hartung [67], there are numer-
ous other methods for accounting for uncertainty in the variance estimate of θ̂. For example,
Sidik and Jonkman [112, 113] suggest a modification to the Knapp and Hartung method, while
Kenward and Roger [66] suggest correcting the conventional REML estimate for small samples.
More recently, Noma [84] proposed several different confidence intervals based on Bartlett-type
corrections [21]. A thorough investigation of all of these methods is required to ensure the
relevance of the key findings and recommendations discussed here.
Another limitation to the simulation study in this chapter is that we have only reported
the results based on meta-analyses fitted using REML. We also investigated the impact of
asymmetric random effects distributions on the inferences drawn from a meta-analysis model
fitted using DerSimonian and Laird’s method of moments. The results were found to be relatively
consistent with the REML results presented here, however, there are numerous alternatives to
fit the meta-analysis. For example, one can use profile likelihood [49] or hierarchical Bayesian
models [55].
6.5.3 Conclusion
In summation, it was demonstrated that the common inferences that one draws from linear
models or meta-analyses, particularly confidence intervals for the average treatment effect, are
robust to departures from symmetry. However, it is worth noting that in both settings, if
the aim is to make predictions about future patients or treatments then it is possible that these
predictions may be compromised by the presence of asymmetry, either in the residual or random
174
effects distribution. This conclusion is in line with existing work by Grilli and Rampichini [41]
who investigate specification of random effects in in multilevel models. They conclude that
“for parameter estimation, the consequences of misspecification are usually minor” whereas
“appropriate selection is crucial for valid predictions of random effects”.
Further, prediction intervals may have suitable coverage even when the normality assumption
is inappropriate, but, they may still be unhelpful clinically. In particular, researchers are better
making probabilistic statements (for example, the probability the treatment is effective in a new
population) and this requires a critical examination of departures from normality, to assess the
impact on such probabilities. In other words, researchers should not routinely use prediction
intervals based on normality without checking if the normality assumption is correct, something
which will generally require a large number of studies. In situations with small numbers of
studies, prediction intervals may be helpful to reveal the uncertainty in predictions, but should
be interpreted cautiously.
Additionally, if one is interested in making more unconventional inferences regarding the
prediction of future observations (using a linear model or a meta-analysis) then it is recom-
mended to account for the asymmetry. For example, if one suspects that there is substantial
asymmetry in the response variable of a linear model, then it may be prudent to make apply
a transformation to the data before making inferences about future observations. Similarly, if
there is evidence of asymmetry in the random effects of a meta-analysis then it is recommended
to apply a more flexible method to account for this asymmetry. For example, Cornell et al. [20]
recommend the use of profile likelihood, which allows for the possibility of asymmetric intervals.
Alternatively, one can apply a flexible Bayesian model, for example, those proposed by Lee and
Thompson [72] or Karabatsos et al. [65], to account for this asymmetry. Cornell et al. also
acknowledge the usefulness of flexible Bayesian methods, however, they note that these “require
knowledge of Bayesian software and perform best with informed choice of a prior distribution.”
Indeed, Higgins et al. [55] state that by using “MCMC methods in a Bayesian framework, para-
metric distributions for the random effects offer the same opportunities for inference as a Normal
distribution.” They also comment that complex models particularly lend themselves to meta-
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analyses with a large number of large studies, where there may be substantial evidence against
the assumption of normally distributed random effects.
6.5.4 Next steps for thesis
So far, the investigations in this thesis have focused on developing and appraising methods for
measuring asymmetry or testing for symmetry, as well as investigating the impact that asym-
metric distributions can have on statistical models that naively assume a symmetric Normal
distribution. For example, in this chapter we investigated how sensitive linear models are to
asymmetric data, as well as examining the robustness of random effects meta-analyses to asym-
metry in the random effects. Prior to that, we developed a new test for symmetry based on
a recently proposed measure of asymmetry η̂; exhibited the usefulness of η̂ in the analysis of
randomised control trials; investigated the small sample properties of η̂; and proposed a meta-
analysis of η̂ to assess the asymmetry in several studies investigating the same population.
However, if determining the distribution of the underlying population is our principal inter-
est, we needn’t restrict ourselves to just considering the location of the mean or the amount of
asymmetry (or skewness, kurtosis or any other single summary statistic). In the next chapter we
further generalise this approach and discuss how to synthesise and compare information about
the entire density function.
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Chapter 7
Meta-analysis of a function and
its applications to analysing
diagnostic test accuracy
7.1 Introduction
The primary goal of this thesis is to develop methods for making inferences about the nature
of the distribution of a given random sample from an unknown distribution. Up to this point,
we have focused exclusively on testing for symmetry or measuring asymmetry. For example,
in Chapter 2 we developed a new test for symmetry based on a recently proposed measure of
asymmetry η̂. In Chapter 3 η̂ was applied to analysing individual randomised control trials. In
Chapter 5 we extended this approach to carry out a meta-analysis of η̂ to assess the distribution
of several studies investigating the same population. Now, in this current chapter we further
generalise this approach to consider a meta-analysis of the density function f and distribution
function F as a whole. After all, if determining the distribution of the underlying population is
our principal interest, we needn’t restrict ourselves to just considering the amount of asymmetry
(or skewness, kurtosis or any other single summary statistic).
This meta-analysis of a density or distribution function provides the foundation to develop a
new type of meta-analysis for use in analysing diagnostic test accuracy, when the test depends
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on dichotomising a continuous random variable. A key area of research in medicine is the
evaluation of continuous measures as diagnostic tests, where the aim is to correctly identify
diseased individuals as test positive (say, high values of the continuous factor) and non-diseased
as test negative (low values). To do this, a threshold is required to define high (above threshold)
and low (below threshold) values. In particular, when individual patient data is available we
can use estimates of the density and distribution function to estimate the distribution of the
continuous random variable. As a result, we are able to estimate the test accuracy at any
threshold, by determining the probability of obtaining a value above or below this point. In
fact, because of the smooth nature of our estimates for f and F we are not even constrained in
our choice of threshold by the data. That is to say, there is nothing to prevent estimation of
the test’s accuracy at a ‘hypothetical’ threshold in a region where the data are sparse or even
missing.
The goal of this chapter is to develop these new methods for analysing diagnostic test ac-
curacy and compare them with existing methods. In section 7.2 we introduce the concept of
a meta-analysis of a density estimate. After presenting the asymptotic theory we carry out a
worked example using the PTH data introduced in the Chapter 5. In section 7.3 we introduce
multivariate meta-analysis and apply this approach to improve upon the meta-analysis of a den-
sity estimate. In section 7.4 we briefly introduce the concept of diagnostic tests and some of the
existing methods for analysing diagnostic test accuracy (DTA). We then discuss how to extend
the meta-analysis of function to develop several novel approaches to conducting meta-analyses
of DTA. In section 7.5 we carry out a simulation study to compare the accuracy of our newly
proposed methods with some of the existing methods for performing meta-analyses of DTA. In
section 7.6 we discuss the results of the chapter.
Aims of the chapter:
• Develop new methods for comparing and synthesising information about the distribu-
tion of a specific population, based on data from multiple studies.
• Apply this methodology to propose new techniques for performing meta-analyses of
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DTA.
• Compare these new methods with some of the existing procedures for conducting
meta-analyses of DTA using both a real life case study and a simulation study.
7.2 Meta-analysis of density estimates
7.2.1 Introduction
When comparing the distribution of data across a number of studies one has a variety of sum-
mary statistics at their disposal. Consider, for instance, the parathyroid hormone (PTH) data
introduced in section 5.4 of Chapter 5. Table 7.1 shows the sample mean, variance, skewness,
and kurtosis, as well as η̂ and the sample size n, for the preoperative PTH data in the individuals
who did not got on to develop hypocalcemia. Table 7.2 shows precisely the same information
for the individuals who did got on to develop hypocalcemia. Each of these summary statistics
can be used to assess whether there is homogeneity between the two groups. It is of course
commonplace to compare samples based on their mean, and in Chapter 5 we compared the two
groups based on their asymmetry coefficient η̂.
In fact, the meta-analysis methods discussed in Chapter 5 to synthesise information about the
amount of asymmetry η, can also be utilised along with a variety of other summary statistics to
check for differences in the distribution of data across a number of studies. For example, one can
readily apply a meta-analysis to synthesise and compare information about the mean, variance,
skewness or kurtosis.
However, when one is assessing the distribution of a single sample, it is natural to construct
a histogram or a density estimate to assess the underlying distribution. When there are mul-
tiple (and possibly heterogeneous) samples available, meta-analyses could also be extended to
synthesise and compare estimates of the density function.
Indeed, the kernel density estimate f̂(x) is approximately normally distributed at every point
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Study Mean Variance Skewness Kurtosis η̂ n
Warren2002 50.41 303.92 −0.59 2.59 −0.17 12
Lo2002 60.17 865.73 1.09 5.66 0.34 89
Richards2003 - - - - - 0
Lam2003 45.56 1099.79 1.83 6.23 0.69 27
Payne0305 - - - - - 0
Warren2004 65.41 1233.70 1.13 4.25 0.31 23
Lombardi2004 52.87 483.22 0.50 2.62 0.42 35
McLeod2006 75.81 1515.79 1.41 5.60 0.40 46
Pooled 60.48 1041.28 1.40 6.31 0.38 232
Table 7.1: Summary statistics for the preoperative PTH levels in the individuals who did not
got on to develop hypocalcemia.
Study Mean Variance Skewness Kurtosis η̂ n
2002Warren 54.52 830.97 −0.30 1.99 −0.06 4
2002Lo 47.97 410.57 −0.64 2.37 −0.75 11
2003Richards - - - - - 0
2003Lam 51.83 770.88 0.11 1.62 0.38 12
0305Payne - - - - - 0
2004Warren 99.70 3041.77 0.48 1.50 0.84 3
2004Lombardi 43.44 391.99 1.13 4.09 0.61 16
2006McLeod 71.41 604.52 1.01 3.75 0.41 14
Pooled 56.03 803.48 1.04 5.10 0.20 60
Table 7.2: Summary statistics for the preoperative PTH levels in the individuals who went on
to develop hypocalcemia.
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x,
f̂(x) ∼ N
(
f(x), σ2
f̂
)
,
where the asymptotic variance, calculated by Bartlett [7], is
σ2
f̂
=
1
nh
f(x)
∫
R
K2(y)dy.
Alternatively, one can perform bootstrapping to estimate the variance. Thus, given multiple
random samples from similar (but possibly heterogeneous) populations, it is possible to construct
an overall summary estimate of the density estimate. Next, we outline a fixed effect and random
effects model for precisely this scenario.
7.2.2 Meta-analysis models for f̂(x)
Suppose we have k independent studies of size ni from the random variablesX
(i), for i = 1, · · · , k.
That is, let X
(i)
1 , · · ·X(i)ni be a random sample from the random variable X(i). Further, suppose
that X(i) has density function f (i)(x). The study specific density function f (i)(x) is readily
estimated from the data in study i using
f̂ (i)(x) =
1
nihi
ni∑
j=1
K
(
X
(i)
j − x
hi
)
, (7.1)
where the optimal bandwidth hi can be estimated using the the data in study i. Then, the
kernel density estimate f̂ (i)(x) is approximately normally distributed at every point x,
f̂ (i)(x) ∼ N
(
f (i)(x), σ2
f̂ (i)
)
,
where the asymptotic variance is given by
σ2
f̂ (i)
=
1
nihi
f (i)(x)
∫
R
K2(y)dy.
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Again, for brevity we write σ2
f̂ (i)
in place of σ2
f̂ (i)(x)
, but the asymptotic variance clearly depends
on the value of x. The standard error of f̂ (i)(x) is
s.e.
[
f̂ (i)(x)
]
=
√
1
nihi
f̂ (i)(x)
∫
R
K2(y)dy. (7.2)
The fixed effect model assumes that the σ2
f̂ (i)
are known and that every estimate f̂ (i)(x) is
estimating the same underlying probability density function
f (i)(x) = fo(x), for i = 1, · · · , k.
Therefore, the fixed effect meta-analysis model is given by
f̂ (i)(x) ∼ N
(
fo(x), σ2
f̂ (i)
)
. (7.3)
By contrast, the random effects meta-analysis model assumes that the study specific f (i)(x)
are randomly drawn from a Normal population with mean fo(x) and variance τ2f . That is, we
assume
f̂ (i)(x) ∼ N
(
f (i)(x), σ2
f̂ (i)
)
f (i)(x) ∼ N (fo(x), τ2f ) , (7.4)
where fo(x) denotes the overall density function of the underlying population and τ2f is the
between study variance in the density function estimate at the point x. Note that, for brevity,
we write τ2f in place of τ
2
f(x), but the between study variance will typically depend on x.
Thus, given multiple random samples from similar (but possibly heterogeneous) populations,
it is possible to construct an overall summary estimate of the density estimate f̂o(x) as well
as an approximate confidence interval for the overall density function. By constructing this
at a number of points we can build up a non-parametric representation of the distribution
underpinning multiple studies, as well as provide confidence bounds.
To summarise, the overall density f̂o(x) can be calculated as follows,
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1. Pool data across studies to determine the range of x.
2. Choose the number of points p to estimate in this range (x1, x2, · · · , xp).
3. For each study, calculate the density estimate f̂ (i)(x) at each xi using equation (7.1) (where
the bandwidth hi is based on the data in study i).
4. For each density estimate, calculate the standard error at every point xi using equation
(7.2).
5. Use this to perform either a fixed effect (7.3) or random effects (7.4) meta-analysis at each
xi to obtain f̂
o(xi).
6. Finally, interpolate the summary points f̂o(xi) to obtain a summary density estimate
f̂o(x).
A simple R function was written to perform the above steps. In the next subsection we provide
some examples using the PTH data.
7.2.3 Examples
Here, we investigate applying the fixed and random effects meta-analysis models to estimate
the density function of the preoperative PTH data. Figure 7.1 shows the summary density
estimates obtained by fitting the fixed effect meta-analysis model (7.3) for diseased and non-
diseased individuals. For both cases we estimate the density at 512 equally spaced points
covering the range of the data (−21.08 to 190.28 for the diseased group and −13.25 to 239.25 for
the non-diseased group) to ensure a suitably smooth density function in each case. The figure
also includes 95% point-wise confidence bands. That is, the curves obtained by interpolating
the upper and lower endpoints of the 95% confidence interval at each point. Similarly, Figure
7.2 shows the summary density estimates obtained by fitting the random effects meta-analysis
model (7.4) at the same points. Moreover, Figure 7.3 shows the value of I2 obtained my fitting
the random effects meta-analysis (using DerSimonian and Laird’s method of moments) at each
point. This reveals that the biggest variability between studies occurs in the tails of the density,
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Figure 7.1: Fixed effect meta-analysis of the density estimate f̂(x) for preoperative PTH data
in diseased (D) and non-diseased (ND) individuals, along with 95% confidence bands.
whereas close to the mode there seems to be agreement across studies. Similarly, beyond the
tails there is no between study variability as all studies estimate the density to be zero.
Figures 7.4 and 7.5 show the fixed and random effects summary density estimate, alongside
the individual study density estimates. There seems to be reasonable agreement between the
fixed and random effects methods. Moreover, the overall density functions appear to be sensible
summaries of the individual study specific density estimates. However, there are a number of
issues with the estimate of fo(x) described above and in the next subsection we highlight the
limitations of this approach.
7.2.4 Issues surrounding f̂ o(x)
Performing a meta-analysis of a density function poses a number of challenges which we shall
attempt to address in this subsection. Firstly, because we perform a meta-analysis at each point
xi separately, we cannot, in general, guarantee that the resulting summary function will be a
bona-fide density estimate. In fact, the approach outlined above will generally systematically
underestimate the density function and so the summary density estimate will not integrate to
one. Indeed, if the sample sizes across studies are well balanced then, for every point on the
density curve, higher weights will generally be given to the to the smaller density estimate (where
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Figure 7.2: Random effects meta-analysis of the density estimate f̂(x) for preoperative PTH
data in diseased (D) and non-diseased (ND) individuals, along with 95% confidence bands.
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Figure 7.3: Heterogeneity (I2) present in the random effects meta-analysis fit using DerSimonian
and Laird’s method of moments.
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Figure 7.4: Summary density estimates from a fixed effect meta-analysis along with the individ-
ual study density estimates for diseased (D) and non-diseased (ND) groups.
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Figure 7.5: Summary density estimate from a random effects meta-analysis along with the
individual study density estimates for diseased (D) and non-diseased (ND) groups.
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the standard error is lower). This can therefore lead to the summary density estimate being
underestimated at all points under consideration. As a result we propose scaling the summary
density estimate in order to ensure that one obtains a genuine density function (i.e. it integrates
to one). That is, the overall ‘average’ density function is given by
f˜o(x) =
f̂o(x)∫
f̂o(u)du
.
Another issue surrounding f̂o(x) is that the estimates of the density at individual points
are naturally correlated with one another. Performing a separate meta-analysis at each point
ignores this potentially important correlation. In the next section we introduce multivariate
meta-analysis to attempt to address this issue. Indeed, considering every point in a single
multivariate meta-analysis allows for the possibility of correlation between points.
7.3 Multivariate meta-analysis
7.3.1 Introduction
Multivariate meta-analysis makes it possible to synthesise information regarding multiple out-
comes whilst allowing for the possibility of correlation within, as well as between, studies. Jack-
son et al. [61] provide an extensive overview of the current state of multivariate meta-analysis,
identifying a number of advantages and disadvantages. For example, an obvious advantage of
carrying out a multivariate meta-analysis is that it increases the available information, and al-
lows for the borrowing of strength from other variables [99]. In the context of medical statistics,
this reduces the uncertainty in the treatment effect estimate and increases statistical power. On
the other hand, a multivariate meta-analysis can involve estimation of many more parameters,
which increases the computational complexity.
Consider a meta-analysis model consisting of k studies with a continuous response vector
Y ij . The within study model has the form
Y ij |µi ∼ N(µi, Si),
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where µ
i
is the vector of study specific treatment effects, and the matrix Si is the covariance
matrix of Y ij . As with the univariate case, the matrices Si are estimated using the individual
patient data within each study [101]. For a random effects model the study specific treatment
effects µi are distributed according to
µ
i
∼ N(µ,Σ),
where µ is the vector of overall treatment effects and Σ is the between study covariance matrix.
Generally Σ will be unstructured, but it is possible to simplify the model by assuming a specific
structure for Σ (e.g. one can assume that all between study correlations are equal.)
The principal difficulty in performing a random effects multivariate meta-analysis lies in
estimating the between study covariance matrix Σ. There are a variety of methods that can
be used to calculate the estimate Σ̂. For example, Jackson et al. [60] recently extended the
DerSimonian and Laird univariate estimate of τ2 to the multivariate setting. More conventional
methods involve estimating Σ using maximum likelihood estimation or restricted maximum
likelihood (REML).
Once the between study variance has been estimated, the estimate of the overall treatment
effect µ̂ is given by
µ̂ =
(
k∑
i=1
(
Si + Σ̂
)−1)−1( k∑
i=1
(
Si + Σ̂
)−1
µ̂
i
)
,
where µ̂
i
is the estimate of µi and Σ̂ is the estimate of the between study covariance matrix.
The overall effect estimate µ̂ is approximately normally distributed with variance
Var
(
µ̂
)
=
(
k∑
i=1
(
Si + Σ̂
)−1
µ
i
)−1
.
Therefore, by applying this result, one can readily obtain approximate confidence intervals for
each effect of interest, and even joint confidence regions for two or more of the effects of interest.
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7.3.2 Multivariate meta-analysis of f
Until now we have considered a separate meta-analysis for each point of interest on the support
of the density function. However, this approach ignores the very real possibility of correlations
between points on the density curve (both within and between studies). One way to address
this issue is to apply a multivariate meta-analysis and estimate the density curve at all points
simultaneously.
It is readily verified that the covariance between f̂(x) and f̂(y) is
S(x, y) := Cov
(
f̂(x), f̂(y)
)
=
1
n2
Cov
∑
i
Kh(Xi − x),
∑
j
Kh(Xj − y)

=
1
n2
∑
i
∑
j
Cov (Kh(Xi − x),Kh(Xj − y))
=
1
n
Cov (Kh(X − x),Kh(X − y)) .
This can be approximated by observing
S(x, y) =
1
n
(
E [Kh(X − x)Kh(X − y)]− E [Kh(X − x)] E [Kh(X − y)]
)
=
1
nh
E
[
1
h
K
(
X − x
h
)
K
(
X − y
h
)]
+O
(
1
n
)
=
1
nh
∫
R
K
(
z +
y − x
h
)
K (z) +
{
f(y) +O(h2)
}
dz +O
(
1
n
)
=
1
nh
f(y)
∫
R
K
(
z +
y − x
h
)
K (z) dz +O
(
1
n
)
.
This motivates the following first order approximation,
S(1)(x, y) =
1
nh
f(y)
∫
R
K
(
z +
y − x
h
)
K (z) dz.
Now, if K has compact support [−1, 1], then we have
S(1)(x, y) =

1
nh
f(y)
∫
R
K
(
z +
y − x
h
)
K (z) dz if |y − x| > h
0 if |y − x| < h.
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This form for the within study covariance matrix is rather insightful, as it clearly shows that
there is non-zero correlation for sufficiently close x and y, namely |x − y| < h. On the other
hand, outside this range the density estimates do not seriously correlate with one another.
However, S(1)(x, y) ≥ 0 for all x and y. Hence, by only considering the first order approxi-
mation we dismiss the possibility of negative correlations. Therefore, alternatively one can use
the second order approximation,
S(2)(x, y) =
1
nh
f(y)
∫
R
K
(
z +
y − x
h
)
K (z) dz − 1
n
f(x)f(y) +O
(
h
n
)
.
Using either of these approaches one can estimate the within study covariance matrix S(x, y).
However, by using approximate estimates of the within study variance and covariance we cannot
guarantee that the resultant covariance matrix is positive definite. This is a problem because,
in order to ensure the numerical stability and convergence of the multivariate model, we require
that the estimates of the within study covariance matrices are all positive definite [62, 79]. In
cases where the covariances matrices fail to be positive definite, this numerical instability can
be remedied in two ways. One approach involves diagonalising the matrix and setting all off-
diagonal covariance terms to zero. However, this removes the within study correlations that
we are keen to represent in our estimate of f(x). An alternative is to ‘augment’ the matrix
so that the negative eigenvalues are made small and positive. For example, in the context of
multivariate meta-analysis, Trikalinos et al. [121] suggest using ridge regression to choose these
‘regularising constants’.
In the next section we discuss how our proposed meta-analysis of a density function can be
modified to aid in the analysis of diagnostic test accuracy.
7.4 Applying to diagnostic test accuracy
7.4.1 Introduction to diagnostic test accuracy
Put simply, a diagnostic test is any medical procedure which attempts to aid in the diagnosis
or detection of disease. For example, in Chapters 4 and 5 as well as this chapter, we conducted
analyses on a collection of observational studies investigating the use of parathyroid hormone
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(PTH) to predict the onset of hypocalcemia after a thyroidectomy [85]. Recall that postop-
erative hypocalcemia is a common complication following a thyroidectomy, but, unfortunately
hypocalcemia is not usually present until 24 to 48 hours after surgery. As result, it is common
practice to keep patients under observation for this time. However, 70% of these patients will
not go on to develop hypocalcemia. As noted by Noordzij et al. [85], this puts unnecessary
strain on healthcare resources if a simple laboratory test is able to accurately classify patients
just hours after surgery.
The main hypothesis of these studies is that postoperative PTH levels are substantially lower
in patients who go onto develop hypocalcemia. Hence, an informative test for hypocalcemia
would be to classify an individual as positive if their PTH levels were low, and negative otherwise.
This motivates the idea of a threshold, below which individuals are classified as positive and
above which individuals are classified as negative. Of course, the downside with applying a
diagnostic test of this kind, as opposed to relying on the gold standard test (that is, the best
possible test, which is assumed to be 100% accurate at classifying diseased and non-diseased
individuals - in this case, a 48 hour monitoring period) is that the diagnostic test will not
necessarily be 100% accurate. As a result, for most diagnostic tests, there will be some error
associated with the positive/negative classification.
Suppose that we have a test based on a continuous marker X, which classifies an individual
as positive if X < δ for some threshold δ. Then, two common measures of test error are
given by sensitivity (the probability of a diseased individual testing positive) and specificity (the
probability of a non-diseased individual testing negative). Or, more formally in this case
Sensδ = P [+ve|D] = P [X < δ|D] and Specδ = P [-ve|ND] = P [X > δ|ND].
In practice these measures can be estimated using a simple sample proportion. For example, for
a given threshold, we can construct the following 2× 2 table.
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Diseased Non-diseased
Positive n11 n12
Negative n21 n22
n1 n0
The above 2×2 table provides a concise representation of the number of true positives n11, true
negatives n22, false positives n12 and false negatives n21 associated with a given test. Further,
n1 and n0 denote the total number of diseased and non-diseased individuals as determined by
the reference standard (or gold standard test).
In this case the sensitivity of the test can be estimated using
Ŝensδ = p̂1 =
n11
n1
, (7.5)
while specificity is similarly estimated using
Ŝpecδ = p̂0 =
n22
n0
. (7.6)
Alternatively, the positive likelihood ratio LR+ expresses how many times more likely a
positive result is in the diseased group compared to the non-diseased group. Assuming that the
test is informative, the positive likelihood ratio is greater than one and is defined as
LR+ =
P [+ve|D]
P [+ve|ND] =
Sens
1− Spec .
Similarly, the negative likelihood ratio expresses how many times less likely a negative result
is in diseased individuals compared to non-diseased individuals and is given by
LR− =
P [-ve|D]
P [-ve|ND] =
1− Sens
Spec
.
This information can be synthesised into a single measure of the accuracy of the test. The
diagnostic odds ratio (DOR) expresses how many times higher the odds of a positive result
in a diseased individual are compared to a non-diseased individual. While the DOR is not as
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clinically meaningful as estimates of sensitivity or specificity it does, however, readily lend itself
to a univariate meta-analysis setting as it summarises the test accuracy in a single value.
All the measures of accuracy mentioned above are sensitive to the choice of the threshold δ,
used to classify an individual as positive or negative. For example, for the PTH data discussed
above, as we increase the threshold the sensitivity of our test increases, but the specificity of our
test decreases. Therefore, the threshold δ needs to be carefully chosen to adequately balance
these two types of error.
One way to visualise the trade-off between sensitivity and specificity is through the use of
a receiver operating characteristic (ROC) curve. The ROC curve plots the true positive rate
(sensitivity) against the false positive rate (1 − specificity) for a variety of thresholds. For
example, returning to the PTH example again, if we set the threshold very low then sensitivity
and (1 − specificity) will both be close to zero (so we find ourselves in the bottom left corner
of the graph). Conversely, for a very large threshold the sensitivity and (1− specificity) will be
close to one. In the intermediate range the ROC curve will be an increasing function between
these two extreme regions.
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Figure 7.6: An example ROC curve describing the accuracy of a test for postoperative hypocal-
cemia based on PTH levels 1-2 hours after surgery, using the study carried out by Payne et al.
[90]. The curve is constructed using linear interpolation between the true positive rates and
false positive rates for the thresholds δ = 0, 10, 15, 20, 50, 100.
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For example, Figure 7.6 shows the ROC curve for a subset of the PTH data, using the study
carried out by Payne et al. [90]. In particular, it provides a graphical representation of the
effectiveness of using PTH levels 1-2 hours after surgery to predict the onset of hypocalcemia.
This particular ROC curve is based on a simple linear interpolation between the true positive
rates and false positive rates for the thresholds δ = 0, 10, 15, 20, 50, 100.
It is commonplace for multiple studies to investigate the accuracy of a specific diagnostic
test. Indeed, as we have already seen, this is exactly the case with the problem of testing for
hypocalcemia using PTH. Noordzij et al. [85] collated the results of 9 different studies investigat-
ing the accuracy of such tests. In the next subsection we discuss some of the existing procedures
for carrying out a meta-analysis of diagnostic test accuracy.
7.4.2 Meta-analysis of diagnostic test accuracy
In the context of diagnostic test accuracy, a meta-analysis aims to calculate and compare esti-
mates of the diagnostic accuracy of a test over a number of studies and investigate the variability
of results between these studies. There are a number of challenges to conducting a meta-analysis
in this context. For example, variation in thresholds may lead to correlation of sensitivity and
specificity estimates between studies. In fact, Putter et al. [94] acknowledge that this correlation
may also arise ‘implicitly’, owing to differences in laboratory equipment or the method of mea-
surement. Moreover, some studies may report multiple thresholds or certain thresholds might
be missing in some studies [102].
There are a number of different meta-analysis methods that aim to produce an overall esti-
mate of at least one of the summary estimates discussed in the previous section (e.g. sensitivity,
specificity, or DOR). The simplest approach is to carry out a separate meta-analysis for each es-
timate, however, this ignores the possibility of correlation between the measures of accuracy. For
example, as noted by Deeks [24], failing to account for the natural trade-off between sensitivity
and specificity can cause underestimation of test accuracy.
Alternatively, if there is information about multiple thresholds or even individual patient
data available, there are several meta-analysis methods which aim to generate a summary ROC
(sROC) curve. For example, one of the earliest models to take this approach is the Moses-
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Littenberg method, given by Moses et al. [83]. More recently, Hamza et al. [48] follow a mul-
tivariate random effects approach to generate a summary ROC curve, and Putter et al. [94]
extend the approach of Hamza et al. using a meta-analysis model which was previously used for
survival curves. Alternatively, Mart´ınez-Camblor [78] proposes a completely different approach,
estimating the summary ROC curve from a weighted average of each study specific ROC curve.
Each of these are obtained using interpolation between the available thresholds, and this gives
rise to a ‘fully non-parametric method’ for estimating the summary ROC.
We are particularly interested here with the case where individual patient data are available.
In this case, for each study, one can construct a 2 × 2 table at every threshold and calculate
sensitivity and specificity estimates. Then, at each threshold it is possible to model sensitivity
and specificity directly using a bivariate meta-analysis model.
Suppose therefore, we have k studies containing the individual patient data and with study
specific sensitivities p
(i)
1 and specificities p
(i)
0 . That is, let n
(i)
0 and n
(i)
1 be the number of non-
diseased and diseased individuals in study i. Further, let p̂
(i)
1 and p̂
(i)
0 be the estimates of
sensitivity and specificity given in equations (7.5) and (7.6), based on the 2× 2 table for study
i. Reitsma et al. [97] suggest modelling the logit transformed sensitivity and specificity, which
are assumed to approximately follow a bivariate Normal distribution. In this case, the within
study model is given by
logit
(
p̂
(i)
1
)
logit
(
p̂
(i)
0
)
 ∼ N

logit
(
p
(i)
1
)
logit
(
p
(i)
0
)
 ,
s21 0
0 s20

 , (7.7)
where
s21 =
1
n
(i)
1 p̂
(i)
1
[
1− p̂(i)1
] and s20 = 1
n
(i)
0 p̂
(i)
0
[
1− p̂(i)0
] ,
and
logit(x) = log
(
x
1− x
)
.
At the between study level, it is assumed that the logit transformed study specific sensitivity
and specificity follow a bivariate Normal distribution. That is,
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logit
(
p
(i)
1
)
logit
(
p
(i)
0
)
 ∼ N

µD
µN
 ,∑
 , (7.8)
where µD and µN are the overall logit-sensitivity and logit-specificity respectively, and
∑
=
 σ2D σDN
σDN σ
2
N

is the between study variance matrix, where σ2D and σ
2
N define the between study variability
in the logit-sensitivity and logit-specificity respectively, and σDN is the covariance between the
two.
A disadvantage of this approach is that it requires an ad-hoc continuity correction in studies
that have a zero in the 2 × 2 table. Moreover, the Normal approximation in equation (7.7)
requires a reasonably large number of samples within each study, and is less reliable when the
true sensitivity or specificity are close to one. Chu and Cole [19] improve upon this method by
proposing a generalised linear mixed model, which removes these two requirements. The main
difference is that, within a single study, they model the number of true positives n
(i)
11 and true
negatives n
(i)
22 using the exact binomial distribution. Namely,
n
(i)
11 ∼ Bin
(
n
(i)
1 , p
(i)
1
)
,
n
(i)
22 ∼ Bin
(
n
(i)
0 , p
(i)
0
)
,
(7.9)
where n
(i)
1 and n
(i)
0 are the total number of diseased and non-diseased individuals in study i, and
p
(i)
1 and p
(i)
0 denote the sensitivity and specificity in study i. Within studies, n11 and n22 are
assumed to be independent as they are based on separate sets of patients. At the between study
level, the model is unchanged and uses equation (7.8), which assumes that the logit transformed
study specific sensitivity and specificity follow a bivariate Normal distribution. Chu and Cole
[19] show that this model can be fit using a mixed effects logistic regression model and that it
is considerably more accurate for sparse data.
In the next section we explain how our meta-analysis of f̂ can be extended to analyse
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diagnostic test accuracy.
7.4.3 Applying meta-analysis of f̂ to analyse diagnostic test accuracy
In this section we apply the meta-analysis of f̂ to develop a new method for assessing the
accuracy of diagnostic tests. Provided that one has access to the individual patient data, it is
possible to apply this method to determine the average distribution of the marker in diseased and
non-diseased patients over several studies. It is then possible to use these average distributions to
calculate the sensitivity and specificity for any threshold of interest. To calculate the sensitivity
and specificity we require an estimate of the cumulative distribution function. For this reason, we
modify the method proposed in section 7.2 to perform a meta-analysis on the smooth distribution
function estimate F̂ . Recall from Chapter 1 that
F̂ (x) =
∫ x
−∞
f̂(u)du
=
∫ x
−∞
1
nh
n∑
i=1
K
(
u−Xi
h
)
du
=
1
nh
n∑
i=1
∫ x
−∞
K
(
u−Xi
h
)
du
=
1
n
n∑
i=1
∫ x−Xi
h
−∞
K (v) dv
=
1
n
n∑
i=1
K
(
x−Xi
h
)
,
where K(x) =
∫ x
−∞K(u)du is a cumulative distribution kernel function. For the theoretical
properties of this estimator refer to Reiss [96] and the references therein. Crucially, Watson and
Leadbetter [126] proved that F̂ (x) is asymptotically normally distributed. Indeed,
√
n ·
[
F̂ (x)− F (x)
]
L−→ N
(
0, F (x)[1− F (x)]
)
. (7.10)
Hence, just as before, it is possible to carry out a meta-analysis of F̂ (x) for each value of x of
interest by using
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s.e.
(
F̂ (x)
)
=
√
1
n
F̂ (x)
[
1− F̂ (x)
]
. (7.11)
Therefore, we now outline how one can calculate the overall summary estimate of F̂ in the
non-diseased groups F̂ o0 and the summary estimate of F̂ in the diseased group F̂
o
1 . Using these
estimates one can readily obtain an estimate of sensitivity or specificity at any desired threshold.
Hall et al. [47] propose precisely this method for generating ROC curves in a single diagnostic
test accuracy study. We generalise their approach to perform similar analyses in a meta-analysis
setting.
Suppose we have individual patient data from k independent diagnostic test accuracy studies
based on a continuous maker. That is, let X
(i)
1 , · · · , X(i)n(i)0 be a random sample from the con-
tinuous marker in non-diseased group in study i. Similarly, let Y
(i)
1 , · · · , Y (i)n(i)1 be an analogous
random sample for the diseased group. For study i, let F̂
(i)
0 and F̂
(i)
1 denote the estimate of F̂
in the non-diseased group and diseased group respectively. That is,
F̂
(i)
0 (x) =
1
n
(i)
0
n
(i)
0∑
j=1
K
(
x−X(i)j
h0;i
)
,
F̂
(i)
1 (x) =
1
n
(i)
1
n
(i)
1∑
j=1
K
(
x− Y (i)j
h1;i
)
,
(7.12)
where h0;i and h1;i are the bandwidths for the control and treatment group in study i. Then,
supposing we classify an individual as diseased if the marker X < δ, we can estimate the
sensitivity and specificity within study i using
Ŝens
(i)
= p˜
(i)
1 = F̂
(i)
1 (δ),
and
Ŝpec
(i)
= p˜
(i)
0 = 1− F̂ (i)0 (δ).
Using equation (7.11) the approximate standard error for F̂
(i)
j (x) is given by
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s.e.
(
F̂
(i)
j (x)
)
=
√
1
n
(i)
j
F̂
(i)
j (x)
[
1− F̂ (i)j (x)
]
, (7.13)
for j = 0, 1 and i = 1, 2, · · · , k. To avoid the possibility of obtaining a standard error equal to
zero, it is possible to carry out the ad-hoc continuity correction, akin to the method by Reitsma
et al. [97]. Hence, the within study model for study i at a particular threshold is given by
p˜(i)1
p˜
(i)
0
 ∼ N

p(i)1
p
(i)
0
 ,Si
 ,
where p
(i)
1 and p
(i)
0 are the sensitivity and specificity for study i and Si is the within study
covariance matrix for study i,
Si =
 1n(i)1 F̂ (i)1 (δ)
[
1− F̂ (i)1 (δ)
]
0
0 1
n
(i)
0
F̂
(i)
0 (δ)
[
1− F̂ (i)0 (δ)
]
 .
The off-diagonal terms of Si are zero, as it is assumed there is no correlation between the
estimates of sensitivity and specificity, due to the fact they are estimated from different patients.
At the between study level, we assume that the study specific sensitivity and specificity are
distributed according to p(i)1
p
(i)
0
 ∼ N

 F o1 (δ)
1− F o0 (δ)
 ,Ψ
 ,
where F o1 (δ) and 1 − F o0 (δ) are the overall sensitivity and specificity respectively, and Ψ is the
between study covariance matrix,
Ψ =
ψ11 ψ12
ψ12 ψ22

where ψ11 and ψ22 are the between study variance in sensitivity and specificity, and ψ12 is
the between study covariance between the two. Therefore, to summarise, the bivariate smooth
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distribution function meta-analysis model is given by
p˜(i)1
p˜
(i)
0
 ∼ N

p(i)1
p
(i)
0
 ,Si
 ,
p(i)1
p
(i)
0
 ∼ N

 F o1 (δ)
1− F o0 (δ)
 ,Ψ
 .
(7.14)
However, the Normal approximation in equation (7.10) will be particularly stretched when
sensitivity or specificity are close to 1, which is typically the region of interest for test accuracy
studies. As a result, we also propose a bivariate meta-analysis on the logit transformed smoothed
distribution function estimate. This model has the formlogit
(
p˜
(i)
1
)
logit
(
p˜
(i)
0
)
 ∼ N

logit
(
p
(i)
1
)
logit
(
p
(i)
0
)
 ,S∗i
 ,
logit
(
p
(i)
1
)
logit
(
p
(i)
0
)
 ∼ N

 logit (F o1 (δ))
logit (1− F o0 (δ))
 ,Ψ∗
 ,
(7.15)
where
S∗i =

1
n
(i)
1 F̂
(i)
1 (δ)
[
1−F̂ (i)1 (δ)
] 0
0 1
n
(i)
0 F̂
(i)
0 (δ)
[
1−F̂ (i)0 (δ)
]
 .
and Ψ∗ is the between study covariance matrix,
Ψ =
ψ∗11 ψ∗12
ψ∗12 ψ∗22

where ψ∗11 and ψ∗22 are the between study variance in logit-sensitivity and logit-specificity, and
ψ12 is the between study covariance between the two.
Indeed, the logit transformed bivariate model is also especially appealing as there are a
number of direct comparisons with the existing method proposed by Reitsma et al. [97], which
we investigate in the next subsection.
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It is also possible to incorporate the possibility of correlations between the estimates of
F̂ (δ) across different values of δ. That is, analyse all thresholds simultaneously and account
for correlations between the multiple thresholds. Indeed, Riley et al. [102] recently proposed an
extension of the method by Reitsma et al. [97] for just this purpose. It was shown by Rosenblatt
[104] that
Cov (Fn(x), Fn(y)) =
1
n
[F (min(x, y))− F (x)F (y)] ,
and similarly it is readily calculated that the covariance between F̂ (x) and F̂ (y) is
Cov
(
F̂ (x), F̂ (y)
)
= Cov
 1
n
n∑
i=1
Kh (x−Xi) , 1
n
n∑
j=1
Kh (y −Xj)

=
1
n2
n∑
i=1
n∑
j=1
Cov (Kh (x−Xi) ,Kh (y −Xj))
=
1
n
Cov (Kh (x−X) ,Kh (y −X)) ,
=
1
n
[E[Kh(x−X)Kh(y −X)]− E[Kh(x−X)]E[Kh(y −X)]]
=
1
n
[F (min(x, y))− F (x)F (y)] +O
(
h2
n
)
,
where Kh(x) = K
(
x
h
)
. However, incorporating the cross-threshold correlations into our model
greatly increases the number of variables in the multivariate meta-analysis and, therefore, fitting
this more complicated model is much more computationally intensive. Moreover, in this case
estimation of the within study variation is also plagued by the same problems as the multivariate
meta-analysis of f̂ , which we identified in section 7.3. That is, it is difficult to guarantee the
positive definiteness of the within study covariance matrix. As a result, for the remainder
of the chapter we restrict our analysis to fitting the bivariate models (7.14) and (7.15) at each
threshold separately. Indeed, the bivariate model is also appealing as there are a number of direct
comparisons with the existing approach proposed by Reitsma et al. [97], which we investigate
in the next subsection.
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7.4.4 Comparisons with the conventional approach
The newly proposed methods outlined above are directly comparable with the method proposed
by Reitsma et al. [97] when analysing the accuracy of a diagnostic test based on a continuous
outcome with individual patient data. Indeed, recall that the standard approach would be to
generate a 2× 2 table at every threshold and calculate sensitivity and specificity from these. In
fact, this approach is identical to considering the empirical distribution function estimates for
the diseased and non-diseased individuals. For example, recall the following 2 × 2 table based
on dichotomising a continuous marker at a given threshold δ.
Diseased Non-diseased
Positive n11 n12
Negative n21 n22
n1 n0
It is clear that
Ŝensδ = p̂1 =
n11
n1
= Fn;1(δ),
and
Ŝpecδ = p̂0 =
n22
n0
= 1− Fn;0(δ),
where Fn;1 and Fn;0 are the empirical distribution function estimates for the random samples
in the diseased and non-diseased individuals respectively. Recall that the empirical distribution
function estimate is given by
Fn(x) =
1
n
n∑
i=1
I[Xi < x].
Also, while it is true that
Fn(x) ∼ Bin(n, F (x)),
there is also the analogous result that
√
n
[
Fn(x)− F (x)
]
L−→ N
(
0, F (x)[1− F (x)]
)
,
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and
√
n
[
logit (Fn(x))− logit (F (x))
]
L−→ N
(
0,
1
F (x)[1− F (x)]
)
.
In fact, this is precisely the approximation used by Reitsma et al. [97] in developing their
bivariate model, using the logit transformed Fn. Hence, our newly proposed logit transformed
method is actually a generalisation of the Reitsma method. Indeed, as we let the bandwidth h
shrink to zero, F̂ (x) converges to Fn(x). This is an obvious corollary of the result
K
(
x−Xi
h
)
→ I [Xi < x] ,
as h→ 0. We present a short proof of this result.
Proof. Suppose that K has compact support [−1, 1]. Then
K (y) =

0 if y < −1
G(y) if − 1 < y < 1
1 if y > 1
,
where G represents an arbitrary increasing function on [−1, 1]. Hence,
K
(
x−Xi
h
)
=

0 if Xi > x+ h
G
(
x−Xi
h
)
if x− h < Xi < x+ h
1 if Xi < x− h
.
Therefore,
K
(
x−Xi
h
)
→
 0 if Xi > x1 if Xi < x
= I [Xi < x] ,
as h→ 0. 
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This is also apparent in Figure 7.7 which shows F̂ (x) for a range of bandwidths, as well
as the empirical distribution function estimate Fn(x), based on a simulated Normal sample of
size n = 30. In this particular case the optimal bandwidth (based on the rule by Silverman
[114]) for the corresponding density function is given by h = 0.52. It is clear that, as the
bandwidth h is decreased from this optimal value, the smooth distribution function estimate
F̂ (x) approaches the empirical distribution function Fn(x). This is an encouraging result, in
terms of the implementation of our method, as it means that we cannot ‘under-smooth’ our
estimates of sensitivity and specificity. Indeed, as we let the study specific bandwidths hi
converge to zero, our logit transformed method approaches the method proposed by Reitsma
et al. [97]. On the other hand, we must be cautious not to select a bandwidth which is too large
to avoid ‘over-smoothing’. In Figure 7.7 the curve for h = 3 represents a wildly over-smoothed
estimate of F . In this case, the bandwidth parameter is so large that the information in the
underlying data is lost and the distribution function estimate is dominated by the kernel K.
7.4.5 Issues surrounding F̂o(x)
There are a number of issues with applying a meta-analysis directly to the smooth distribution
function estimate. Because we apply a separate weighting at every point, the resulting function
need not necessarily be an increasing function and thus, the summary ROC curve may be
ill-defined. One way to ensure that the overall estimate of F̂ (x) is an increasing function of
x is to generate the distribution function estimate in two stages. For example, it is possible
to first calculate a summary density estimate f̂ using the meta-analysis techniques outlined
in the previous section, before numerically integrating this function to arrive at an estimate
of F which is surely increasing. Indeed, one can estimate the density function for the non-
diseased individuals f˜
(0)
o (x) and diseased individuals f˜
(1)
o (x), before estimating the sensitivity
and specificity using
Sens =
∫ δ
−∞
f˜ (1)o (u)du, Spec =
∫ ∞
δ
f˜ (0)o (u)du.
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Figure 7.7: Distribution function estimates using the empirical distribution function estimate
Fn(x) (dotted line) and the smooth distribution function estimate F̂ (x) with bandwidth h
(coloured lines), based on a Normal sample of size n = 30. As the bandwidth h is decreased,
F̂ (x) approaches Fn(x).
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However, due to the complicated nature of this estimate, it is more difficult to determine the
resulting standard errors for the sensitivity and specificity. As a result, for the purposes of
evaluating diagnostic test accuracy we focus on applying meta-analysis directly on F̂ .
7.4.6 Real data example
We now revisit the parathyroid hormone (PTH) meta-analysis data introduced at the start of
this section to investigate applying the bivariate smooth distribution function models to a real life
data set. Figures 7.8 and 7.9 show the summary smooth distribution function estimate obtained
by applying the bivariate meta-analysis model to the PTH levels 1-2 hours after surgery, on the
raw and logit scales respectively. The figures also include the individual study estimates and
the overall curve appears to be a sensible average of these curves.
Figure 7.10 shows the corresponding sensitivity and specificity estimates obtained by fitting
the model on the raw and logit scale, while 7.11 shows the ROC curve obtained by applying both
these methods. It is apparent that there is a reasonable disparity between the two methods.
This can likely be attributed to the fact that this particular collection of data is made up of
several small studies and so the Normal approximation is inappropriate for both scales.
Recall that, when individual patient data are available, the usual approach for evaluating
diagnostic test accuracy over multiple studies is to generate a 2× 2 table at every threshold. It
is then possible to perform multiple bivariate meta-analyses at every threshold using the model
proposed by Reitsma et al. [97] or the bivariate binomial method by Chu and Cole [19]. We now
compare our newly proposed methods with these existing procedures.
Figure 7.12 compares the overall sensitivity and specificity estimates generated using our
newly proposed smooth distribution function methods with the conventional 2 × 2 table ap-
proaches given by Reitsma et al. and Chu and Cole for PTH levels 1-2 hours after surgery.
Further, Figure 7.13 compares the corresponding summary ROC curves generated by all of
these methods. It is immediately clear that the distinctive feature of the newly proposed meth-
ods is that they produce smooth sensitivity, specificity and ROC curves, even in a sparse data
set such as this. This is in stark contrast to the existing methodologies that both produce some-
thing close to a step function, with jumps at thresholds where at least one individual changes
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Figure 7.8: Smooth distribution function estimates obtained by fitting the bivariate model on
the raw scale along with the individual study estimates for the PTH levels 1-2 hours after surgery
for diseased (left) and non-diseased (right) individuals.
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Figure 7.9: Smooth distribution function estimates obtained by fitting the bivariate model on
the logit scale along with the individual study estimates for the PTH levels 1-2 hours after
surgery for diseased (left) and non-diseased (right) individuals.
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Figure 7.10: Overall sensitivity and specificity estimates obtained by applying the bivariate
smooth distribution function method on the raw and logit scale for the PTH levels 1-2 hours
after surgery.
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Figure 7.11: ROC curves obtained by applying the smooth bivariate method on the raw (Raw-
SBM) and logit (Logit-SBM) scale for the PTH levels 1-2 hours after surgery.
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classification (from positive to negative or vice versa).
It is also apparent from these figures that the sensitivity and ROC curve generated using
the method by Reitsma et al. is not an increasing function. Furthermore, it is less noticeable for
the Chu and Cole method, but this also generates an improper sensitivity and ROC curve. This
elucidates the fact that the drawbacks of our newly proposed methods, highlighted in section
7.4.5, are not limited to our method, but are also facets the existing procedures too. Moreover,
this example demonstrates that our smooth methods may actually improve upon the existing
methods in this regard.
It is also clear from the figures that the actual summary estimates at each threshold vary
considerably across the different methods. Therefore, the question remains as to which is method
provides the most reliable estimate of test accuracy. In the next section we compare all of these
methods in a more thorough fashion by conducting a simulation study designed to investigate
the accuracy of these proposed methods at analysing diagnostic test accuracy.
7.5 Simulation study
7.5.1 Introduction
We compare our new methods for carrying out meta-analyses of diagnostic test accuracy with
the existing method given by Reitsma et al. [97], and Chu and Cole [19] using a simulation study.
The study will generate a continuous response for diseased and non-diseased individuals over
several studies and assess the accuracy of the techniques over several thresholds. The simulation
study will be used to answer a number of pertinent questions:
1. Principally, how do our newly proposed methods perform compared with the existing
methods by Reitsma et al. and Chu and Cole for analysing diagnostic test accuracy? In
particular we compare
• Bias in the sensitivity and specificity meta-analysis results.
• Empirical standard error of the overall sensitivity and specificity estimates.
• Mean square error of the overall sensitivity and specificity estimates.
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Figure 7.12: Comparison of the overall sensitivity and specificity estimates generated using the
smooth bivariate method on the raw and logit scales with the conventional 2×2 table approaches
for PTH levels 1-2 hours after surgery.
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Figure 7.13: Comparison of the summary ROC curves generated using the smooth bivariate
method on the raw (Raw-SBM) and logit (Logit-SBM) scales with the conventional 2× 2 table
approaches for PTH levels 1-2 hours after surgery.
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• Coverage of the confidence intervals for overall sensitivity and specificity.
2. In how many of these meta-analyses do we observe impossible sensitivity, specificity, or
ROC curves? That is, how frequently do we obtain a non-monotonic overall sensitivity or
specificity curve?
3. How much variability is there in the between study variance of sensitivity and specificity
across thresholds?
7.5.2 Methods
The simulation study will involve the following fixed parameters governing the distribution of
the continuous response:
M The overall mean of the continuous response in healthy individuals.
X The average difference between diseased and non-diseased individuals (M+X is the overall
mean of the continuous response in diseased individuals).
κ2 The between study variance of the mean of the continuous response.
σ2i The within study variance of the continuous response in study i.
In order to choose these fixed distributional parameters for the simulation study, we use the
PTH data as a template. In particular, we consider the PTH level 1-2 hours after surgery, which
maximises the amount of available data (299 individuals). As the individual patient data are
available for this dataset, it is readily calculated that the overall means of the non-diseased and
diseased group are 40.84 and 10.90 respectively. Therefore, in our simulation study we set the
overall average for the non-diseased group to be 40 and the overall treatment effect to be −25.
The within study standard deviation in the PTH data varies from 15 to 25, however, in order
to calculate the true sensitivity and specificity it is convenient to set the within study variance
as equal across all studies. By fitting a random effects meta-analysis it is readily calculated
that, for this dataset, I2 = 14.5% [0%; 58.1%]. We are particularly interested with the case
where there is a reasonably large level of heterogeneity between studies. As a result, we choose
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σ2i = 20
2 = 400 for every study i, and select a value of κ2 = 100 to reflect this. Therefore, to
summarise, we make the following choices for the fixed parameters:
M = 40, X = −25, κ2 = 100 and σ2i = 400 ∀i.
The simulation study will also involve varying the following parameters:
k The number of studies.
ni The total number of diseased and non-diseased individuals in study i.
pi The prevalence of the disease.
In particular, we consider k = 5, 10 and 20 studies and a range of random sample sizes. For
example,
ni ∼ U(20, 50) and U(100, 300).
Both these choices for sample size fall well within the boundaries of real life diagnostic test
accuracy studies, based on a review of the recent literature by Bochmann et al. [8]. Indeed,
Bochmann et al. found the median sample size to be 122.5 with substantial variation across
studies. We will also investigate the effectiveness of both methods for high and low prevalence
(pi = 0.5 and 0.25). Again, these choices were informed by another review of the recent diag-
nostic test accuracy literature by Bachmann et al. [5], who found that the median prevalence
was 43% with interquartile range 27% to 61%. Another important parameter is the number
of thresholds T to consider. Since our method relies on the availability of individual patient
data we can chose any threshold of interest and, therefore, we use a reasonably large number of
thresholds. In order to ensure the convergence of all methods, we restrict ourselves to thresholds
which give sensitivity and specificity greater than or equal to 0.5. In particular, we consider
T = 26 equally spaced thresholds over the range [M + X;M ] = [15, 40]. This facilitates the
construction of sensitivity, specificity and ROC curves over this range.
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7.5.3 Simulation model
Let n0i and n
1
i denote the number of non-diseased and diseased individuals respectively in study
i. Further, let t0ij denote the continuous response of non-diseased individual j in study i where
j = 1, · · · , n0i and i = 1, · · · , k. Similarly, let t1ij denote the continuous response of diseased
individual j in study i where j = 1, · · · , n1i and i = 1, · · · , k. Then,
t0ij ∼ N(µi, σ2i ),
and
t1ij ∼ N(µi +X,σ2i ),
where
µi ∼ N(M,κ2).
Alternatively, in contracted form
tdij ∼ N(M + dX, σ2i + κ2), d = 0, 1. (7.16)
Using this model we generate tdij for all patients and all studies, before applying the new and
existing methods to calculate estimates of sensitivity and specificity. By assuming that the study
specific variances σ2i = σ
2 are equal, we can calculate the true overall sensitivity and specificity
at every threshold δ,
Sensδ = P [X < δ|D] = F1(δ), Specδ = P [X > δ|ND] = 1− F0(δ),
where F1 and F0 are the Normal cumulative distribution functions with means M +X and M
respectively, and variance σ2 + κ2. Hence, it is possible to directly compare the test accuracy
estimates of sensitivity and specificity with the true overall sensitivity and specificity. The
simulation study is outlined in Table 7.3.
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Step 1 Randomly generate the k = 5 study specific sample sizes ni ∼
U(100, 300).
Step 2 Generate the individual patient data (IPD) for each study using equation
(7.16) with M = 40, X = −25, σ2i = 400 and κ2 = 100. In particular,
assuming a prevalence of pi = 0.5 simulate pini observations for the
diseased group and (1 − pi)ni observations for the non-diseased group
(rounding to the nearest integer where necessary).
Step 3 At each threshold T = 15, 16, · · · 40 generate a 2×2 table using the IPD.
Step 4 At each threshold, fit the smooth bivariate method on the raw (Raw-
SBM) and logit (Logit-SBM) scale along with the existing bivariate
methods by Reitsma et al. [97] and Chu and Cole [19].
Step 5a At each threshold, extract the summary estimates of sensitivity and
specificity for each method along with the estimates of between study
variance for sensitivity and specificity τ2.
Step 5b At each threshold, generate maximum likelihood confidence intervals for
sensitivity and specificity and check to see whether they contain the true
sensitivity or specificity.
Step 5c For each method, evaluate the monotonicity of the resulting sensitivity
and specificity curves. That is, check to see whether the sensitivity
(specificity) is non-decreasing (non-increasing) with the threshold.
Step 6 Repeat Steps 1-5c 10, 000 times and, for each method, calculate the
average bias, empirical standard error, mean square error, and average τ
at each threshold. Also report the coverage of sensitivity and specificity
for each threshold. Further, calculate the average ROC curve and the
total number of invalid sensitivity and specificity curves for each method.
Step 7 Repeat Steps 1-6 for k = 10 and 20 as well as for low prevalence
(pi = 0.25) and smaller sample sizes, ni ∼ U(20, 50).
Table 7.3: Step by step guide to the simulation study.
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7.5.4 Results
Large within study sample size
First, we compare the performance of the smooth distribution function method (on the raw and
logit scales) with the existing methods by Reitsma et al. [97] and Chu and Cole [19] for relatively
large samples in each study. Figure 7.14 shows the bias in the estimates of the overall sensitivity
and specificity using each of the methods, where the overall within study sample sizes are drawn
from ni ∼ U(100, 300), and the prevalence is taken to be pi = 0.5. That is, the total number
of observations per study ni is divided equally the treatment and control arms, appropriately
rounding if necessary. It is apparent that the logistic regression method (Chu and Cole) is by
far the least biased. In fact, the method is almost completely unbiased. By contrast, all other
methods are downwardly biased for the thresholds under consideration here. Of the two newly
proposed methods, applying the method on the raw scale is most effective at minimising bias.
However, both smooth methods are substantially more biased than the existing methods.
Figure 7.15 shows the empirical standard error in the estimates of the overall sensitivity and
specificity using the smooth distribution function method (on the raw and logit scales) along with
the existing methods by Reitsma et al. and Chu and Cole. The new methods radically improve
on the variability in the estimates, something which is quite typical of smoothing methods. The
smoothing methods incorporate more information from the surrounding thresholds, reducing
the variability of the estimate, but at the expense of adding bias. Both newly proposed methods
perform very closely in terms of empirical standard error.
Figure 7.16 shows the mean square error (MSE) in the estimates of the overall sensitivity
and specificity using the smooth distribution function method (on the raw and logit scales)
along with the existing methods by Reitsma et al. and Chu and Cole. The mean square error
is extremely variable across thresholds, which is reflective of the changeable bias and variance.
The new methods out perform the existing methods in the regions of low bias (when sensitivity
or specificity are close to 0.5). Alternatively, for thresholds where the sensitivity or specificity is
close to 0.9, typically the region of interest, the existing methods outperform the new methods.
Figure 7.17 shows the coverage of the 95% confidence intervals for the overall sensitivity
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and specificity using the smooth distribution function method (on the raw and logit scales)
along with the existing methods by Reitsma et al. and Chu and Cole. The existing methods
are much more consistent in terms of coverage, although, both existing methods produce overly
conservative confidence intervals. The new methods appear to produce confidence intervals that
are either overly conservative or too short at the extreme ends of the thresholds.
Figure 7.18 shows the square-root of the between study variance in sensitivity and specificity
for the smooth distribution function method (on the raw and logit scales) along with the existing
methods by Reitsma et al. and Chu and Cole. It is important to note that the between study
variance is not reported on the same scale for every method. Indeed, all the methods report
the between study variance on the logit scale with the exception of the new method on the raw
scale. The key point is that the largest between study variability occurs when the sensitivity or
the specificity are close to 0.9.
Table 7.4 shows the number of invalid overall sensitivity and specificity curves obtained using
the smooth distribution function method (on the raw and logit scales) along with the existing
methods by Reitsma et al. and Chu and Cole. It is clear that when there are only a small
number of studies (k = 5) the new methods are far less likely to produce an invalid sensitivity
or specificity curve. Indeed, of the 10, 000 simulated meta-analyses, the new methods don’t
generate any invalid sensitivity or specificity curves. However, the existing methods improve in
this regard as the number of studies is increased.
Figure 7.19 shows the average ROC curve obtained by averaging the overall sensitivity and
specificity across all 10, 000 iterations of the simulated data, along with the ‘true’ summary ROC
curve. This reinforces the earlier discovery that the Chu and Cole method is almost completely
unbiased, as there is very little difference between the ROC curve generated using this approach
and the ‘true’ summary ROC curve. Further, in this large sample setting, the summary ROC
curve generated by using the approximate method by Reitsma et al. does not deviate far from
the ‘true’ summary ROC. By contrast, the newly proposed methods are noticeably more biased,
with the both procedures undervaluing the performance of the test.
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Figure 7.14: Bias in the estimates of the overall sensitivity and specificity using the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.5.
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Figure 7.15: Empirical standard error (SE) in the estimates of the overall sensitivity and speci-
ficity using the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(100, 300) and a prevalence pi = 0.5.
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Figure 7.16: Mean square error (MSE) of the estimates of overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(100, 300) and a prevalence pi = 0.5.
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Figure 7.17: Coverage of the 95% confidence intervals for overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(100, 300) and a prevalence pi = 0.5.
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Method
Sensitivity Specificity
k = 5 k = 10 k = 20 k = 5 k = 10 k = 20
Logit-SBM 0 0 0 0 0 0
Raw-SBM 0 0 0 0 0 0
Reitsma 270 2 0 276 4 0
Chu & Cole 240 8 0 189 1 0
Table 7.4: The number of invalid summary sensitivity and specificity curves for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.5.
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Figure 7.18: Comparing the square-root of the between study variance in sensitivity and speci-
ficity for the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(100, 300) and a prevalence pi = 0.5.
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Figure 7.19: Average ROC curve based on the 10, 000 simulation study results for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.5.
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Large within study sample size with lower prevalence
Next, we compare the performance of the smooth distribution function method (on the raw and
logit scales) with the existing methods by Reitsma et al. [97] and Chu and Cole [19], but assuming
a lower level of prevalence pi. Figures 7.20 to 7.25 and Table 7.5 show the same information where
the overall within study sample sizes are drawn from ni ∼ U(100, 300), but for a prevalence of
pi = 0.25. That is, the total number of observations per study ni is divided between the treatment
and control arms in the ratio of 1:3, appropriately rounding where necessary.
The comparisons between the methods don’t change for lower prevalence, however, the esti-
mates of sensitivity become more imprecise for every method. For example, the bias, empirical
standard error, and mean square error in the overall sensitivity estimate all increase. Moreover,
for the existing methods, the number of invalid sensitivity curves increases more than 10 fold
when k = 5 and k = 10. For example, for the Chu and Cole method, when pi = 0.5 the number
of invalid sensitivity curves increases from 240 and 8 to 2558 and 233 for k = 5 and k = 10
respectively. By contrast, the newly proposed smooth methods do not show such a staggering
increase. In fact, when pi = 0.25 there are only 2 invalid sensitivity curves for the logit trans-
formed method, both of which occur for k = 5. In all other cases the new methods produce no
invalid sensitivity or specificity curves whatsoever.
Method
Sensitivity Specificity
k = 5 k = 10 k = 20 k = 5 k = 10 k = 20
Logit-SBM 2 0 0 0 0 0
Raw-SBM 0 0 0 0 0 0
Reitsma 3485 273 1 33 0 0
Chu & Cole 2558 233 7 24 0 0
Table 7.5: The number of invalid summary sensitivity and specificity curves for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.25.
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Figure 7.20: Bias in the estimates of the overall sensitivity and specificity using the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.25.
15 20 25 30 35 40
0.
00
5
0.
01
0
0.
01
5
0.
02
0
0.
02
5
0.
03
0
0.
03
5
Threshold
SE
: S
en
sit
ivi
ty
15 20 25 30 35 40
0.
00
5
0.
01
0
0.
01
5
0.
02
0
0.
02
5
0.
03
0
0.
03
5
Threshold
SE
: S
pe
cif
ici
ty
Figure 7.21: Empirical standard error (SE) in the estimates of the overall sensitivity and speci-
ficity using the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(100, 300) and a prevalence pi = 0.25.
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Figure 7.22: Mean square error (MSE) of the estimates of overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(100, 300) and a prevalence pi = 0.25.
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Figure 7.23: Coverage of the 95% confidence intervals for overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(100, 300) and a prevalence pi = 0.25.
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Figure 7.24: Comparing the square-root of the between study variance in sensitivity and speci-
ficity for the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(100, 300) and a prevalence pi = 0.25.
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Figure 7.25: Average ROC curve based on the 10, 000 simulation study results for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(100, 300) and a prevalence pi = 0.25.
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Small within study sample size
Finally, we compare the performance of the smooth distribution function method (on the raw
and logit scales) with the existing methods by Reitsma et al. [97] and Chu and Cole [19] for
comparatively smaller studies. Figures 7.26 to 7.31 and Table 7.6 show the same information, but
where the overall within study sample sizes are drawn from ni ∼ U(20, 50), and the prevalence
is taken to be pi = 0.5. Thus, again the total study specific sample size ni is divided equally the
treatment and control arms, appropriately rounding if necessary.
For example, Figure 7.26 shows the bias in the estimates of the overall sensitivity and speci-
ficity using the smooth distribution function method (on the raw and logit scales) in the small
sample case, along with the existing methods by Reitsma et al. [97] and Chu and Cole [19].
Firstly, it is apparent that for sparse data such as this, the superiority of the Chu and Cole
method over the approximate method by Reitsma et al. is truly emphasised. Indeed, the ap-
proximate method becomes increasingly biased as sensitivity or specificity is increased. By
contrast, the newly proposed method on the raw scale performs exceptionally well in terms of
bias. In fact, the method is comparable to Chu and Cole’s exact method. Again, applying the
new methodology on the logit scale does not appear to be advantageous and produces by far
the most biased estimates of sensitivity and specificity.
Figure 7.27 shows the empirical standard error in the estimates of the overall sensitivity
and specificity for all the methods in the small sample case. Once more, the newly proposed
smooth methods improve on the variability in the estimates. This time it appears that the logit
transformed method performs best, in terms of producing estimates of sensitivity and specificity
with less variability
Figure 7.28 shows the MSE in the estimates of the overall sensitivity and specificity obtained
using each method for sparse data. Again, the MSE is sensitive to the threshold of interest,
which is reflective of the changeable bias and variance. For example, the new method on the logit
scale out performs the other methods in the regions of low bias (when sensitivity or specificity
are close to 0.5). However, for thresholds where the sensitivity or specificity is close to 0.9,
typically the region of interest, the new method on the raw scale consistently outperforms the
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other methods. This is because, for small samples, the new method is competitive with existing
methods in terms of bias and provides an improvement in terms of variance.
Figure 7.29 shows the coverage of the 95% confidence intervals for the overall sensitivity and
specificity, applying each method to small samples. As for the large sample case, the new method
on the logit scale appears to produce extremely erratic confidence intervals that are either overly
conservative or too short at the extreme ends of the thresholds. However, in contrast to the
large sample scenario, the new method on the raw scale seems to compete quite closely with the
existing methods. However, this new method and the method by Reitsma et al. appear to be
overly conservative for lower values of sensitivity and specificity. On the other hand, the exact
method by Chu and Cole appears to be extremely consistent in terms of coverage.
Figure 7.30 shows the square-root of the between study variance in sensitivity and specificity
for every method. As before, the between study variance is not reported on the same scale
for every method. Again, all the methods report the between study variance on the logit scale
with the exception of the new method on the raw scale. With the exception of the Chu and
Cole method, there appears to be considerably less variability in between study variance across
thresholds when n is small. In particular, the newly proposed method (on either scale) appear to
produce an almost flat line, which suggests that the between study variability of the sensitivity
and specificity estimate is constant across thresholds. This possibly reflects the impact of the
smoothing implemented by the new methods. Indeed, one expects there to be less variability
across thresholds, as an estimate of sensitivity or specificity at a given threshold is actually uses
information from neighbouring thresholds. Hence, this can result in the variability being ‘spread
out’ across thresholds.
Table 7.6 shows the number of invalid overall sensitivity and specificity curves obtained using
every method when the data are sparse. It is clear that, as with the large sample case, the new
smooth methods radically out perform the existing methods in this regard. In particular, for
sparse data the new method on the raw scale clearly out performs all the others. For example,
when there are only k = 5 studies of sparse data, the raw method produces only 1 invalid
specificity curve. This is less than the new method on the logit scale (209) and a considerable
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improvement on the methods by Reitsma et al. (9551) and Chu and Cole (8561).
Figure 7.31 shows the average ROC curve obtained by averaging the overall sensitivity and
specificity across all 10, 000 iterations of the simulated data for n ∼ U(20, 50), along with the
‘true’ summary ROC curve. This reinforces the earlier discovery that the new method on the raw
scale and the existing method by Chu and Cole are almost completely unbiased. Indeed, there
is very little difference between the ROC curve generated using these approaches and the ‘true’
summary ROC curve. Further, in this small sample setting, it is noticeable that the approximate
method by Reitsma et al. underestimates the performance of the test, as it deviates somewhat
from the ‘true’ summary ROC. However, the newly proposed method on the logit scale remains
noticeably more biased, seriously undervaluing the performance of the test.
Method
Sensitivity Specificity
k = 5 k = 10 k = 20 k = 5 k = 10 k = 20
Logit-SBM 219 7 9 209 9 0
Raw-SBM 5 1 0 1 2 0
Reitsma 9517 7006 1160 9551 6983 1616
Chu & Cole 8305 5484 1001 8561 5670 1029
Table 7.6: The number of invalid summary sensitivity and specificity curves for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(20, 50) and a prevalence pi = 0.5.
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Figure 7.26: Bias in the estimates of the overall sensitivity and specificity using the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(20, 50) and a prevalence pi = 0.5.
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Figure 7.27: Empirical standard error (SE) in the estimates of the overall sensitivity and speci-
ficity using the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(20, 50) and a prevalence pi = 0.5.
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Figure 7.28: Mean square error (MSE) of the estimates of overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(20, 50) and a prevalence pi = 0.5.
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Figure 7.29: Coverage of the 95% confidence intervals for overall sensitivity and specificity using
the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with
the existing methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes
drawn from U(20, 50) and a prevalence pi = 0.5.
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Figure 7.30: Comparing the square-root of the between study variance in sensitivity and speci-
ficity for the smooth bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales
along with the existing methods by Reitsma et al. and Chu and Cole, based on k studies with
sample sizes drawn from U(20, 50) and a prevalence pi = 0.5.
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Figure 7.31: Average ROC curve based on the 10, 000 simulation study results for the smooth
bivariate method on the raw (Raw-SBM) and logit (Logit-SBM) scales along with the existing
methods by Reitsma et al. and Chu and Cole, based on k studies with sample sizes drawn from
U(20, 50) and a prevalence pi = 0.5.
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7.6 Discussion
7.6.1 Key findings
In this chapter we introduced the concept of a meta-analysis of a density estimate, and discussed
how it could be applied to the analysis of DTA studies. We started by proposing a simple
univariate model to estimate a density function at a single point of interest, when there are
multiple studies from the same population. Next, we introduced multivariate meta-analysis
and showed how this could be used to improve upon the meta-analysis of a density estimate by
considering every point on the curve simultaneously. After introducing the concept of diagnostic
tests, we discussed how this methodology could be directly applied to develop several novel
approaches to perform meta-analyses of DTA. We also introduced some of the existing methods
for analysing DTA and then compared these with our newly proposed models using a real data
example as well as a simulation study. The key findings and recommendations are summarised
in the box below and discussed in more detail thereafter.
Key findings
• Bias in the estimates of sensitivity and specificity
– The logistic regression method (Chu and Cole) performs best in terms of bias and
is approximately unbiased in all the scenarios considered here.
– All other methods are downwardly biased for the thresholds under consideration
here.
– Of the new methods, the method on the raw scale outperforms the method on
the logit scale in terms of bias.
– For small sample sizes, the new method on the raw scale competes closely with
the Chu and Cole method in terms of bias.
• Empirical standard error of the sensitivity and specificity estimates
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– The new methods radically improve upon the existing methods in terms of the
precision of the sensitivity and specificity estimates (quite typical of smoothing
methods). Both newly proposed methods perform very closely in terms of empir-
ical standard error.
• Mean square error (MSE) of the sensitivity and specificity estimates
– MSE varies depending on threshold, which is reflective of the changeable bias and
variance.
– For large samples, the new methods out perform existing methods in the regions
of low bias (when sensitivity or specificity are close to 0.5) and vice-versa when
sensitivity and specificity are close to 0.9.
– For small samples, the new method on the raw scale performs best in terms of
MSE.
• Coverage of confidence intervals for sensitivity and specificity
– For large samples, the new methods are either overly conservative or too short at
the extreme ends of the thresholds.
– The existing methods are much more consistent in terms of coverage, however,
they are slightly overly conservative.
– For sparse data, the new method on the raw scale is competitive with the existing
methods in terms of coverage.
• Between study variability in sensitivity and specificity across thresholds
– Different methods report between study variability on different scales (all methods
use the logit scale, with the exception of the new method on the raw scale).
– Biggest variation in sensitivity or specificity occurs when sensitivity or specificity
are are close to 0.9.
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– For small samples there is far less variation across thresholds, particularly for the
smooth methods.
• Number of invalid overall sensitivity or specificity curves
– New methods produce far fewer invalid overall sensitivity and specificity (and
therefore sROC) curves.
– For small samples, the new method on the raw scale performs best in this regard.
Recommendations Given individual patient data from multiple studies:
• Use the approach of Chu and Cole at each threshold simultaneously, as this produces
unbiased estimates and suitable coverage.
• Occasionally, the sROC this produces may not be well-defined (strictly increasing) as
sensitivity and specificity are being estimated completely independently at neighbour-
ing thresholds and thus are not constrained.
• If a smooth ROC curve is of interest, one might therefore utilise the approach of
Hamza et al. [48] that extends the Chu and Cole method to fit smooth functions across
studies. However, this may not always be a viable option and, especially in sparse data,
the newly proposed smoothing method (on the raw scale) therefore provides a useful
alternative.
• When applying the new methodology it is important to validate this approach using the
exact method by Chu and Cole. If the methods are in relatively close agreement then
the new method can be used estimate the sensitivity and specificity at any threshold.
On the other hand, if the results of the two methods are excessively disparate then one
is forced to conclude that the smooth method does not provide sufficiently accurate
estimates of sensitivity and specificity.
The newly proposed methods have a number of advantages over the existing methods. The
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most notable improvement is that the new methods generate a smooth ROC curve, which
allows the sensitivity or specificity to be calculated at any threshold (even if there is little/no
data available data at that point). This is in stark contrast to the existing methods proposed
by Reitsma et al. [97] and [19], which generate unsightly step functions. For these methods,
there is only a change in sensitivity and specificity at a threshold where at least one individual
changes from being positive to negative (or vice versa). This is problematic if the data are
particularly sparse for certain thresholds where one might be interested in estimating sensitivity
and specificity. For example, suppose that for a given test one is interested in obtaining an
estimate of the sensitivity when the threshold is set at θ = 30. Further, suppose that due to the
sparseness of the available data, the closest thresholds for which there is a change in a diseased
individual’s classification are θ = 20 and 35. In this scenario, rigorously using the sensitivity
curve generated by applying the methods given by Reitsma et al. or Chu and Cole will give the
same sensitivity as at θ = 20 or 35. Of course, this is a naive approach to follow, as we know that
the sensitivity should be bound between the sensitivity at θ = 20 and θ = 35. Unfortunately,
one is then faced with the dilemma of appropriately selecting an estimate on this range. For
example, should one take the average sensitivity, or should one account for the relative closeness
of the neighbouring thresholds?
The advantage of the newly proposed methods, based on the smooth distribution function,
is that this quandary is neatly averted by providing a suitably smooth estimate of sensitivity
and specificity. Indeed, the method borrows strength from thresholds in a neighbourhood about
the threshold of interest θ, by allowing the estimates of sensitivity or specificity at neighbouring
thresholds to contribute to the estimates of sensitivity or specificity at θ. This smoothing of the
data introduces bias, but reduces the variability in the estimates of sensitivity and specificity.
This trade off is controlled by the bandwidth parameter h. At one extreme, when h → ∞ the
newly proposed methods have minimal variance, but large bias. Conversely, when the bandwidth
is small the newly proposed methods will have lower bias, but larger variance. In fact, when
h→ 0, the newly proposed method on the logit scale reduces to the method by Reitsma et al. [97].
The added flexibility afforded by the smoothing parameter h can be regarded as a considerable
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advantage of this method.
Another advantage of the newly proposed smooth methods, revealed by both the simulation
study and the real data example, is that the smooth methods are far less likely to generate an
invalid ROC curve. It was demonstrated that the existing methods can often produce a non-
increasing ROC curve, particularly when the data are excessively sparse. This creates a number
of problems when trying to draw inferences from the ROC curve (or indeed the corresponding
sensitivity and specificity curves).
As we have already alluded to, one of the disadvantages of smoothing the data is that
it introduces bias to the estimates of sensitivity and specificity. This is something that was
particularly evident from the large sample simulation results of section 7.5. Indeed, when the
study specific sample sizes ni were sampled from U(100, 300), the existing methods consistently
outperformed the smooth methods in terms of bias. However, it is worthy of note that this
disparity in bias between the new and existing procedures is less clear for smaller sample sizes.
Indeed, when n was sampled from U(20, 50) the new method on the raw scale was actually less
biased than the method proposed by Reitsma et al. and competed closely with the exact method
of Chu and Cole.
Another limitation of the newly proposed methodology is the requirement of individual
patient data, so that all thresholds are available in all studies. Indeed, this is likely to be
an extremely restrictive requirement in practice, since aggregated data is much more readily
available. By limiting a meta-analysis to studies that publish individual patient data, one is
likely to omit a large amount of useful aggregated data. By contrast, the methods given by
Reitsma et al. and Chu and Cole can readily utilise aggregated data. Indeed, incorporating
aggregated data is often an issue for conducting a meta-analysis of diagnostic test accuracy, as
different studies will often report different thresholds. Riley et al. [102] comment that missing
thresholds often cause the binomial method proposed by Hamza et al. [48] to not converge.
For this reason, they extend the method of Reitsma et al. [97] as it can readily handle studies
with missing thresholds. Moreover, one can jointly model all thresholds and obtain smooth,
well-defined, ROC curves. However, the simulation study in this chapter indicates that this
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method is likely to produce downwardly biased estimates of sensitivity and specificity, due to
the need for the Normal approximation. Although, this may be accepted if one can use more of
the evidence and produce a well-defined ROC curve. Riley et al. [103] also propose a sensitivity
analysis to examine the impact of missing thresholds that retains the binomial modelling, which
relies on imputed data.
7.6.2 Recommendations
It is clear that the exact binomial modelling approach of Chu and Cole should be the default
method when individual patient data are available. Indeed, where possible it is recommended
to carry out the approach of Chu and Cole at each threshold simultaneously, as this produces
unbiased estimates and suitable coverage. Occasionally, however, the sROC this produces may
not be well-defined (strictly increasing) as sensitivity and specificity are being estimated com-
pletely independently of neighbouring thresholds and thus are not suitably constrained. If a
smooth ROC curve is of interest, one might therefore utilise the approach of Hamza et al. [48]
that extends the Chu and Cole method to fit smooth functions across studies. However, this
may not always be a viable option and, especially for sparse data, the newly proposed smooth
method (on the raw scale) therefore provides a useful alternative.
Indeed, the desirable features of the new methods discussed here indicate that the new
approaches provide a helpful addition to the existing methodology for analysing diagnostic tests.
The smooth methods are particularly useful when the data are very sparse or there are gaps
in the data at the threshold of interest, as they allow the construction of smooth curves for
sensitivity and specificity. In these cases we recommend applying the new methodology on the
raw scale alongside the exact method by Chu and Cole, to validate the results of the smooth
method. If the two methods are in agreement then one can use the smooth method to estimate
the sensitivity and specificity at any threshold, a luxury not afforded by the Chu and Cole
method. If, on the other hand, the results of the two methods are excessively disparate then one
is forced to conclude that the smooth method does not provide sufficiently accurate estimates
of sensitivity and specificity.
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7.6.3 Possible extensions
This chapter has focused primarily on the performance of two new methodologies for analysing
diagnostic test accuracy. In particular, we considered two bivariate models based on the smooth
distribution function estimate, one on the raw scale and the other on the logit scale. However,
there are number of possible extensions to both the methodology and the analysis conducted
here. We discussed, briefly, the possibility of performing a multivariate meta-analysis at every
threshold simultaneously. This would allow for the additional borrowing of strength from neigh-
bouring thresholds, by allowing for the very real possibility of correlations in the estimates of
sensitivity and specificity between thresholds [99].
As previously stated, the primary focus of this chapter has been to investigate the usefulness
of a meta-analysis of a density or distribution function to the analysis of DTA studies. However,
the methodology discussed in section 7.2 can be readily adapted for use in a number of different
settings. For example, one can modify the methods to estimate the hazard rate or survival
function when there are individual patient data available from multiple heterogeneous studies.
Similarly, the methods can also be generalised to perform non-parametric curve estimation in a
regression setting where there are multiple heterogeneous data sets.
In the next, and final, chapter we discuss the conclusions of the thesis as a whole and identify
some areas for further research.
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Chapter 8
Conclusions and future work
8.1 Overview of thesis
The overarching theme of this thesis has been to develop non-parametric methodology, with the
principal aim of making inferences about a random sample with an unknown distribution func-
tion. In fact, the thesis can be partitioned in a number of different ways. For example, Chapter
2 is driven by developing the mathematical theory therein, while the subsequent chapters are
motivated by genuine applications in medical statistics. To look at it another way, Chapters
2 to 6 focus exclusively on the importance of symmetry and asymmetry in statistical models,
whereas Chapter 7 broadens the scope of the investigation to assessing the distribution of data
in a more general sense. Meta-analysis and, more generally, the analysis of medical research
data have also been recurring themes.
In particular, we started by discussing how to effectively measure asymmetry and test for
symmetry, and introduced a recently proposed measure for asymmetry η̂. Using this measure we
developed a new test for symmetry, before evaluating its improvement on existing methods. We
then discussed how the measure (and test) can be used to inform effectual analysis of statistical
models of relevance to medical research. We also considered a new measure, which was shown to
provide a valuable aid when making small sample inferences about η. Both of these procedures
were then applied to the problem of assessing the asymmetry in multiple trials, by considering a
meta-analysis of the measures of asymmetry. Next, we conducted a simulation study to analyse
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what effect ignoring violations of symmetry assumptions can have on some of the most commonly
used statistical models. Finally, we broadened our investigation to develop methods to synthesise
information about the entire distribution of several samples, by proposing a meta-analysis of the
density or distribution function. This led to the development of a novel method for synthesising
test accuracy studies.
8.2 Key findings from each chapter
This thesis has contributed towards the development of new statistical methodology and novel
medical statistics applications. The key contributions are listed in the box below and summarised
in more detail thereafter.
Chapter 2
- Revealed that existing tests of symmetry do not have power which is reflective of
the size of asymmetry.
- Proposed a new test for symmetry, based on a recently proposed measure of
asymmetry η
- The power of the new test was shown to better reflect the size of asymmetry, and
to improve upon the power of most existing tests.
Chapter 3
- Demonstrated the applicability of the asymmetry measure η̂ (and the correspond-
ing test for symmetry) in a number of situations of relevance to medical research.
Chapter 4
- Investigated the small sample performance of the asymmetry measure η̂ and pro-
posed an alternative measure ζ̂ theoretically better suited to small samples.
- For symmetric distributions the sampling distribution of η̂ appears to be approx-
imately Normal, even for samples as small as n = 15. Therefore, in the context
241
of testing for symmetry, p-values should not be too badly compromised when the
sample size is small.
- The most accurate confidence intervals (in terms of coverage) are obtained by
using the asymptotic variance for η̂.
Chapter 5
- Explored the problem of assessing the asymmetry in multiple studies.
- When every study is reasonably large (say, n > 30), it is recommended that
meta-analysis be performed directly on η̂.
- If there are a number of studies with insufficient sample sizes to ensure the ac-
curacy of the asymptotic theory, then the results should be the subject of a
sensitivity analysis by also considering a meta-analysis of ζ̂.
Chapter 6
- Investigated the impact of asymmetry on linear models and meta-analyses in the
context of medical statistics.
- Conventional inferences (i.e. estimating an average treatment effect and confi-
dence interval) are generally robust to asymmetry (in the residuals or the random
effects) for linear models and meta-analyses.
- Clinically relevant inferences (i.e. prediction of future observations/effects or
probability statements) are potentially seriously compromised by asymmetry.
Chapter 7
- Extended our investigations to synthesise information about the density and dis-
tribution function as a whole.
- Explored the potential applications of this method to meta-analyses of diagnostic
test accuracy.
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- Where possible, the exact binomial approach of Chu and Cole [19] should be the
default, as this produces unbiased estimates and suitable coverage.
- New methodology can be useful, particularly for sparse data where a smooth
ROC curve is desired.
In Chapter 2 it was shown that, while there are a wealth of options for a statistician wishing
to test for symmetry on a set of data, some of the most commonly used tests of symmetry do
not have power which is reflective of the size of asymmetry. That is, while the tests have good
rejection levels for non-symmetric distributions, their power does not increase as asymmetry
increases. This is because the primary rationale for the test statistics that are proposed in
the literature to test the symmetry is to detect the departure from symmetry, rather than the
quantification of the asymmetry. As a result, tests of symmetry based upon these statistics do
not necessarily generate power that is representative of the departure from the null hypothesis
of symmetry. Recent research by Patil et al. [88] has produced new measures of asymmetry,
which have been shown to effectively quantify the amount of asymmetry. We proposed a new
test based upon one such measure η̂ and derived the asymptotic distribution of the test statistic,
before analysing the performance of this proposed test through the use of a simulation study.
Our primary aim for Chapter 2 was to develop a new test for symmetry that improves upon
the existing methods. This new test, based on a recently proposed measure of asymmetry, was
shown to be an extremely competitive test. Indeed, a simulation study revealed that the new
test exhibits an increase in power compared to most tests. Moreover, it was also shown that the
new test had power that better reflected the amount of asymmetry in the underlying data. This
work is the subject of a research paper by Partlett and Patil, which is currently under review
for publication in the Annals of the Institute of Statistical Mathematics.
In Chapter 3 we discussed the potential applications of the new test, with a particular em-
phasis on informing the analysis of randomised trials in medical research. Moreover, with the
help of a large data set consisting of multiple randomised control trials investigating hyperten-
sion, it was also shown that the measure η̂ is an effective summary statistic. Indeed, η̂ can be
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used for making inferences such as assessing baseline imbalance in clinical trials and checking
for asymmetry in linear model residuals. In addition, it was revealed that η̂ can be a useful aid
in preconditioning data. That is, it can be used to objectively determine whether asymmetry
within data is sufficient to require a normalising transform, inform what sort of transformation
is likely to be effective, and provide an objective measure of whether the transformation has
been a success. However, it was also established that one of the shortcomings of η̂ is that the
distribution given in Chapter 2 is asymptotic. As a result, one requires a reasonably large sample
to apply the Normal approximation.
In Chapter 4 we identified and addressed the problem of small sample estimation of η. In
particular, it was demonstrated that it is not appropriate to assume a Normal distribution for
η̂ in small samples. This provided the motivation for a new measure ζ̂, which was subsequently
shown to be more informative for small samples. We derived the asymptotic distribution of this
new measure and demonstrated that this distribution is more robust to small samples. That is, ζ̂
appeared to follow a Normal distribution more closely for finite samples. We also introduced and
discussed the bootstrap to assist in the calculation of the standard error and confidence intervals
for the new measure. Yet, a simulation study revealed that, irrespective of sample size, the best
coverage results were obtained by using the asymptotic variance for η̂, truncating the confidence
intervals at −1 or 1 if necessary. Hence, one might check how discrepant the results are to
the ζ̂ approach using bootstrapping, and, if the two approaches are unreasonably incongruent
then one can conclude that there are too few samples to accurately assess the asymmetry in the
population.
In Chapter 5 both η̂ and ζ̂ were applied to the more general problem of assessing the asym-
metry in multiple studies. That is, we investigated measuring asymmetry in data across several
studies with the aim of obtaining an ‘overall’ measure of asymmetry in the underlying popula-
tion. In particular, we explored the potential pitfalls of simply pooling data across all studies
and treating it as a single study, before proposing a meta-analysis on the asymmetry measures
to combat this problem. A meta-analysis of the asymmetry measures η̂ and ζ̂ was shown to
have a number of genuine applications in medical statistics, principally, allowing the comparison
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and synthesis of information about the distribution of multiple (possibly heterogeneous) sam-
ples from a single population. It was shown that when the sample size is reasonably large in
every study, one can carry out the meta-analysis directly on the asymmetry measure η̂ using the
asymptotic theory to calculate the variance. However, if several studies have small samples then
the asymptotic theory begins to breaks down. In these cases, it was demonstrated that η̂ may
still be appropriate, but the best course of action is to examine whether the conclusions change
by performing a meta-analysis of ζ̂. If there is a reasonable agreement between the methods
then the confidence intervals based on η̂ were shown (by the simulation study in Chapter 4) to
produce the most accurate confidence intervals in terms of coverage. If the results of the two
methods are excessively discrepant then this indicates that further research is needed to draw
firm conclusions regarding the amount of asymmetry in the underlying population.
We concluded our investigation of asymmetry in Chapter 6 with an extensive analysis into
the effect that ignoring asymmetry in the data has on the accuracy of the inferences drawn from
a number of popular statistical models, and assessed to what extent these methods are robust
to departures from symmetry. In particular, we discussed the potential pitfalls of ignoring
violations of symmetry or normality assumptions in linear models and meta-analyses. The
principal aim here was to formulate some key recommendations regarding the sample size or
number of studies required to perform accurate analyses in this case. It was demonstrated
that the common inferences that one draws from linear models or meta-analyses, particularly
confidence intervals of the treatment effect estimate, are robust to departures from symmetry.
However, it is worth noting that in both settings, if the aim is to make predictions about
future patients or treatments then it is possible that these predictions may be compromised by
the presence of asymmetry, either in the residual or random effects distribution. Indeed, while
prediction intervals may have suitable coverage when the normality assumption is inappropriate,
they may still be unhelpful clinically. Therefore, if one is interested in making clinically relevant
inferences regarding the prediction of future observations (using linear models or meta-analyses)
then it is recommended to account for the asymmetry. For example, if one suspects that there
is substantial asymmetry in the response variable of a linear model, then it may be prudent to
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make apply a transformation to the data before making inferences about future observations.
Similarly, if there is evidence of asymmetry in the random effects of a meta-analysis then it is
recommended to apply a more flexible method to account for this asymmetry, for example, those
proposed by Lee and Thompson [72] or Karabatsos et al. [65].
In Chapter 7, we moved away from the investigation of the asymmetry of an unknown
distribution and considered, more generally, a method for synthesising information about the
distribution as a whole. That is, we widened the scope of our investigation to encompass the
problem or comparing and synthesising information about the probability density function and
cumulative distribution function, based on several samples from similar (but possibly hetero-
geneous) populations. That is to say, we generalised the methods of Chapter 5 to allow for
the synthesis of information about the entire density or distribution function of several stud-
ies. We also provided a detailed demonstration of one potential application of this method,
namely, conducting meta-analyses of diagnostic test accuracy studies. In particular, we pro-
posed a couple of novel methods that have a number of desirable properties when compared to
the existing methodology in this area. The ultimate objective of Chapter 7 was to develop these
new methods for conducting meta-analyses of diagnostic test accuracy studies, and compare
their accuracy with the existing methods proposed by Reitsma et al. [97] and Chu and Cole [19].
It was demonstrated that the exact binomial modelling approach of Chu and Cole should be the
default method when individual patient data are available, as this produces unbiased estimates
and suitable coverage. Occasionally, however, the sROC this produces may not be well-defined
(strictly increasing) as sensitivity and specificity are being estimated completely independently
of neighbouring thresholds and thus are not suitably constrained. If a smooth ROC curve is of
interest, one might therefore utilise the approach of Hamza et al. [48] that extends the Chu and
Cole method, however, for sparse data this may not always be a viable option. Thus, the newly
proposed smooth method on the raw scale provides a useful alternative, especially for sparse
data. In these cases it is recommended to apply the new methodology on the raw scale alongside
the exact method by Chu and Cole, to validate the results of the smooth method. If the two
methods are in agreement then one can use the smooth method to estimate the sensitivity and
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specificity at any threshold, a luxury not afforded by the Chu and Cole method. If, on the other
hand, the results of the two methods are excessively disparate then one is forced to conclude that
the smooth method does not provide sufficiently accurate estimates of sensitivity and specificity.
This is because, just like the method proposed by Reitsma et al., the newly proposed smooth
methods are biased.
The main conclusion of this thesis is that asymmetry plays a crucial role in statistical models.
In particular, it is important to validate symmetry and other distributional assumptions. Indeed,
the simulation study in Chapter 6 identified that some of the commonly used statistical models
(e.g. linear models and meta-analyses) are vulnerable to departures for symmetry, with pre-
dictions particularly influenced. Thus, when one suspects that these distributional assumptions
have been violated, it is imperative to assess the exact nature of the underlying distribution.
This accentuates the importance of the methods outlined in Chapters 5 and 7, which aim to
synthesise information about the distribution underpinning multiple studies.
8.3 Publications submitted and in-progress
The contents of Chapter 2 (along with elements of Chapter 4) is the subject of a research
paper by Partlett and Patil entitled “Measuring Asymmetry and Testing Symmetry”, which is
currently under review for publication in the Annals of the Institute of Statistical Mathematics.
Furthermore, a paper entitled “Random effects meta-analysis and the consequences of ig-
noring asymmetry”, which expands the meta-analysis simulation study in Chapter 6, is at an
advanced draft stage. Additionally, Chapter 5 and Chapter 7 will also make interesting method-
ology papers and drafts are currently being prepared for later this year.
8.4 Future work
A consequence of the reasonably broad nature of this thesis is that there are a wide variety of
possibilities to extend it. For example, one extension could be to consider developing a test
based on the strong measure of asymmetry ηs, which was briefly introduced in Chapter 2. To
recap, Patil, Bagkavos and Wood [89] discuss a stronger measure ηs, where the condition ηs = 0
is, both, necessary and sufficient for the symmetry. A drawback of the stronger measure ηs is
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a loss of the ‘user-friendly’ aspect of η. Despite this, further investigation into the estimators
of ηs and their asymptotic properties is of genuine interest as Patil, Bagkavos and Wood show
that ηs ≥ η. Therefore, a test based on an estimate of ηs has the potential to be more powerful
than than the test developed in Chapter 2. Given the already impressive performance of the
test based on η̂ this could be an extremely valuable extension. Aside from testing for symmetry
it would also be of interest to see how ηs lends itself to analysis of randomised trials.
Another possible extension is to investigate the usefulness of other bootstrap methods for
drawing inferences based on η̂ in small samples. For example, in this thesis we focused on the
non-parametric bootstrap with simple bootstrap confidence intervals, but, it may be possible
to approximate the sampling distribution of η̂ more effectively by applying other bootstrap
methods, such as the parametric bootstrap or the smoothed bootstrap [27]. Additionally, one
may be able to improve the upon the coverage results of Chapter 4 by constructing bootstrap
confidence intervals that adjust for bias [29]. In a similar vein, it would also be of interest to
assess the small sample properties of η̂s.
Furthermore, supposing that one is able to demonstrate the asymptotic normality of the
stronger measure η̂s, the measure would readily lend itself to the meta-analysis methods dis-
cussed in Chapter 5. It would also be of interest to perform a more rigorous analysis of these
meta-analysis methods for varying levels of heterogeneity via a simulation study. In addition,
one could readily extend the meta-analysis results of this chapter to perform meta-analyses of
the classical skewness measures, for example, those proposed by Pearson [91] and introduced in
Chapter 1. In particular, it would be interesting to compare these results with the meta-analysis
of η̂, as well as determine whether or not the conclusions that are drawn about the overall dis-
tribution of a collection of studies are sensitive to the measure of skewness or asymmetry that
is used to compare them.
For the simulation study in Chapter 6 it would of interest to open the study up to a wider class
of asymmetric distributions, akin to those considered in Chapter 2. Moreover, this simulation
study could also be extended to investigate the effect of unchecked asymmetry on the bias
and standard error of the model estimates and the impact on prediction error for linear and
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meta-analysis models. In fact, these extensions are being currently being pursued in a draft
of a paper titled “Random effects meta-analysis and the consequences of ignoring asymmetry”,
based on the second half of Chapter 6. It would also be interesting to see whether the results
generalise to more complicated meta-regression models [118] or even multivariate models. In
particular, one could assess the impact of asymmetry in the data or the random effects on the
estimation of covariates or between study covariances and the subsequent implications for clinical
interpretations. Equally pressing is a more thorough analysis of the performance of the flexible
Bayesian meta-analysis methods, which are frequently lauded in this thesis [72, 78]. While these
methods have been appraised by Lee and Thompson [72] and Mart´ınez-Camblor [78] in the
context of skewed data, a more meticulous appraisal of their performance for a wide range of
asymmetric distributions would further elucidate their robustness to asymmetry. Similarly, an
in-depth evaluation of the robustness of Bayesian linear regression to asymmetric data would
be equally worthy of attention [15]. Alternatively, for random effects meta-analysis, one could
appraise the performance of profile likelihood [49], recommended by Cornell et al. [20], for the
broad range of asymmetric random effects distributions considered here.
Another obvious extension to Chapter 6 would be to investigate methods for examining, in
a statistically rigorous fashion, whether there is asymmetry in the random effects. Methods
for evaluating the asymmetry in this context should account for the fact that there is likely to
be only a small number of studies. Moreover, it is imperative that the methods guard against
finding artificial patterns in the data.
As we have previously alluded to, in Chapter 7 we carried out a detailed demonstration of
one potential application to our meta-analysis of a function, namely, conducting meta-analyses
of diagnostic test accuracy studies. In particular, we proposed a couple of novel methods that
have a number of desirable properties when compared to the existing methodology in this area.
However, there are number of possible extensions to the methodology. For example, the possi-
bility of performing a multivariate meta-analysis at every threshold simultaneously was briefly
raised, but not pursued in detail. This would allow for the additional borrowing of strength from
neighbouring thresholds by allowing for the very real possibility of correlations in the estimates
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of sensitivity and specificity between thresholds [48, 102, 103]. In addition, we also briefly dis-
cussed the possibility of performing a two-stage estimate of the distribution function. It would,
of course, be of considerable interest to investigate the feasibility of both of these methods in
more detail.
Moreover, the newly proposed meta-analysis methods were only compared with two examples
from the existing methodology, namely, the methods proposed by Reitsma et al. [97] and Chu
and Cole [19]. In fact, there are a wealth of other meta-analysis methods which have their roots
in analysing diagnostic test accuracy, and could also be compared with the new methods. For
example, Rutter and Gatsonis [107] describe a multilevel model for fitting a hierarchical summary
ROC (HSROC) curve and Kuss et al. [70] recently proposed a method based on beta-binomial
distributions.
Furthermore, the meta-analysis methods in Chapter 7 can be readily generalised for use in a
number of different settings. For example, a meta-analysis of a function can be used to estimate
the hazard rate or survival function when one has access to individual patient data available
from multiple, possibly heterogeneous, studies. The methods can also be applied in an even
more general setting, namely, to perform non-parametric regression curve estimation in the case
where there are multiple, possibly heterogeneous, data sets. Indeed, both of these topics would
make for fascinating research topics in there own regard.
8.5 Conclusion
This thesis has provided an important contribution to the theory and application of examining
distributional assumptions and properties, with particular emphasis on quantifying and exam-
ining asymmetry. We also investigated several applications using single and multiple research
studies. Though many issues remain for future work, it is hoped that the findings will help im-
prove the awareness and application of measuring asymmetry and encourage more consideration
of distributional assumptions when making predictions and utilising data from multiple studies.
250
Appendix A
Gine´ and Mason proof
A.1 Introduction
Let X1, · · · , Xn be a random sample from a population with distribution function F . Further,
let F (j)(x) = d
j
dxj
F (x). Gine´ and Mason [38] study the uniform in bandwidth behaviour of
estimators of
T (F ) =
∫
R
φ
(
x, F (x), F (1)(x), · · · , F (r)(x)
)
dF (x),
which have the form
Tn(h) =
1
n
n∑
i=1
φ
(
Xi, Fn,i(Xi), F
(1)
n,h1,i
(Xi), · · · , F (r)n,hr,i(Xi)
)
,
where h = (h1, · · · , hr), hi > 0, is a vector of bandwidths and
Fn,i(Xi) =
1
n− 1
∑
1≤i 6=j≤n
K
(−1)
0 (Xi −Xj),
with K
(−1)
0 (x) = I{x > 0}, and for 1 ≤ m ≤ r,
F
(m)
n,hm,i
(Xi) =
1
n− 1
1
hm
∑
1≤i 6=j≤n
K(m−1)m
(
Xi −Xj
h
)
, i = 1, · · · , n,
where K
(0)
m = Km is an L1 kernel, m − 1 times differentiable with K(m−1)m (x) = d
m−1Km(x)
dxm−1
satisfying ∫
R
Km(u)du = 1.
Define the sequence of processes in ~λ = (λ1, · · · , λr) , 0 < a ≤ λm ≤ b <∞, for m = 1, · · · r, by
vn
(
~λ
)
=
√
n
{
Tn(~λ ◦ hn)− T (F )
}
,
where {hn} is a sequence of vectors hn = (h1,n, · · ·hr,n) with positive coordinates converging to
zero and
~λ ◦ hn = (λ1h1,n, · · · , λrhr,n) .
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Gine´ and Mason construct i.i.d. random variables Y1, Y2, · · · , Yn with mean 0 and finite variance,
such that
sup
~λ∈[a,b]r
∣∣∣∣∣vn (~λ)− 1√n
n∑
i=1
Yi
∣∣∣∣∣ = op(1). (A.1)
A.2 Notation
Towards defining the random variables Y1, Y2, · · · , Yn, let
ϕ(x) = ϕ
(
x, F (x), F (1)(x), · · · , F (r)(x)
)
,
and
ϕm(x) =
∂
∂ym
ϕ(x, y0, y1, · · · , yr)|(y0,y1,··· ,yr)=(F (x),F (1)(x),··· ,F (r)(x)).
Let
ζ(Xi) = ϕ(Xi)− Eϕ(X) = ϕ(Xi)− T (F ),
ζ0(Xi) =
∫ ∞
Xi
ϕ0(y)f(y)dy −
∫
R
F (y)ϕ0(y)f(y)dy,
and, for m = 1, · · · , r, let
χm(y) =
dm−1
dym−1
(ϕ(y)f(y)) = − d
m
dym
∫ ∞
y
ϕ(x)f(x)dx,
where d
0
dy0
g(y) = g(y), and set for i ≥ 1,
ζm(Xi) = (−1)m−1 {χm(Xi)− Eχm(X)} .
Define
Yi = ζ(Xi) +
r∑
m=0
ζm(Xi), i ≥ 1. (A.2)
A.3 Conditions
For the main result one requires the following assumptions:
I For each m = 1, · · · , r, f (m−1) is bounded.
II For some 0 < α ≤ 1, and each m = 1, · · · , r, f (m−1) is in G2r+α−1,Km(H), where H is
some non-negative measurable function satisfying E
[
H2(X)
]
<∞, which may depend on
f (m−1). Gs,k(H) is the class of all measurable functions g on R for which there is a positive
constant MK(g) such that for all h sufficiently small∣∣∣∣1h
∫
R
g(u)K
(
x− u
h
)
du− g(x)
∣∣∣∣ ≤ hsMk(g)H(x), ∀x.
III Uniformly in x ∈ supp(f), the function ϕ(x, y0, y1, · · · , yr) and its partial derivatives
∂ϕ/∂yi, i = 0, · · · , r, satisfy a global Lipschitz condition with respect to the variables
252
y0, · · · , yr on a bounded open convex subset of Rr+1 containing the closure of the range,{(
F (x), f(x), f (1)(x), · · · , f (r−1)(x)
)∣∣∣x ∈ R.} .
IV ϕm,m = 0, 1, · · · , r, are bounded on the support of f .
V For each m = 1, · · · , r, the function χm is Lipschitz of order 0 < β ≤ 1 and∫
R
|u|β|Km(u)|du <∞.
VI The kernels K
(m−1)
m ,m = 1, · · · , r, are in L2(R) and of bounded variation in R.
VII The kernels Km are smooth and has bounded support.
VIII With 0 < α ≤ 1 as in condition II, for m = 1, · · · , r,
√
n
h2r−1m,n
log(1/hm,n)
→∞ and √nh2r+α−1m,n → 0.
A.4 Theorem statement
Theorem A.3 Under conditions I-VIII, for all 0 < a < b < ∞, equation (A.1) holds. More-
over, if 0 < Var(Y ) <∞, where Y is defined as in equation (A.2), then the processes{
vn
(
~λ
)
: ~λ ∈ [a, b]r
}
converge in law in l∞([a, b]r) (in the sense of Hoffmann-Jorgensen) to the
constant Gaussian process G
(
~λ
)
= G where G is N(0,Var(Y1)), that is,{
Tn(~λ ◦ hn)− T (F )
}
−→d N(0,Var(Y1)),
uniformly in ~λ ∈ [a, b]r.
253
Appendix B
Selected R code
Introduction
All the simulations and plots in this thesis were produced using the statistical programming
language R. In this appendix we present a selection of the R code used in this thesis. The
required packages include, but are not limited to, boot, meta, mvmeta, zoo and fdrtool.
Calculating the test statistics based on η
The following simple R function takes two arguments: x- a set of data, and xcuts- the number of
points to use in the numerical integration (used to estimate the variance). The function returns
the standardised test statistics based on η̂ and ζ̂.
uTnm_T <- function(x , xcuts = 512){
#1. Preamble functions
fisherz<-function(r){
Z = (1/2)*log( (1+r)/(1-r) )
return(Z)
}
AUC <- function(X,Y){
id <- order(X)
int = 0
if( length(Y) > 1){ int = sum(diff(X[id])*rollmean(Y[id],2)) }
return(int)
}
## Calculate integrals based on X at the points x
If2<-function(X,f2,x){
n = length(x)
if2 = rep(0,n)
for( i in 1:n){
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# pick out all the Xs > x
Xx = X[ X > x[i] ]
f2x = f2[ X > x[i] ]
if2[i] = AUC(Xx,f2x)
}
return(if2)
}
# #
IfF<-function(X,f,F,x){
n = length(x)
ifF = rep(0,n)
fF = (F - 0.5)*f
for( i in 1:n){
Xx = X[X > x[i] ]
fFx = fF[X > x[i] ]
ifF[i] = AUC(Xx,fFx)
}
return(ifF)
}
# #
remNaN<-function(x){
y <- x[!is.na(x)]
return(y)
}
#2. Calls a C function to calculate f^(Xi)
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fden<-function(x){
x = sort(x)
nx = length(x)
v = rep(0, nx)
h = bw.nrd0(x)
crun = .C("fden", as.double(x), out = as.double(v), as.integer(nx),
as.double(h))
fnh = (1/(nx - 1)) * (1/h) * (crun$out)
return(fnh)
}
#3. Main function: Calculating eta-hat
x=remNaN(x)
x = sort(x)
n = length(x)
f = fden(x)
F = (ecdf(x))(x)
#
denf = density( x , kernel = c("epanechnikov") , n = xcuts )
xs = denf$x
fs = denf$y
Fs = (ecdf(x))(xs)
#
Tcov = -cov( f , F )
etah = -cor( f , F )
zetah = fisherz(etah)
#4. Estimating the variance
ix = If2(xs,fs^2,x)
ix2 = IfF(xs,fs,Fs,x)
A = var(f)
B = var(F)
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mu = mean(f)
Y = ( (2/sqrt(A*B))*( f*F - 0.5*f ) + (1/sqrt(A*B))*ix +
etah*( (F - 0.5)^2/(2*B) + (f-mu)^2/(2*A)
+ (1/B)*ix2 + (1/A)*(f - mu)*f ) )
sig2 = var(Y)
zsig2 = var(Y)*(1/( 1 - etah^2 )^2)
# #
T1 = sqrt(n)*etah/sqrt(sig2)
T2 = sqrt(n)*zetah/sqrt(zsig2)
return( list( eta = T1 , zeta = T2 ) )
}
##
Smooth meta-analysis method (Chapter 7)
The following function is used to perform meta-analyses of individual patient diagnostic test ac-
curacy data using the smooth distribution function. The function takes a number of arguments,
but most crucially XDXND- the continuous outcome in the diseased and non-diseased group re-
spectively, and pos_for- which specifies whether the test gives a positive outcome for large or
small values.
logit_Fh_dta<-function(XD , XND , xx = xx0 , nx=32 , tc = 0.5 ,
cc = "study" , meth = "reml" , pos_for = "large" , Sigma = "unstr",
bw.scale = 1, max.iter = 100 , study_labels = NULL ,
ss_lb = 0 , ss_ub = Inf , scale = "logit" ){
## xx - the exact thresholds to determine the test accuracy
## nx - the number of equally spaced points at which to calculate the
## test accuracy
## scale ="raw" carries out the meta-analysis on the raw sens/spec
## scale ="logit" carries out the meta-analysis on the logit scale.
## cc = "all" corrects every 2x2 in every study at every threshold.
## cc = "study" only corrects the 2x2 tables for studies and thresholds where
## there is an offending 0.
## cc = "single" only corrects the offending observation.
#1. Preamble functions
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remNaN<-function(x){
y <- x[!is.na(x)]
return(y)
}
logit <- function( x ){
log(x/(1-x))
}
ilogit<-function(x){
exp(x)/(exp(x)+1)
}
if( scale != "logit" & scale !="raw" ){
print("Scale must be one of logit or raw")
return()
}
axb<-function( a , x , b ){
x = max( c( x , a ) )
x = min( c( x , b ) )
return(x)
}
#2. Prepare input data
XDm = unlist(XD)
XDm = remNaN(XDm)
XNDm = unlist(XND)
XNDm = remNaN(XNDm)
Xmerge = sort( c( XDm , XNDm ) )
fromm = min(Xmerge)
too = max(Xmerge)
xx0 = seq( fromm , too , length.out = nx )
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if( xx[1] == "all"){ xx = Xmerge }
nx=length(xx) # no. of meta-analyses
if( length(XD) != length(XND) ){ print("XD and XND have different length")}
k = length(XD) # no. of studies
###
#3. Prepare outputs
metaA = rep(0,nx)
metaA = as.list( metaA )
Sens = rep(0,nx)
Spec = rep(0,nx)
seDi = rep(0,nx)
seNDi = rep(0,nx)
Sensl = rep(0,nx)
Sensu = rep(0,nx)
Specl = rep(0,nx)
Specu = rep(0,nx)
Sens.tau = rep(0,nx)
Spec.tau = rep(0,nx)
converge_fail = rep(0,nx)
#4. Calculate smooth distribution function
Fhat<-function(data,xs,bws = 1){
data=sort(data)
n = length(data)
h = bw.nrd0(data)
h = h*bws
Fh = rep(0, length(xs))
for( i in 1:n){
Fh = Fh + pnorm( (xs - data[i] )/h )
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}Fh = (1/n)*(Fh)
return(Fh)}
# variance: F(x)(1-F(x))/n
# need to correct for when Fh = 0 and Fh = 1
# Construct 2x2 table
for( j in 1:nx){
theta = xx[j] #threshold
# tp = rep(0,k)
# fn = rep(0,k)
# tn = rep(0,k)
# fp = rep(0,k)
tpr = rep(0,k) #sens
tnr = rep(0,k) #spec
SS = as.list( rep(0,k))
for( i in 1:k){
Di = XD[[i]]
NDi = XND[[i]]
Di = remNaN(Di)
NDi = remNaN(NDi)
nDi = length( Di )
nNDi = length( NDi )
if( pos_for == "small" ){
FnXD = Fhat(Di ,theta, bws = bw.scale) #sens
FnXND = Fhat(NDi ,theta, bws = bw.scale) #1-spec
tp = FnXD*nDi
fn = nDi - FnXD*nDi
tn = nNDi - FnXND*nNDi
fp = FnXND*nNDi
}
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if( pos_for == "large" ){
FnXD = 1-Fhat(Di ,theta, bws = bw.scale) #sens
FnXND = 1-Fhat(NDi ,theta, bws = bw.scale) #1-spec
tp = FnXD*nDi
fn = nDi - FnXD*nDi
tn = nNDi - FnXND*nNDi
fp = FnXND*nNDi
}
if( cc == "all"){
tp = tp + tc
fn = fn + tc
tn = tn + tc
fp = fp + tc
nnDi = tp + fn
nnNDi = fp + tn
tpr[i] = tp/(nnDi)
tnr[i] = tn/(nnNDi)
}
if( cc == "study"){
## check to see if any cell is not greater than 0.
## due to numerical instability check to see whether
## any are >= nDi or nNDi as well
if( tp <= 0 | fn <= 0 | tn <= 0 | fp <= 0 |
tp >= nDi | fn >= nDi | tn >= nNDi | fp >= nNDi ){
tp = tp + tc
fn = fn + tc
tn = tn + tc
fp = fp + tc
}
nnDi = tp + fn
nnNDi = fp + tn
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tpr[i] = tp/(nnDi)
tnr[i] = tn/(nnNDi)
}
if( cc == "single"){
## check to see if any cell is not greater than 0.
if( tp <= 0 | fn >= nDi ){ tp = tp + tc }
if( fn <= 0 | tp >= nDi ){ fn = fn + tc }
if( tn <= 0 | fp >= nNDi ){ tn = tn + tc }
if( fp <= 0 | tn >= nNDi ){ fp = fp + tc }
nnDi = tp + fn
nnNDi = fp + tn
tpr[i] = tp/(nnDi)
tnr[i] = tn/(nnNDi)
}
if( scale == "raw" ){
S11 = tpr[i]*(1-tpr[i])/nDi
S22 = tnr[i]*(1-tnr[i])/nNDi
SS[[i]] = matrix( c( S11 , 0 , 0 , S22 ) , 2 , 2 )
}
## scale the variance
if( scale == "logit" ){
S11 = 1/( tpr[i]*(1-tpr[i])*nDi )
S22 = 1/( tnr[i]*(1-tnr[i])*nNDi )
SS[[i]] = matrix( c( S11 , 0 , 0 , S22 ) , 2 , 2 )
}
## Additional check for computational issues in SS[[i]]]
SS[[i]][1,1] = axb( ss_lb , S11 , ss_ub)
SS[[i]][2,2] = axb( ss_lb , S22 , ss_ub)
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}## We now have a vector of length k for the estimate of the true
## positive/negative rate for threshold xx[j]
## Compute the variance
sensSE = sqrt( tpr*(1-tpr)/nDi )
specSE = sqrt( tnr*(1-tnr)/nNDi )
## Bivar set up
if( scale =="raw" ){
YY = cbind(tpr,tnr) }
## Appropriately scale sens and spec
if( scale =="logit" ){
YY = logit( cbind(tpr,tnr) )
}
#5. Perform the meta-analysis
metsAj = mvmeta( YY , SS , method = meth, bscov = Sigma ,
control = list( maxiter = max.iter ) )
metaA[[j]] = metsAj
Sens[j] = (summary( metsAj )$coefficients)[1,1]
Spec[j] = (summary( metsAj )$coefficients)[2,1]
#
# Report the 95% upper and lower bounds
#
Sensl[j] = (summary( metsAj )$coefficients)[1,5]
Sensu[j] = (summary( metsAj )$coefficients)[1,6]
Specl[j] = (summary( metsAj )$coefficients)[2,5]
Specu[j] = (summary( metsAj )$coefficients)[2,6]
# tau for raw/logit Sens and Spec
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Sens.tau[j] = sqrt(summary( metsAj )$Psi[1,1])
Spec.tau[j] = sqrt(summary( metsAj )$Psi[2,2])
# Note whether convergence failed
converge_fail[j] = 1 - as.numeric( metsAj$converge )
}
## logit transform results
if( scale == "logit" ){
Sens = ilogit( Sens )
Spec = ilogit( Spec )
Sensl = ilogit( Sensl )
Sensu = ilogit( Sensu )
Specl = ilogit( Specl )
Specu = ilogit( Specu )
}
return(list( thresh = xx , Sens = Sens , Spec = Spec , mets = metaA ,
Sensl = Sensl ,Sensu = Sensu ,Specl = Specl , Specu = Specu ,
Senstau = Sens.tau, Spectau = Spec.tau , conv = converge_fail ) )
}
##
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